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Feline reaginic antibody has been shown to be present in the serum of some cats with allergic skin
disease or parasitic infections. However few studies have attempted to characterise feline IgE and the
production of antisera specific for feline IgE has yet to be reported. The involvement of this isotype in feline
allergic diseases is thus unclear.
The first aim of these studies was to purify and characterise feline IgE to produce specific
polyclonal antisera and investigate anitigen-specific IgE responses in cats. Cats naturally or experimentally
infected with T. cati were immunised with dinitrophenylated ascaris antigen (DNP-Asc). All cats developed
immediate skin reactivity to DNP coupled to bovine serum albumin (DNP-BSA) and the sera of the nine cats
had a heat labile homocytotropic antibody detectable by Prausnitz-Kiistner (PK) tests. Reagin-rich fractions
were prepared from these sera by a variety of techniques and used for the preparation of antisera in rabbits.
Resultant antisera were passed through an immunoabsorbent column of heated normal cat serum. An
immunoabsorbent column prepared with the putative anti-IgE serum removed PK reactivity from the cat
sera, and the reactivity was recovered following acid elution. The antiserum failed to detect any recognised
immunoglobulin in cat sera but precipitated with a heat labile protein with y-1 electrophoretic mobility in
the sera of parasitised cats. These findings support the contention that the antiserum is specific for feline
Ten normal cats were immunised with Dermatophagoides farinae (DF) antigen and intradermal skin
tests (IDSTs) were performed weekly. Sera from the latter were also assessed for DF-specific IgE by ELISA
and PK tests. Detectable DF-specific IgE was induced in all of the 10 cats, however levels were found not to
be correlated with the development ofpositive IDSTs nor with the levels of IgE as assessed by PK tests.
Sera from 10 cats with symptoms consistent with atopy, from 15 normal household cats and from 11
laboratory maintained cats were assessed for allergen-specific IgE and IgG to DF by ELISA. Although DF-
specific IgE was detectable in all the atopic cats, there was no significant difference between the levels in
this group and in the clinically normal household cats. However levels in both these groups were
significantly higher than those in the laboratory maintained cats.
The influence of vaccination and endoparasitism on the IgE response to a food antigen was assessed
in 34 cats. Seventeen kittens experimentally infected with T. cati and 17 parasite-free kittens were dosed
with human serum albumin (HSA) daily for 3 weeks. Seven cats from both groups were given two injections
of a live attenuated viral vaccine. The group of parasitised cats had significantly higher levels of HSA-
specific IgE, IgG and IgA than did the group of parasite-free cats. Vaccinated cats had also higher levels
than non vaccinated cats but only in the group of parasite-free cats. None of the cats developed clinical signs
of food allergy.
The findings from these studies are strongly suggestive of the existence of a heterogeneity of IgE in
cats, and imply that endoparasitism and vaccination have an immunomodulatory role on the antigen specific
antibody response.
IgE.
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CHAPTER I. INTRODUCTION
I. Immunoglobulin E
I.l. Immunoglobulin E (IgE) in man and dogs
1. Early studies on human reaginic antibodies
The presence of reaginic antibodies in the serum of allergic individuals was first
described by Prausnitz and Ktistner in 1921. They showed that an intracutaneous
injection of fish antigen into a sensitive individual gave a wheal and erythema reaction.
Subsequently they showed that the injection of serum from Kiistner, who was allergic to
fish, into Prausnitz's skin followed by the intradermal injection of the fish antigen at the
same site on the next day resulted also in skin reactivity. Therefore they concluded that
the reactivity to the allergen could be transferred to a normal individual by injecting
serum from the sensitive individual. These observations suggested that atopic patients
have an unusual type of antibody that mediates immediate hypersensitivity reactions.
The active principle in the serum capable of mediating immediate
hypersensitivity reactions in response to antigenic challenge was called reagin (Coca and
Grove, 1925).
In 1959, Ishizaka et al. suggested that the bridging of two cell-bound antibody
molecules by antigen to form a biologically active complex on the cell surface may be
responsible for the induction of allergic reactions and that the biologic activities of
antibody molecules are associated with the Fc portion of the molecules (Ishizaka and
Ishizaka, 1959; Ishizaka et al., 1962).
2. Characterisation of human reaginic antibody
By 1960, evidence was accumulating that supported the concept that reaginic
antibodies belonged to the IgA class which at that time was the latest of the
immunoglobulin classes to be isolated and characterised. However, Ishizaka and
Ishizaka (1966) reported that the reaginic activity was associated with a previously
undescribed immunoglobulin class. They showed that reaginic antibody titres,
determined by PK reactions using sera from ragweed-sensitive patients, did not truly
parallel the levels of IgA. They also showed that anti-IgA antibody was not able to
neutralise the PK reactivity in sera from allergic individuals. They then prepared
1
antibodies specific for reaginic antibody and were able to detect allergen-specific
antibody in the sera of allergic patients by radioimmunoelectrophoresis. The adsorbed
antiserum did not give a precipitin band with IgG, IgA, IgM and IgD but the skin-
sensitising activity of the sera of allergic patients was removed by the addition of this
antiserum (Ishizaka and Ishizaka, 1966). Therefore they suggested that the reaginic
activity was associated with a previously undescribed immunoglobulin class designated
yE because of the erythema that the allergen provokes following the injection into the
skin of allergic individuals (Ishizaka et al., 1966a). They also showed that the levels of
allergen-specific antibody closely paralleled the levels of this isotype (Ishizaka et
al.,1966b). Furthermore, antigenic analysis ofyE revealed antigenic determinants which
are not shared by any immunoglobulin of the other classes or subclasses. This
immunoglobulin therefore represented a distinct immunoglobulin class (Ishizaka et al.,
1966b&1967).
Simultaneously, Johansson and Bennich (1967) discovered a myeloma protein
that was not recognised by antisera to any of the known Ig classes. They termed this
protein IgND. Later the myeloma protein and yE were found to share the same antigenic
structure and physicochemical properties (Bennich et al., 1969).
In 1971, the direct demonstration of the cytophilic properties of IgE was achieved
by Ishizaka and collaborators. They showed that it bound to basophils and mast cells and
sensitised these cells for anti-IgE induced release of histamine and serotonin (Ishizaka et
al., 1971). The minimum concentration of human IgE required for sensitising human
skin for a positive PK reaction was estimated to be 0.2 ng/ml (Ishizaka and Ishizaka,
1975). Ishizaka and Ishizaka (1978) using antibodies specific for IgE-receptors on rat
mast cells showed that bridging of IgE-receptors can also activate mast cells for
mediator release.
3. Structure and physicochemical properties of IgE
3.1. Structure of immunoglobulins
The basic subunit of all immunoglobulin molecules consists of 4 polypeptides, 2
identical heavy chains (HC) and 2 identical light chains (LC). Each of these chains
consists of an amino-terminal variable (V) region and a carboxy terminal constant (C)
region. The carboxy terminal constant region domains of each chain are defined by 2
isotypes of Ig LC (k and X) and 5 isotypes of Ig HC (a, 8, s, y and p.). In man, the a and y
classes comprise 2 and 4 subclasses respectively. The heavy chains (HCs) of the
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subclasses share many common antigenic determinants. The variable regions of each Ig
HC and light chain (LC) pair to form the antigen binding site of the molecule whereas
the immunoglobulin HC constant regions are responsible for the effector functions
common to antibodies of a given isotype (Honjo, 1983). Antibodies of different isotypes
differ significantly in their abilities to fix complement, to bind to heavy chain-specific
receptors (Fc receptors) present on a wide variety of cell types, to cross mucosal and
placental barriers, and to form polymers of the basic 4-chain immunoglobulin molecule.
3.2. Structure of IgE
Human IgE has a molecular weight of approximately 190 kilodaltons (KDa) with
a reported range from 184.5 to 196 KDa (Johansson and Bennich, 1967; Bennich and
Johansson, 1971; Kochwa et al, 1972; Ishizaka, 1988). Epsilon heavy chains have an
estimated molecular weight ranging from 69.8 to 72.5 KDa (Bennich and Johansson,
1971; Kochwa et al, 1972; Ishizaka, 1988) and are composed of five domains (Csl-
Cs5), all rich in carbohydrate.
The 2 heavy chains are connected with each other by 2 inter-HC disulphide
bonds. IgE is split into Fc and Fab fragments by papain, and susceptible to pepsin
digestion which yields F(ab')2 fragments. The 2 constant-terminal domains of IgE share
many common amino acid sequences with those of IgG (Helm et al., 1991). However, in
contrast to IgG, IgE is bent and the distance between the N- and C-terminals of the IgE
molecule in solution is no more than 7 nm, compared with the 17.5 nm implied by a
planar structure (Zheng et al., 1991).
The principal binding site for the high affinity receptor of mast cells has been
shown to be located on Cs3 in both the mouse and man (Presta et al., 1994).
3.3. Physicochemical properties of IgE
One of the classical properties of reagins, first demonstrated by Coca and Grove
(1925), is their heat sensitivity. Reaginic antibody is inactivated by heating at 56°C for 4
hours (Loveless, 1940; Ishizaka et al., 1967). The loss of affinity of IgE for tissue by
heating has been ascribed to structural changes in the CH3 and CH4 regions of the
molecule (Bennich and Dorrington, 1972). On the other hand the antigen-binding
capacity which resides in the Fab portion is preserved.
Sensitivity to reduction-alkylation is another property of reaginic antibody.
Ishizaka and Ishizaka (1968a) showed that the ability of IgE antibodies to sensitise
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human skin for PK reactions was lost following reduction in 0.1 M mercaptoethanol and
subsequent alkylation.
Therefore, it appears that the Fc portion of the IgE molecule is essential for
binding to target cells and that the disulphide bonds are essential for the biological
characteristics of the molecule whose sensitisation persists for a long time. IgE does not
have the capacity to activate either complement pathway.
Since IgE is larger than IgG, it is eluted earlier following gel filtration. When an
IgE-rich fraction was filtered through a Sephadex G-200 column, it was detected in the
ascending portion of 7S peak, which is similar in position to that of IgA and IgD
(Ishizaka et al, 1966a; Ishizaka and Ishizaka, 1967).
Using sucrose density gradient ultracentrifugation, Anderson and Vannier (1964)
found that the average sedimentation coefficient of human reaginic antibodies was 7.8S.
IgE has y-1 mobility upon immunoelectrophoresis at pH 8.6 and because of its
lower concentration and its slower diffusion, its precipitin line is closer to the well than
the precipitin line of IgG.
It elutes at a higher molarity from diethylaminoethyl (DEAE) ion-exchange
columns when compared with the bulk of IgG and it was not found in the IgG fraction
that was excluded from DEAE using 0.005M phosphate buffer pH 8.0 (Ishizaka et al,
1966a; Ishizaka and Ishizaka, 1967).
Unlike IgG, IgE is still soluble in 40 % saturated ammonium sulphate (Isersky et
al., 1974). A low proportion (7 to 8 %) of IgE binds to protein A (Johansson and
Inganas, 1978).
IgE antibody does not cross the placenta but can be synthesised by the human
foetus as early as the 11th week of gestation (Miller et al., 1973).
3.4. Physicochemical properties of canine IgE
In the dog, preliminary characterisation of IgE was first undertaken by Patterson
et al. in 1963. These workers observed that the canine reagin shares a number of
characteristics with the human counterpart. It was found to be soluble in 33% saturated
ammonium sulphate, but precipitated by 50%. It migrated with the p globulins upon
electrophoresis, was heat labile, was capable of sensitising normal recipients for
cutaneous and systemic anaphylaxis and was incapable of inducing a passive cutaneous
anaphylaxis (PCA) reaction in guinea pigs.
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In 1967, Rockey and Schwartzman showed that canine reaginic antibody had a
sedimentation coefficient of 8-9S, was mercaptoethanol sensitive and was recovered on
Sephadex G200 before the elution of the bulk of the 7SyG globulin.
The term IgE for the canine reaginic antibody was subsequently introduced by
Schwartzman et al in 1971. They induced anti-DNP reaginic antibody in atopic dogs
with ragweed hypersensitivity by immunisation with dinitrophenylated ragweed antigen.
They showed that the induced and spontaneous reaginic antibodies were
immunochemically very close to each other but different from the other classes of
immunoglobulins.
Halliwell et al. (1972) demonstrated the antigenic similarity between canine IgE
and human IgE. They showed that the PK titre to ragweed was decreased by absorption
of canine reaginic serum with anti-human IgE and that anti-human IgE was able to elicit
reversed cutaneous anaphylaxis in the dog. More recently, Peng et al. (1996) directly
demonstrated the cross-reactivity of dog IgE with human IgE by Western blot analysis
using an anti-human IgE. Moreover, canine reaginic antibody from dogs suffering from
allergic disease is able to sensitise both human and equine basophils (Prelaud et ah,
1993; Sainte-Laudy and Prost, 1996).
It was in 1973 that Halliwell successfully isolated, purified and further
characterised canine IgE from dogs infected with Toxocara canis (I Canis) (Halliwell,
1973a).
Canine IgE antibody was found to have a molecular weight of 196 KDa for the
whole molecule and of 73 KDa for the s chain, which is closely similar to the molecular
mass of human IgE (Peng et al., 1993a).
A proportion of canine IgE binds to protein A as does human IgE but it does not
bind to protein G (Peng et ah, 1991&1997).
4. Metabolism of IgE
IgE has a short half-life in serum of only 2 to 3 days and has the shortest survival,
highest fractional catabolic rate and lowest synthetic rate of the 5 major classes of
immunoglobulin (Waldman, 1969). However IgE can persist in the skin for 2 to 3 weeks
and the average half-life for loss of sensitisation at passively sensitised skin sites was
reported to be 13 days (Cass and Anderson, 1968).
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5. Levels of total serum IgE
5.1. In man
In man, total serum IgE concentrations are highly variable. Usually the level of
total IgE in normal individuals is very low with a range of around 20-200 ng/ml
(Zetterstrom and Johansson, 1981). The level is usually lowest in neonates and rises
gradually in early childhood to reach to adult levels before 7 years of age (Johansson et
al., 1968). Elevated IgE concentrations are found in patients suffering from IgE-
mediated allergic disease or that are heavily parasitised (Johansson et al., 1968;
Patterson et al., 1973; Falk and Bolle, 1980). In patients with allergic conditions, the
range may be 133 to 5850 ng/ml with a mean of 1191 ng/ml, whereas much higher
concentrations of IgE up to 140,000 ng/ml were found in patients with parasitic
infections (Bennich and Johansson, 1971). Nevertheless, although elevated IgE levels
are a common feature of atopic individuals, normal serum levels of IgE can be seen in
some atopic patients, especially those with "pure" atopic dermatitis, lacking allergic
respiratory disease (Jones et al., 1975). IgE levels were also found to be increased in
patients with non-IgE mediated asthma and with nonallergic rhinitis (Henderson et al.,
1971).
Although many studies have shown that total serum IgE concentrations tend to be
higher in allergic people as compared with nonallergic individuals, the diagnostic value
of total serum IgE levels is limited (Klink et al., 1990). The diagnostic sensitivity and
specificity of total IgE determinations is highly dependent on the cut-off level (Wittig,
1980). Klink et al (1990) concluded that there is no single level that clearly distinguishes
different groups with a level of precision that is clinically meaningful.
5.2. In dogs
In normal dogs, the level of total IgE is higher than in man and was found to
range from 2 to 410 pg/ml. However, serum total IgE concentrations were not
significantly different in atopic, parasitised and normal individuals (Vriesendorp et al.,
1975; Nimmo Wilkie et al., 1990; Hill and DeBoer, 1994). The reason is obscure, but it
has been hypothesised to be the result of inhibited T. canis larvae in the muscle tissue of
most dogs which could lead to polyclonal activation of IgE-synthesising plasma cells
(Schwartzman, 1984).
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6. Receptors for IgE
The most important biological property of IgE is its ability to bind to cell
receptors via the Fc region. Mast cells and basophils are not the only cells which have
membrane receptors that bind to the Fc portion of IgE. B and T lymphocytes,
macrophages, eosinophils, platelets, Langerhans' cells, follicular dendritic cells and
natural killer also express receptors for IgE.
Receptors for IgE molecules can be divided into 2 distinct groups. The first type
of receptor is characterised by having a very high affinity for IgE and is called the high-
affinity receptor (FcsRI). In contrast, the second one binds IgE with much lower affinity
and is called the low-affinity receptor (FceRII).
6.1. The high-affinity receptor FceRI
The high affinity receptor for IgE is expressed on the surface of mast cells and
basophils and also on the surface of Langerhans' cells (Grabbe et al., 1993), monocytes
(Maurer et al, 1994), dendritic cells (Osterhoff et al., 1994) and eosinophils (Capron and
Capron, 1994).
FcsRI expressed by mast cells and basophils has a tetrameric structure. It is
composed of an a chain which includes the IgE-binding site, one chain with 4
transmembrane domains and 2 disulphide-linked y chains (Metzger, 1992). This receptor
belongs to the immunoglobulin superfamily. The IgE receptor binding site is located on
Cs3 and the IgE molecule adopts a bent conformation to bind to FcsRI with its convex
surface facing the membrane (Zheng et al., 1991). FcsRI binds monomeric IgE with a
very high affinity (Ka = 1010/M). The binding of IgE with the cell receptor is reversible
and does not involve covalent bonding.
The cross linking of several surface-bound IgE molecules, by antigen or other
molecules such as lectins (eg concanavalin A (con-A) and phytohemagglutin (PHA)),
stimulates degranulation. Surface-bound IgE molecules can also be bridged by anti-IgE
antibody. Antibodies to the IgE receptor can activate cells in the absence of IgE
(Basciano et al., 1986). Receptor bridging (directly or indirectly via bridging of IgE
molecules) is the critical event (Basciano et al., 1986), and results in the formation of
aggregates, patches and caps, with subsequent internalisation of antigen-IgE-IgE
receptor complexes (Furuichi et al., 1986). A very small number of FceRI bridges can be
sufficient to provide an activating signal to basophils and mast cells (Pruzansky and
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Patterson, 1988). Most studies suggest that bridging of 100 or fewer IgE molecules will
completely activate the cell for histamine release. Since mast cells/basophils appear to
have approximately 100,000 receptors per cell (see below), it appears that bridging of
less than 1% of the total IgE molecules on the cell surface activates biological events in
the cell and the release of histamine (DeLisi and Siraganian, 1979a&b; Maeyama et ah,
1986).
Surface expression of FcsRI on mouse mast cells can be influenced by the level
of IgE (Hsu and Mac Glashan, 1996). Also the level of FcsRI expression on the surface
of circulating human basophils (Malveaux et ah, 1978) and on bone marrow basophils
in mice (Lantz et ah, 1997) exhibits a strong positive correlation with the serum
concentration of IgE. Moreover, the administration of IgE in vivo can significantly
upregulate FcsRI expression on mouse basophils, and genetically IgE-deficient mice
have very low expression of basophil FcsRI (Lantz et ah, 1997). Cytokines are other
factors that may regulate FcsRI surface expression. Indeed, 11-4 has been shown to up¬
regulate levels of mRNA for the FcsRIa-chain in human eosinophils (Terada et ah,
1995) and can up-regulate expression of FcsRI on the surface of human mast cells (Torn
et ah, 1996).
FcsRI expressed on antigen-presenting cells such as monocytes and Langerhans'
cells exhibits profound differences, in terms of structure and function, from that
expressed on mast cells and basophils (Bieber, 1994). This receptor is trimeric and
composed of an IgE-binding a chain and 2 disulphide-linked y chains.
6.2. The low-affinity receptor FcsRH
A second receptor for IgE, FcsRII (CD23), is found on other reticulo-endothelial
cells including B and T cells, macrophages, eosinophils, platelets, Langerhans' cells,
follicular dendritic cells and natural killer cells. FcsRII has a lower affinity for IgE (Ka =
10" /M). It is not a member of the immunoglobulin supergene family but is classified as
a type II integral membrane protein. It is composed of a C-type lectin domain in its
extracellular sequence and a cytoplasmic N-terminus. Although CD23 is a C-type lectin,
it does not bind to the carbohydrate component of IgE. The binding site for FcsRII has
been mapped to Cs3 (Nissim et ah, 1993). However, it is distinct from the FcsRI site.
CD23 is spatially associated with the major histocompatibility complex (MHC)
class II molecule human leucocyte antigen (HLA)-DR on the surface of B cells
(Bonnefoy et ah, 1988). CD23 bearing normal murine B cells are very efficient in IgE-
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dependent antigen presentation to T cells and in adhesion of B cells to each other. This
observation implies that B cell CD23 is capable of internalising IgE immune complexes
(Kehry and Yamashita, 1988).
In addition it is a multifunctional lymphokine, being an autocrine growth factor
for the differentiation of activated B cells, and acting as a cofactor for the 11-4 induced
heavy chain switching to IgE expression (Holgate et al., 1993). It has been shown to act
synergistically with a suboptimal concentration of 11-4 to induce IgE production by
normal B cells (Pene et al., 1988). CD23 has also been shown to increase IgE production
by B cells derived from atopic individuals (Sarfati et al., 1984).
Proteolysis of the FcsRII receptor gives rise to soluble fragments which all bind
to IgE and appear to have a role in the regulation of IgE synthesis (Conrad et al., 1991).
Soluble fragments can stimulate the growth and differentiation of the precursors of
plasma cells, T cells and basophils.
7. Functions of IgE
IgE appears to be paradoxical in its role since through the same type of
mechanism, namely immediate hypersensitivity, it has a protective role in parasite
infections (Hagan, 1993; Capron and Capron, 1994) and is primarily responsible for the
pathogenesis of allergic diseases resulting from exposure to innocuous environmental
substances in atopic patients (Platts-Mills, 1993).
7.1. Protective role of IgE
Helminth parasites have a unique role in inducing IgE synthesis, in both an
antigen-specific and also antigen non-specific manner (Ogilvie, 1964; Jarret and Bazin,
1974; Dessaint et al., 1975; Turner et al., 1979; Zakroff et al., 1989).
The production of specific IgE to helminth parasites has been linked to host -
protection (Hagan et al., 1991). However the benefit of this to the host remains unclear.
Capron and Dessaint (1975) proposed that the high level of non-specific IgE resulting
from potentiation by parasitic helminths may serve to favour the survival of the parasite.
However the presence of excess polyvalent IgE could also reduce the risk of anaphylaxis
induced by parasite-specific antigens and so protect the host from the potentially lethal
consequences of hyperreactivity to parasite antigens (Moqbel and Pritchard, 1990). This
host protective role of parasite-specific IgE could be dominant (Pritchard, 1993).
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On the other hand, IgE can also mediate antibody-dependent cell-mediated
cytotoxicity reactions against helminth parasites. It has been demonstrated that IgE
antibodies, in the form of immune complexes with antigen, were both sufficient and
necessary to mediate macrophage and eosinophil-dependent killing of helminths such as
schistosomula (Capron et al., 1977; Capron et al., 1981).
However, recently administration of anti-IgE antisera into parasitised animals
was not able to decrease the capacity of the immune system to kill the parasites (Amiri et
al., 1994).
7,2. Mechanisms of type 1 hypersensitivity
The classic Gell and Coombs classification of hypersensitivity disorders
(Coombs and Gell, 1975) is applicable to discussions of cutaneous hypersensitivity
disorders and remains the immunopathologic scheme used by most authors.
Type 1 hypersensitivity results from an IgE response to an allergen.
Subsequently, IgE binds to the high affinity receptor of mast cells and basophils via its
constant Ce3 region. On re-exposure to the same allergen, the specific cross linking of 2
molecules of IgE on sensitised mast cells or basophils by the allergen leads to
degranulation with the release of inflammatory mediators resulting in allergic disease
(Halliwell and Gorman, 1989).
When mast cell bound IgE is aggregated by antigen or anti-IgE, high affinity
receptors are rapidly immobilised, possibly by interaction with the cytoskeleton (Mao et
al., 1991). The early signal resulting in exocytosis that follows the aggregation of FcsRI
is the activation of tyrosine kinase (Eiseman and Bolen, 1992). A second event which
follows the aggregation of FceRI is the activation of G-proteins (Sagi-Eisenberg, 1993).
Both tyrosine kinase and G-protein activator can lead to the activation of phospholipase-
C (Sagi-Eisenberg, 1993; Jouvin et al., 1994). The activation of phospholipase-C in turn
2+
leads to the release of Ca from intracellular stores and to the activation of protein
kinase C (Dekker and Parker, 1994). Exocytosis is the last stage in the secretory pathway
and involves fusion of the granule membranes with those of the plasma membrane.
Calcium plays an important role in exocytosis in mast cells which may be facilitated by
the calcium binding protein calmodulin. Indeed, calmodulin may play a role in the
regulation of intracellular enzyme and cytoskeletal proteins (Chok and Shmaudershok,
1992). G-proteins are involved in the redistribution of actin filaments (Norman et al.,
1994).
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Activation ofmast cells leads to the release of a variety of preformed (histamine,
heparin, serotonin) and newly synthesised (prostaglandins, leukotrienes) inflammatory
mediators. The synthesised mediators include the important arachidonic acid-derived
mediators. Arachidonic acid is activated by membrane derived phospholipase and is then
acted upon by either the cycloxygenase or the lipoxygenase pathway. The former leads
to the generation of prostaglandins and the latter to the leukotrienes. In addition,
multiple multifunctional lymphokines and cytokines are also released as a result of IgE-
mediated mast cell activation. Those released include II-1, 11-3, 11-4, 11-6 and tumour
necrosis factor a (Burd et al., 1989; Plaut et al., 1989).
The type I reaction was initially considered to be a short-lived acute event, not
necessarily leading to prolonged inflammation. However this concept has undergone
revision based upon the recognition that the LPR, which can occur in a variety of target
organs including skin, lung, nose and eyes, can contribute substantially to the clinical
symptomatology. The LPR is also believed to be IgE dependent (Dolovitch et al., 1973).
7.3. IgE on antigen presenting cells
The existence of the high affinity receptors on Langerhans' cells supports a role
for this cell in the pathogenesis of atopic dermatitis (AD) involving IgE-mediated
antigen presentation to autologous T cells. Many observations suggest that IgE-bearing
Langerhans' cells may initiate atopic dermatitis lesions and possibly contribute to the
amplification of the IgE response towards environmental allergens in man and dogs
(Reitamo et al., 1986; Adinoff et al., 1988; Mudde et al., 1990; Olivry et al., 1996). A
recent study has demonstrated that the effectiveness of allergen presentation by
monocyte-enriched peripheral blood mononuclear cells (PBMCS) was amplified by the
presence of allergen-specific IgE bound to these cells (Maurer et al., 1995).
8. Heterogeneity of IgE
There is differential glycosylation of IgE molecules and it has been shown that
IgE from ND myeloma contains much more carbohydrate than that from another
myeloma (PS). This could be responsible for the heterogeneity of the IgE molecule in its
ability to interact with histamine releasing factors (HRF) (MacDonald et al., 1987).
MacDonald et al. (1991) have designated the IgE which binds to HRF and which is only
present in some atopic patients, as 'IgE+' (MacDonald, 1987).
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Lyczack et al. (1996) demonstrated the existence of 4 human IgE isoforms which
include the classic secreted form and three novel isoforms with altered carboxyl
terminals. These isoforms are predicted to be secreted proteins. They may have some
unique properties as circulating, cytophilic immunoglobulins and may differ in their
ability to carry out IgE-mediated functions through binding to their different receptors.
One of those isoforms is secreted as half-molecules (heavy-light chain).
The possible heterogeneity of canine IgE has been proposed recently by Peng et
al. (1997) who showed that canine IgE appeared to be composed of two subpopulations,
differing in physicochemical characteristics.
9. Production of IgE
9.1. Sites of production of IgE
9.1.1. Man
The distribution of IgE producing cells in man was studied using fluorescent
antibody techniques (Tada and Ishizaka, 1970). IgE producing plasma cells were found
to be numerous in lymphoid tissues such as tonsils, adenoid, bronchial and peritoneal
lymph nodes but to be low in the spleen and subcutaneous lymph nodes. IgE plasma
cells were also detected in the respiratory and gastrointestinal mucosa suggesting that
IgE antibodies may be formed locally in those organs in response to antigenic stimuli. It
was suggested that the distribution of IgE plasma cells could differ depending upon the
method of immunisation and/or the animal species employed. In certain situations they
may be found predominantly in the spleen and lymph nodes (Ishizaka and Ishizaka,
1975).
Ishizaka and Ishizaka (1975) suggested that the preferential distribution of IgE
plasma cells in the respiratory and gastrointestinal tracts in the primate might be due to
frequent exposure of the lymphoid tissues to small amounts of environmental antigens
which may be favourable for IgE synthesis.
Since mast cells are able to express CD40-L (see induction of IgE synthesis) and
can also produce 11-4, these cells could increase the production of allergen-specific IgE




In the dog, IgE-producing cells have been reported to be prominent in few
tissues, namely, the mucosa of the small intestine and the mediastinal and mesenteric
lymph nodes (Halliwell, 1975a). However in an experimental situation Gebhard et al.
(1995) reported the production of IgE-producing canine X murine heterohybrids using
popliteal lymph node cells from dogs subsequent to the injection of the filarial nematode
Brugia pahangi into the left rear paw.
9.2. Cells involved in the production of IgE
T helper cells which are usually characterised by expression of CD4 (CD4+), can
be subdivided into Thl, Th2 and ThO populations based on their profile of cytokine
production (Romagnani, 1994).
- One subclass, Thl, which produces the cytokines interferon-y (IFN-y), tumor
necrosis factor-p (TNF-p) and 11-2 among others (but not 11-4 and 11-5), is important for
cell-mediated immunity, delayed hypersensitivity reactions and in the generation of
protective immune responses against intracellular pathogens. INF-y induces switching to
IgG2a in mouse B cells (Collins and Dunnick, 1992). It has been shown recently that
IFN-y is predominant in chronic skin lesions of patients with atopic dermatitis (AD) and
therefore Thl cells may also play a role in the maintenance of the late and chronic phase
ofAD (Thepen et al., 1996; Werfel et al., 1996).
- The second subtype, Th2, produces 11-4, 11-5, 11-6, 11-10 and 11-13 which
promote most of the humoral immune responses, including IgE, and is responsible for
inducing most of the immunoglobulin class switching (Mosmann and Coffman, 1989)
and for the initiation of the cutaneous inflammation in patients with AD.
- ThO cells represent a heterogeneous population of partially differentiated
effector cells comprising multiple discrete subsets that can secrete both Thl and Th2-
type cytokines (Romagnani, 1994).
Strong evidence suggests that Thl and Th2 cells do not derive from distinct
lineages, but rather develop from the same Th-cell precursor dependent upon a number
of influences such as the route of antigen entry, the physical form of antigen, the type of
adjuvant and the dose of antigen. The precursors are also influenced by genetic factors
acting at the level of antigen presentation. The early presence of 11-4 is the most potent
stimulus for Th2 differentiation, whereas 11-12 and IFN-y favour Thl development
(Seder and Paul, 1994).
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The mechanisms responsible for the early production as well as the source of 11-4
remain unclear. Naive Th cells are able to produce small amounts of 11-4 from their
initial activation and are the principal source of 11-4 production after priming. However
other 11-4 sources (CD4+NK11+ cells) can also contribute to the development of Th2
responses (Seder and Paul, 1994; Constant and Bottomly, 1997). Moreover a recent
study (Machado et al., 1996) demonstrated an IgE-independent release of mediators of
the allergic response by mast cells and basophils challenged with allergens, including
house dust mite (HDM), bee venom and parasite secretions. Therefore these authors
suggested that these cells might be the initial source of 11-4 production (Machado et al.,
1996). The inducing effect of 11-4 is dominant to those of the other cytokines. Recently it
has been shown that 11-6 derived from antigen-presenting cells is also able to stimulate
naive Th cells to become effector Th-2 cells by inducing the initial production of 11-4 in
CD4+ T cells (Rincon et al., 1997).
9.3. Regulation of the production of IgE
IgE antibody production is normally highly regulated, which results in minimal
concentrations of IgE in body fluids.
9.3.1. Role of the antigen in the production of IgE
Allergens are proteins or protein-bound substances which bind reagins and
promote reaginic antibody responses. Any definition of an allergen must cover its two
distinctive functions. The allergenicity of an allergen is its ability to elicit a local or a
systemic reaction in an already allergic individual whereas the immunogenicity of an
allergen is its property to stimulate the production of reaginic antibodies (Strejan et al.,
1973).
Certain individuals are genetically more prone to make IgE responses than others
and are therefore more likely to develop atopic disease (see atopy in man and in the
dog). On the other hand, the route of entry, dosage, frequency of exposure and molecular
characteristics of an antigen are also important in determining whether the antigen will
be clinically important as an allergen in the population at large.
The fundamental property of immunogenicity is dependent upon the structure of
the antigen (Scla, 1969; Chestnut and Grey, 1985).
The use of adjuvant can also influence the production of IgE. Aluminium
hydroxide (alum) and Bordetella pertussis (B. pertussis) are known to enhance IgE
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synthesis (Jarret and Stewart, 1972) while complete Freund's adjuvant (CFA) is reported
to suppress IgE but enhance IgG production (Hirashima et al., 1981).
9.3.2. Induction and regulation of IgE synthesis
9.3.2.1. Induction
Immunological reactions are not only dependent on the recognition of antigen but
also on the activation of the appropriate effector system.
9.3.2.1.1. First step
The first step in the allergic reaction, the activation of Th-2 cells, involves a
sensitisation phase, commencing with the initial exposure to the antigen bound to MHC
class II molecules (Norman, 1993). Allergen-specific Th-2 cells are then activated.
9.3.2.1.2. Second step
Two signals are then required for the induction of human IgE synthesis by B cells
(Vercelli et al., 1989).
- The first signal delivered to B cells is derived from activated Th2 cells and consists of
the cytokine 11-4 (Parronchi et al., 1991).
- The second signal can be supplied by a number of stimuli. Often, it involves a physical
interaction between the B cell and another cell. It can be provided by Th-2 cells by
linking their surface MHC class II molecules with CD4 antigen on the B-lymphocyte
surface. The linkage of the CD40 antigen, a molecule found on the B cell itself, with its
ligand (CD40-L) can also provide the second signal (Parronchi et al., 1991).
These two signals activate germline s transcription and promote further B cell
differentiation, class switching and the eventual secretion of allergen-specific IgE from
plasma cells.
9.3.2.1.3. Isotype switching and Ig synthesis
Expression of IgE is controlled both by heavy chain switching and by selection
of IgE-committed cells for survival and differentiation.
The variable region of Ig is encoded by multiple germ-line elements which are
assembled into complete V(D)J variable regions during B cell differentiation. The heavy
chain class switching is the expression by a B lymphocyte of different heavy chain
isotypes sharing the same VDJ region. This phenomen allows a single B cell clone to
produce antibodies that retain variable region specificity in association with a different
CH region gene, and with a different effector function (Vercelli and Geha, 1992). This is
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thought to result from the recombination event that juxtaposes a downstream CH gene to
the expressed V(D)J gene.
9.3.2.2. Regulation
It is clear that 11-4 is particularly important in regulating B cell growth. Its ability
to regulate immunoglobulin isotype expression in murine B cells by the induction of
germ-line transcription of the Ce gene, has been clearly shown, making it a substrate for
the recombinase (Rothman et al., 1988). It is able to promote the isotype switch of B
cells to IgE production and can act directly on B cells. However B cells require an
additional activation signal. This signal induces a switch recombinase able to cause
switching to any active CH gene.
It is noteworthy that 11-4 as well as other soluble factors, are not only released by
T cells but also by mast cells and basophils upon cross linkage of the IgE (Burd et al.,
1989; Plaut et al., 1989, Bradding et al., 1992; Brunner et al., 1993) and also by an
antibody independent mechanism (Machado et al., 1996) (see cells involved in the
production of IgE).
More recently, Gauchat et al. (1993) showed that mast cells and basophils can
also express CD40-L. Thus through the production of 11-4, mast cells and basophils are
able to induce an IgE synthesis by B cells (Gauchat et al., 1993). This suggests that these
cells may play a key role in allergy not only by producing inflammatory mediators but
also by directly regulating IgE production independently from T cells (Gauchat et al.,
1993). However, in a recent study, mast cells were not found to be a source of 11-4 in the
chronic lesional skin of patients with AD (Thepen et al., 1996).
Stimulation of human B cells with 11-4 and Epstein-Barr virus and with anti-
CD40 and 11-4 have been shown to induce T cell-independent IgE synthesis
(Thyphronitis et al., 1989). The second signal can therefore be provided by infection
with EBV (Thyphronitis et al., 1989), monoclonal antibodies directed against CD40
(Rousset et al., 1991), and activated CD4+ cells (Gascan et al., 1991a &b). However the
nature of the second signal required for IgE induction is unclear in the EBV system
(Geha, 1992).
11-13 has been found to induce isotype switching to IgE and IgG4 in humans. II-
13 acts much like 11-4 and it has been suggested that these two cytokines may share
some components on their receptors, because they compete for the same high-affinity
receptors (Callard et al., 1996).
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The finding that IgE can be a major regulator of mouse mast cell and basophil
FcsRI expression in vivo identifies a potentially important mechanism for enhancing the
expression of effector cell function in IgE-dependent allergic reactions or immunologic
responses to parasites (Lantz et al, 1997).
The low affinity IgE receptor (FcsRII or CD23) also has a role in the regulation
of IgE. The soluble fragments resulting from the proteolysis of this receptor can either
promote or inhibit IgE synthesis (Sarfati et al., 1992).
Hydrocortisone has been reported to provide the second signal and increase IgE
levels in vivo, in combination with human 11-4. However, its role in the induction of IgE
synthesis is still not clear. The sequential IgE isotype switching in human B cells
induced by hydrocortisone leads to increased polyclonal IgE production but no increase
in allergen-specific IgE (Bohle et al., 1995; Niisslein et al., 1994).
9.3.2.3. Regulation of IgE synthesis by cytokines other than 11-4 and 11-13
A number of cytokines are able to modulate Il-4-dependent IgE synthesis. 11-5
and 11-6 are able to upregulate the IgE response induced by 11-4. IL-3, IL-9 and TNF-a
are also able to enhance the IgE response. IFN-y, INF-a, transforming growth factor
(TGF)-p, IL-8, 11-10 and 11-12 inhibit Il-4-dependent IgE synthesis (deVries, 1994; Pene
et al., 1988). The mechanism of the modulation of IgE synthesis by these cytokines is
still poorly understood (deVries, 1994).
Thus, in summary, extracellular signals and nuclear events shift the balance
between Thl and Th2 cell development in response to a specific allergen, and exert a
profound influence on IgE synthesis and hence the development of atopic disease.
9.3.2.4. The "allergic breakthrough" concept
The concept of "allergic breakthrough" first introduced by Katz (1978)
hypothesises that IgE antibody production is maintained at a low level following
sensitisation because of the existence of normal suppressive or dampening mechanisms
that exist specifically to limit the quantity of IgE antibodies produced during any
particular response. It was postulated that the bypassing of this dampening mechanism
by any one of a number of perturbations such as parasite or viral infestations, can result
in "allergic breakthrough" if, at that point in time when the threshold of the damping
mechanism is lowered, the individual becomes sensitised to one or more allergenic
substances. Possible perturbation may include respiratory viral infections, endoparasites
and hormonal fluctuations. In consequence, sensitisation could occur quite
17
coincidentally at the time when the damping mechanism has been lowered to a level
insufficient to control the IgE antibody synthesis. The sensitisation might be either at the
first allergen exposure or upon reexposure.
1.2. Reagiiiie antibody in other species
1. Characteristics of reaginic antibody in other species
Binaghi and Benacerraf (1964) first described the production of reaginic
antibodies in rats by immunisation with antigen plus B. pertussis vaccine. Later, IgE was
characterised in many other species including the guinea pig (Ovary et al., 1976),
monkey (Ishizaka and Ishizaka, 1968b), dog (Halliwell, 1973), mouse (Lehrer, 1976),
rabbit (Zvaifler and Becker, 1966), rat (Isersky et al, 1974), cow (Neilsen and Wilkie,
1979; Gershwin, 1981), horse (Suter and Fey, 1981), pig (Roe et al 1993 ) and sheep
(Yilmaz et al., 1993).
The concentration of reaginic antibody in the serum is always low, a fact that
clearly distinguishes it from the other immunoglobulins. However, the discovery of IgE
myelomas in the rat (Bazin et al., 1974) and the mouse (Bottsher and Hammerling, 1978)
have facilitated the ready purification of IgE, whereas in other species, the lack of IgE
myelomas and the low level of serum IgE make the purification of IgE more difficult.
Therefore in these species, IgE has been purified by fractionation of sera from allergic,
parasitised and/or immunised animals. To date, IgE e chains have been purified and
characterised only in the dog (Peng et al., 1993a) and the sheep (Yilmaz et al., 1993).
Reaginic antibodies in animals share many physicochemical and
immunochemical properties to their human counterpart. They are characterised by a
relatively fast electrophoretic mobility, a sedimentation coefficient of approximately 8 S
and a molecular weight of between 183 and 187 KDa in the rat (Bazin et al., 1974;
Bennich et al., 1978), 184 and 200 KDa in the mouse (Bottscher and Hammerling, 1978;
Liu et al., 1980) and of 200 KDa in horse (Suter and Fey, 1983). The molecular weight
of the b chain was found to be 68 KDa in the rat (Bazin et al., 1974) and 75 KDa in the
mouse (Bose et al., 1984). Using PK or PCA tests, it has been shown that reaginic
antibody was eluted following chromatography on Sephadex G200 in a position similar
to that ofman (Roe et al., 1993; Yilmaz et al., 1993).
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Rabbit reaginic antibody has been shown to be heat stable (Lindqvist, 1968).
Skin sensitising activity was still detected in serum after being heated at 56°C for 32 hr
(Lindqvist, 1968).
While human, canine and feline IgE were demonstrated to bind to protein A,
neither bovine (Gershwin and Dygert, 1983), mouse (Ey et ah, 1978) nor rat IgE
(Medgyesi et al., 1978) show affinity for this protein.
The half life of serum IgE in the rat has been estimated to be 12 hr (Tada, 1975).
2. Cross-reactivity between IgE of different species
It has been shown by reversed cutaneous anaphylaxis (RCA) as well as by other
methods (ELISA, RIA, gel diffusion, western blot and histamine release by mast cells
and basophils) that human IgE cross reacts with monkey (Ishizaka and Ishizaka, 1968b),
rat (Conrad et al., 1983; Kanyeresi et al., 1971; Perelmuter and Khera, 1970), bovine
(Gershwin, 1981; Nielsen, 1977), ovine (Yilmaz et al., 1994), equine (Suter and Fey,
1983) and canine IgE (Halliwell et al., 1972). Feline reaginic antibody has also been
shown to cross react with canine IgE (DeBoer et al., 1993).
A recent study has demonstrated that polyclonal anti-mouse IgE and anti-human
IgE were able to induce RCA in dogs while monoclonal anti-human, anti-rat and anti-
mouse IgG were not (Peng et al., 1996). Therefore, the IgE structure appears to be
relatively well conserved between species. However, of all the five isotypes of
immunoglobulin, the sequence of the IgE C region is the least well conserved across
species (Patel et al., 1995).
3. Reaginic antibody in cats
Several studies have already shown that cat serum contains a protein with IgE-
like properties (Walton et al., 1968; Powell et al., 1980; DeBoer et al., 1993; Baldwin,
1993; Foster, 1995; Foster et al., 1995). Walton et al. (1968) demonstrated the existence
of reaginic antibody with whole cow's milk in a cat with dermatitis and enteritis by PK
testing. In another study, reaginic antibodies to the ear mite Otodectes cynotis were
demonstrated and are believed to be responsible for the extreme pruritus that is
associated with some cases ofparasitic otitis externa (Powell et al., 1980).
More recently, DeBoer et al. (1993) showed that cats have a reaginic antibody
that is antigenically cross-reactive with canine IgE and has an apparent molecular weight
similar to that of IgE in other species (DeBoer et al., 1993; Alaba, 1997).
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Foster et al. (1995) demonstrated that the passive cutaneous anaphylaxis (PCA)
reactivity was eluted following chromatography using Sephadex G200 in a position
similar to that of other species, and that feline reaginic antibodies are bound by Protein
A.
Since the isolation and purification of IgE antibody by conventional methods is
very difficult, Foster (1995) attempted to isolate and determine feline Cs gene sequences
by the use ofmolecular biology techniques with the aim of preparing an IgE peptide and
raising a specific antiserum. The CH3 domain was found to have sequences that were
very similar to those of the other species. The whole of the CH3 sequence was cloned
and sequenced, however the antisera raised against the resulting peptide recognised
epitopes only in the peptide and not in the native molecule. Therefore the expressed
protein appears to differ antigenically from the synthetic peptide (Foster, 1995).




The term atopy, derived from a Greek word which means "out of place" or
"strangeness", was first introduced by Coca and Cooke in 1923 to describe three familial
diseases of man that appeared to have many features in common, namely atopic
dermatitis, allergic asthma and hay fever. Although the pathogenesis of atopy was
unknown, the conditions were thought to be inherited, in a dominant mode.
In 1933, atopic dermatitis (AD), considered one manifestation of atopic
hypersensitivity, was defined by Wise and Sulzberger. These authors cited the cardinal
features of atopy, which included an atopic family history, antecedent infantile eczema,
localisation in the flexural areas, grey-brown discoloration of the skin, absence of
vesicles, vasomotor instability, many immediate positive reactions to scratch or
intradermal tests, and the presence of reagins in the serum.
In 1935, Hill and Sulzberger further emphasised the importance of food and
airborne sensitivities in the development ofAD.
Since then, human AD has traditionally been defined as an inflammatory skin
disorder characterised by severe pruritus, a chronically relapsing course and a distinctive
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clinical morphology and distribution. This inflammatory skin disorder is frequently
associated with elevated serum IgE levels and a personal or family history of AD,
allergic rhinitis and/or asthma (Leung et al., 1987; Champion and Parish, 1992; Bos et
ah, 1994).
1.1.2. Dogs
In the dog, the first case of canine atopy was reported in 1941 by Wittich. This
condition is now recognised as one of the more common causes of pruritic skin disease
in this species (Halliwell and Schwartzman, 1971).
Atopy is defined in dog as an inherited predisposition to develop reaginic
antibodies to environmental allergens resulting in allergic disease (Halliwell and
Gorman, 1989). The skin is believed to be the major target organ.
Canine atopy, canine atopic disease, canine atopic dermatitis, and canine allergic
inhalant dermatitis have all been proposed as names for this disease in the dog (Halliwell
and Gorman, 1989). This may reflect the uncertainty regarding the exact pathogenesis of
this disease in the canine species.
1.2. Asthma
1.2.1. Man
Asthma (Greek for "panting") is a complex disease of the lower airways.
Bronchial asthma is characterised by a history of episodic wheezing, by evidence of
airflow obstruction that is reversible, either spontaneously or following bronchodilator
therapy, and by pathological evidence of inflammatory changes in the bronchial mucosa
(Arm and Lee, 1992). The inflammation of the airways is a characteristic feature of
asthma and the obstruction of the airway lumen by smooth muscle constriction and
mucus plugging may be the consequence of the inflammatory cascade (Arm and Lee,
1992). These pathophysiologic findings are believed to be caused by the interaction of
genetic susceptibility and adverse environmental factors (Hoover and Platts-Mills,
1995).
Allergic and non-allergic asthma have both been described in man. Allergic
asthma is characterised by a type 1 hypersensitivity reaction to inhaled allergen followed
by a late-phase reaction, with inflammation and persistent bronchial
hyperresponsiveness (Busse and Reed, 1993). It occurs most frequently in young
individuals. A family history and elevated serum IgE are common features of the
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disease. Although the cause of asthma in many patients can be attributed to allergen
sensitisation, there are a number of individuals with asthma who have no evidence of
hypersensitivity to common inhaled allergens. These "non allergic" patients have as
much evidence of inflammation in the lungs, but the cause remains an enigma in many
of the cases (Hoover and Platts-Mills, 1995).
1.2.2. Dogs
Bronchoconstriction has been induced in dogs infected with T. canis following
nebulisation with ascaris antigen (Booth et al., 1970). Nebulisation of atopic dogs with
pollen allergens to which they are sensitised, also induced bronchoconstriction
(Patterson and Sparks, 1962). However, spontaneous allergic asthma appears to be
exceedingly rare in the dog (Halliwell and Gorman, 1989), with only one convincing
case reported in the literature (Chamberlain and Baker, 1974). This may be a reflection
of the relative paucity of mast cells in the pulmonary tracts in the dog (Halliwell and
Gorman, 1989).
2. Epidemiology
In the dog, reports of the incidence of atopy vary from 3.31 to 85% of the cases
referred to dermatologic clinics (Halliwell and Schwartzman, 1971; Austin, 1976).
According to Griffin (1993a) atopic disease occurs in some 10% to 15% of the canine
population. These considerable differences probably reflect not only geographic
differences but also practice bias and lack of defined criteria. The disease appears to
begin between 6 months and 3 years of age in 75% of atopic dogs and onset after 7 years
of age is very rare unless the dog has moved to a new environment (Griffin, 1993a).
Although studies are conflicting, most report a slight female sex predisposition
(Halliwell and Gorman, 1989; Griffin, 1993a).
3. Etiology and pathogenesis of atopy
3.1. Studies of the immunoglobulins involved
3.1.1. Total immunoglobulin levels
3.1.1.1. Man
Serum levels of total IgG, IgA and IgM are generally in the normal range in
humans with AD, although elevation of IgM and IgG, and even decreased IgG have been
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recorded (Buckley et al., 1968; Ohman and Johansson, 1974). However, IgA deficiency
appears to occur more frequently in atopic than in normal individuals (Kaufmann and
Hobbs, 1970). Elevated total IgG4 has been reported in patients with atopic dermatitis
(Gondo et al., 1987; Shehade et ah, 1988) and a link between IgE and IgG4 production
has been suggested (Shehade et al., 1988). However the biological and pathological
significance of this elevated subclass remains unclear.
Total serum IgE is elevated in over 80% of patients with AD (Gurevitch et al.,
1973; Stone et al., 1973; Adkinson and Platts-Mills, 1988). However normal serum
levels of IgE are seen in some patients with AD who do not have coexistent allergic
respiratory disease (Ohman and Johansson, 1974; Jones et al., 1975). Serum IgE levels
often correlate with the extent and severity of the disease (Stone et al., 1973), although
IgE concentrations may remain elevated through a prolonged lag period during
remission (Gunnar et al., 1970). IgE can also be elevated in other skin disorders (Stone
et al., 1973; O'Loughlin et al., 1977). Moreover, AD has been described in four children
suffering from agammaglobulinemia (Peterson et al., 1962). These observations raised
the question ofwhether IgE is simply an incidental feature ofAD, secondary to defective
control mechanisms governing many other characteristics of the atopic diathesis.
However, there is no doubt that IgE has a role in atopy in some allergic patients.
A consistent finding is that mononuclear leukocytes spontaneously produce increased
quantities of IgE in vitro (Saxon et al., 1980; Sampson and Buckley, 1981).
3.1.1.2. Dogs
Hill et al. (1995) measured the total concentration of IgE, IgA and IgG in the
serum of normal, atopic and parasitised dogs and found no significant difference in total
IgE level between all 3 groups. However, in both atopic and parasitised dogs, the level
of IgA was shown to be lower whereas the level of IgG was higher than in the control
group. On the other hand, Hall and Campbell (1993) and Mueller (1993) failed to
demonstrate significant differences in the concentration of total serum IgA in atopic and
normal dogs. However, the level of allergen-specific IgA at the epidermal surface of the
skin appeared to be increased in atopic dogs in a similar manner to that of IgE (Mueller,
1993). The fact that total serum IgE levels do not appear to be a good predictor of atopy
in dogs was also confirmed by Esch and Grier (1997).
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3.1.2. Allergen-specific immunoglobulins involved
3.1.2.1. Man
3.1.2.1.1. Allergen-specific IgE
The level of allergen-specific IgE in the serum of atopic patients is variable and
dependant on the age, the degree and duration of the most recent allergen exposure, the
degree and duration of exposure to cross-reactive allergens, and whether or not
immunotherapy has been employed (Gleich et al., 1982; Somville et al., 1989).
While specific IgE may be difficult to detect in infants because of the very low
IgE concentration present, the levels are typically highest in school-age children and
young adults. In contrast sera from children with atopic dermatitis usually have very
high total IgE concentrations which may produce non-specific binding and lead to false
positive serological results (Sampson and Albergo, 1984). Therefore the
radioallergosorbent test (RAST) for allergen-specific IgE is reported to be unreliable in
atopic dermatitis (Sampson and Albergo, 1984).
The level of allergen-specific IgE has been shown to be influenced by the pollen
exposure and to peak approximately 4 weeks after a seasonal pollen exposure before
gradually falling (Somville et al., 1989).
3.1.2.1.2. Allergen-specific IgG
Specific IgG antibodies to some allergens were shown to be higher in atopic than
in non-atopic individuals (Chapman and Platts-Mills, 1978). However at higher exposure
levels of the antigen, the concentration of allergen-specific IgG is not different between
allergic and non-allergic patients (Aalberse et al., 1993).
Levels of allergen-specific IgG4 were also found to be higher in atopic patients
than in normal controls (Shakib et al., 1977; Merrett et al., 1984). This is not surprising
since both IgG4 and IgE synthesis were shown to be IL-4 dependent and to require the
presence of Th2 cells (Ishizaka et al., 1990; Spiegelberg, 1991a&b). Nevertheless most
healthy non-allergic individuals produce specific IgG4 antibodies when exposed to
relatively high doses of allergens (Chapman and Platts-Mills, 1978; Platts-Mills et al.,
1978). Therefore measurable titres of allergen-specific IgG were reported not to be
useful in the establishment of a diagnosis of human atopy (Aalberse et al., 1983; van der
Zee and Aalberse, 1991).
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However, statistically, patients with food allergy or with atopic eczema were
found to have higher levels of allergen-specific IgG4 than non-allergic controls
(Aalberse et ah, 1993).
High levels of IgG4 antibodies are frequently reported in patients undergoing
immunotherapy. However without immunotherapy, IgG antibodies are not restricted to
the IgG4 sub-isotype. Rather, in many cases, IgGl antibodies are predominant,
particularly in the early response to chronic exposure to allergen (Aalberse et al., 1993).
3.1.2.2. Dogs
3.1.2.2.1. Allergen-specific IgE
Although allergen-specific IgE antibodies are usually associated with atopic
disease in dogs (Halliwell and Gorman, 1989; Halliwell, 1990), normal dogs can also
exhibit allergen-specific IgE responses (Lian and Halliwell, 1998). Also one report
claimed that the levels of allergen-specific IgE were not elevated in atopic dogs (Codner
and Lessard, 1993). This will be discussed in detail in the diagnosis section (see allergy
testing).
3.1.2.2.2. Allergen-specific IgG
Willemse et al. (1985a) looked at the incidence of allergen-specific IgGd
antibodies in the serum of atopic dogs and found an 89% incidence in dogs with positive
intradermal skin tests (IDSTs) (55/60) whereas of the dogs with negative IDSTs 11/20
(55%) had detectable IgGd antibody. They suggested that the IgGd subclass may play a
role in the pathophysiology of atopy in the dog. Also Prelaud and Sainte-Laudy (1989)
found high levels of allergen-specific IgG in the serum of atopic dogs.
Day et al. (1996) compared the level of allergen-specific IgG of four different
subclasses in normal and atopic dogs. Whereas the concentration of Dermatophagoides
farinae (DF) and Dermatophagoides pteronyssinus (DP)-specific IgG4 were shown to be
higher than other subclasses in the serum of atopic dogs, lower levels of DP-specific
IgGl, IgG2 and IgG3 were detected. The IgG subclass response differed from one
allergen to another and the authors claimed that the results suggest a degree of IgG
subclass restriction in the humoral immune response in canine atopy which may be




There is clear evidence that both the atopic condition in general, and also specific
allergic disorders are under genetic control (Zamel et ah, 1996). However,
environmental factors are also highly relevant (Tada, 1975).
While there are certainly major genes which control atopy in general, there are
also likely to be disease-specific genes which determine whether an atopic individual
develops asthma, rhinitis or conjunctivitis. Therefore, if, as is likely, more than one gene
predisposes to the syndrome of atopy, then significant numbers of individuals will carry
two or more of these genes (Cookson, 1994).
Segregation analysis of atopic individuals as measured by serum IgE levels
supports a recessive mode of inheritance, although further studies are required to
ascertain whether this is the case when disease symptoms are used as the relevant
phenotype (Meyers et ah, 1994). Because many of the components that are required for
an allergic response are found on several cells, atopy could theoretically result from an
abnormal regulation of this process at several control points. Indeed, some of the
products of the first "generation" of genes implicated in predisposition to atopy have
clearly defined roles (Casolaro et ah, 1996). The important role in the pathophysiology
of atopy played by the MHC class II molecules, proinflammatory cytokines, high-
affinity receptor for IgE, T cell receptors, adhesion molecules, chemokines and their
receptors, and histamine releasing factors, makes the genes encoding for those molecules
prime candidates for atopy genes, and as such they are receiving close attention in
studies on the genetics of atopy (Casolaro et ah, 1996). The HLA class II genes (locus
for antigen-specific IgE synthesis) (Marsh et al, 1982; Casolaro et ah, 1996), the
chromosome llql3 (locus for atopy) (Sandford et ah, 1993; Cookson, 1994) and the
chromosome 5q (locus for total serum IgE concentration) (Meyers et ah, 1994; Marsh et
ah, 1994&1995) have all been shown to be involved in atopic diseases.
3.2.2. Dogs
Strong breed predilection and evidence of familial involvement in some dogs
suggest a genetic basis for the disease, but the mechanism of inheritance is still unknown
(Reedy and Miller, 1989). A study done by Vriesendorp et ah (1975) on the relationship
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between dog leukocyte-antigens (DLA) and atopy produced inconclusive results.
However the DLA haplotype 9,4 was thought to offer protection against the disease.
In a first limited breeding study, Schwartzman et al. (1971) showed that all of the
offspring from two atopic parents developed evidence of atopic disease by the age of 2.
More recently de Week, Zunic and collaborators. (1995&1997&1998) have
established colonies of high IgE and low IgE responder beagle dogs. The results suggest
that the high allergen-specific IgE response observed in some dogs following
experimental immunisation is inherited as a single dominant trait. On this base de Week
revived the hypothesis that atopy is based on an autosomal dominant gene with reduced
penetrance. He claimed that the reduced penetrance could be explained by the need to be
exposed to sensitising allergens early in life and by the fact that sensitisation by
inhalation, which this worker proposes as the most likely route, is subjected to some
additional environmental control. However full details of these studies have yet to be
published.
Breed predispositions are evident and, depending on the geographic location,
certain striking breed tendencies clearly emerge (Halliwell and Schwartzman, 1971;
Scott , 1981; Schick and Fadok, 1986; Carlotti and Costargent, 1994; Saridomichelakis
and Koutinas, 1996).
3.3. Route of allergen penetration
In dogs, the route of access of aeroallergens remains uncertain. It was always
assumed to be via the respiratory tract, but it is unclear how allergens are transported
from the respiratory tract to the skin via the circulation in order to cross-link IgE on mast
cells (Halliwell and Gorman, 1989).
Although there is evidence in favour of the respiratory route (Butler et ah, 1983),
there are also other lines of evidence that argue against this route (Willemse et ah, 1984;
Helton-Rhodes et al., 1987). On the other hand, the localisation of the lesions in atopic
dogs is similar to that of the lesions seen in allergic contact dermatitis and suggests that
the percutaneous penetration of aeroallergens plays a significant role in the dog as in
man (Halliwell and Gorman, 1989).
The existence of IgE positive epidermal Langerhans' cells in dogs with AD is an
important finding which has added more evidence in favour of an epidermal route of
allergen penetration (Olivry et al., 1996). The number of epidermal and dermal dendritic
cells is higher in atopic dogs and there is an apparent correlation between the level of
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expression of IgE by dendritic cells and the level of total IgE in the serum of these dogs
(Olivry et ah, 1996). In addition, the skin of dogs with AD was shown to be infiltrated
by CD4+ and CD8+ T cells (Olivry et ah, 1997a; Sinke et ah, 1997). Eosinophils and
proteins derived from these cells were also found in the epidermis of the lesional skin of
atopic dogs (Frank and McEntee, 1995; Olivry et ah, 1997a).
3.4. Immunopathogenesis
3.4.1. Role of IgE in antigen capture and production of inflammation
It has become clear over the years that there are many other factors involved in
the pathogenesis of atopy than merely IgE. However the precise role of each of the many
abnormalities that have been identified in atopic patients in the proposed pathogenesis of
the disease remains controversial. Multiple allergic and nonallergic factors are involved,
which produce variable clinical signs, confusing test results, and unpredictable responses
to therapy.
The central importance of the type I hypersensitivity reaction has already been
discussed in the previous section.
A number of the cutaneous factors related to the pathogenesis such as the
participation of T cells directly or indirectly, and the role of IgE and Langerhans' cells in
antigen presentation have also been discussed in previous sections.
Additional abnormalities have been identified in atopic patients although their
exact role in the pathogenesis of the disease remains unclear. Amongst these are the
possible existence of a heterogeneity of IgE and the existence ofmutants of the FcsRI on
mast cells (Shirakawa et al., 1994).
3.4.2. Mast cells
3.4.2.1. Introduction
Although mast cells are clearly critical in the pathogenesis of disorders of IgE-
dependent immediate hypersensitivity, these cells are not simply troublemakers devoid
of any redeeming biologic value. It is clear that they also participate in the late-phase
reactions associated with allergy not only by the liberation of newly formed mediators
but also by the release of cytokines, such as 11-4 and TNF-a (Schwartz and Huff, 1993).
Mast cell differentiation and proliferation is predominantly regulated by 2
separate mechanisms. The first is dependent on a fibroblast-derived growth factor,
termed stem cell factor (Costa et ah, 1996), and the second is dependent on T-cell-
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derived cytokines such as 11-3 (Mitsui et al., 1993), 11-4 (Schmitt et al., 1987) and 11-10
(Thompson-Snipes, 1991).
Multiple transcription factors, such as AP-1 and the nuclear factor of activated T
cells, are induced in the cytoplasm in activated cells in response to extracellular signals.
They shuttled to the nucleus where they exert positive or negative control over gene
expression. The transcription factors have an important role in the induction of cytokines
in mast cells (Nechushtan and Razin, 1998).
Protein kinases C have been implicated in the regulation ofmast cell growth and
in the expression of AP-1 component in response to FcsRI aggregation (Razin et al.,
1994).
3.4.2.2. Dogs
The number of mast cells, the histamine content of mast cells and the total
histamine content of lesional skin in atopic dogs, are all increased as compared to normal
skin (Nimmo Wilkie et al., 1990; DeMora et al., 1996). The correlation between mast
cell numbers and cutaneous histamine concentration in atopic dogs was found to be very
good (r = 0.84) (Nimmo Wilkie et ah, 1990). However, in the dog as in man, some data
suggest that mast cells play a minor role in AD (see section 3.4.4., Olivry et al., 1997a).
3.4.2.2.1. Mediator releasability
DeMora et al. (1996) have studied the releasability of histamine from canine skin
mast cells following stimulation by two different secretagogues in normal and atopic
dogs. Calcium ionophore, that activates mast cells by a mechanism independent from
antigen-antibody binding, elicited a similar response from mast cell populations in both
atopic and normal dogs while concanavalin A (con-A), which mimics antigen induced
release, was able to induce a significant increase of histamine secretion from mast cells
from atopic dogs than from nonatopic dogs. However the processes involved and the
importance of these differences in the pathogenesis of canine atopy are not known.
3.4.3. Role of cell mediated immunity in canine atopy
3.4.3.1. Nature of the cutaneous inflammatory infiltrate
Olivry et al. (1997a) have shown similar patterns of inflammation in the lesions
of canine and human AD. The epidermal infiltrate of lesional atopic canine skin was
shown to be characterised by Langerhans' cells, T-cells expressing the ap- or y8 -T cell
receptors, occasional intact or degranulated eosinophils, and rare neutrophils. The dermis
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was infiltrated by mast cells, dermal dendritic cells, memory helper T cells, and small
numbers of neutrophils and eosinophils.
Similar differences between the neutrophil infiltrate found in spontaneous
lesional atopic skin and in induced cutaneous LPR reported in man were seen in dogs
(Olivry et al., 1997a). Indeed in the spontaneous lesional atopic skin, neutrophils were
found to constitute only a small percentage of the total inflammatory cells (Olivry et al.,
1997a), whereas they were the predominant cell type in the dermis of induced cutaneous
LPR (Becker et al., 1988; Thomsen et al., 1993).
3.4.3.2. Studies on cell-mediated immune function
Cell-mediated immune function in atopic dogs has been studied and some
abnormalities identified (Nimmo Wilkie, 1990, Nimmo Wilkie et al., 1991&1992).
These workers demonstrated that the ability of histamine to induce suppression in
peripheral blood mononuclear cells was significantly decreased in atopic dogs as
compared to normal dogs. However the total number of histamine type 1 or type 2
receptors was not different for cells from normal or atopic dogs. On the other hand, they
did not investigate the total numbers of cells that bear these receptors which might still
be decreased in atopic dogs. A reduction of con-A-induced suppression by atopic canine
peripheral blood mononuclear cells was obtained only at supraoptimal doses of con-A
while it was not significantly different from the control group at suboptimal and optimal
doses.
Nimmo Wilkie and collaborators studied immunologic parameters in normal
dogs, dogs with atopic disease and dogs with induced type 1 hypersensitivity to ascaris
antigen (Nimmo Wilkie, 1990). Atopic dogs were shown to have alterations of
histamine-modulated function, increased cutaneous response to intradermally injected
mitogens and decreased con-A induced suppression. The alterations of histamine-
modulated function detected in atopic dogs were also found in dogs with induced type 1
hypersensitivity and anaphylaxis following intravenous administration of ascaris
antigen. However the increased response to intradermally injected mitogens and the
decrease in con-A-induced suppression reported in atopic dogs were not shown in dogs
with experimentally-induced anaphylaxis (Nimmo Wilkie, 1990). Therefore the authors
concluded that some of the altered cell-mediated immune functions ohserved in dogs
with AD result from type 1 hypersensitivity (Nimmo Wilkie et al., 1990). Dogs with
atopic dermatitis were also shown to have a significantly reduced response to the contact
allergen dinitrochlorobenzene but paradoxically to have significantly increased response
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to intradermally injected mitogen PHA and con-A and no change in lymphocyte
blastogenesis (Nimmo Wilkie et al., 1991).
3.4.4. Basophils
Basophils share similarities with mast cells . Some of the mediators are common
to both cells, as are most of the preformed granule-associated mediators. However
neutral proteases are only found in very small concentrations (Schwartz and Huff, 1993).
Basophils also release the newly-generated mediators derived from arachidonic acid with
the exception ofPGD2.
Like mast cells, they can induce IgE-dependent but also IgE-independent release
of 11-4 (Machado et al., 1996) and could therefore be the initial source of Il-4-production
(see Immunoglobulin E). Basophils can also generate and secrete high levels of 11-13.
Human basophils, like human mast cells , can also produce TNF-a (Schwartz and Huff,
1993).
3.4.5. Histamine releasing factors
Basophils are responsive to an unique set of cytokines that have been termed
histamine releasing factors (HRFs) (MacDonald, 1996). HRFs are produced by a variety
of cells including T and B cells, mononuclear cells, alveolar macrophages and platelets.
HRFs can induce histamine release from basophils either by an IgE cell surface-
dependent or an IgE-independent mechanism (MacDonald et al., 1993). They only affect
basophils sensitised with IgE from atopic individuals, termed IgE+ (MacDonald, 1987).
HRFs have been detected in human respiratory secretions, late skin blister fluids
in atopic patients and bronchoalveolar lavage fluids (MacDonald et al., 1993). Patients
with atopic dermatitis and food hypersensitivity were found to have higher rates of
spontaneous histamine release from basophils and which was believed to result from
HRF production (Sampson et al., 1989).
The gene encoding an IgE-dependent HRF produced by lymphocytes from atopic
children and produced in biological fluids of allergic patients has recently been cloned
and prepared in recombinant form by MacDonald and collaborators (1995). Polyclonal
antibodies recognised and removed the biological activity of both the recombinant and
native HRF (MacDonald et al., 1995).
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3.4.6. Keratinocytes
Keratinocytes not only function as mechanical barriers but play also important
roles in mediating cutaneous immune responses and inflammation by their production of
a wide variety of cytokines and by direct cell-cell contact via adhesion receptors
(Takashima and Bergtresser, 1996). Keratinocytes, Langerhans' cells and dendritic
epidermal T cells (y8 T cells) can communicate with each other by their production of
cytokines. Keratinocytes and Langerhans' cells can promote the development, modulate
the phenotype, and regulate the immune function of dendritic epidermal T cells.
Conversely, dendritic epidermal T cells regulate the function of both keratinocytes and
Langerhans' cells (Takashima and Bergtresser, 1996).
Interestingly, Malaviya et al. (1996) demonstrated in a very recent study that
keratinocytes from normal people were able to produce histamine and were likely to be
the chief cell type responsible for the histamine found in the epidermis, although
Langerhans' cells and melanocytes may also contribute. Moreover, when keratinocytes
were stimulated by ultraviolet B light, the quantity of histamine release was comparable
to that released by mast cells . It was also shown that the release of significant amounts
of histamine into the extracellular environment after irradiation was not specifically
associated with cell injury or cell death (Malaviya et ah, 1996). The results suggest that
such release of keratinocyte-derived histamine may play an important role in mediating
the inflammatory response of the skin. Ultraviolet light injury may therefore contribute
to the inflammation in some atopic individuals.
3.4.7. Eosinophils
The recruitment of eosinophils from the blood into the tissues involve their
adhesion to endothelial cells through adhesion molecules and their migration to the site
which is controlled by three main cytokines: 11-3, 11-5 and granulocyte/macrophage-
colony stimulating factor (GM-CSF) (Desreumaux and Capron, 1996). 11-4 alone or in
combination with IFN-y has been recently shown to induce the production of an
eosinophil chemotactic protein (eotaxin) by dermal fibroblasts (Mochizuki et al., 1998).
3.4.7.1. Mediators produced and their effects
Following activation resulting from the presence of IgE or IgA and/or cytokines
that interact with specific receptors on their membrane, eosinophils release their granules
which contain four distinct cationic proteins.
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These proteins have major protective effects in host defences against helminth
parasites but also contribute to tissue damage and to acute and chronic manifestations of
inflammation in allergic diseases. Membrane receptor expression, oxidative metabolism
and the release of granule proteins are all controlled by 11-3,11-5, GM-CSF (Desreumaux
and Capron, 1996) and HRFs (MacDonald, 1996). Membrane expression of VCAM-1 on
endothelial cells, which is predominantly involved in the migration of eosinophils in the
respiratory mucosa, is upregulated by 11-4 and 11-13 (Bochner et ah, 1995).
3.4.7.2. Cytokines produced and their effects
Eosinophils can contribute to the pathogenesis of allergic disorders not only by
releasing tissue damaging basic protein but also by producing specific lipid mediators
and various cytokines. Lipid mediators include leukotriene C4, platelet activating factor
and lipoxin factor. Cytokines produced by eosinophils can have autocrine growth factor
activities such as 11-3, 11-5 and GM-CSF. They also have a potential role in the
inflammatory response and the development of fibrosis in the case of 11-8, TNF-a and
TGF-a. They may be involved in the regulation of the immune system, in the case of II-
4, 11-2 and IFN-y (Desreumaux and Capron, 1996). Eosinophils may also promote IgE
synthesis and potentially be a source of early 11-4 (Nonaka et ah, 1995). However, little
is known about the precise role of eosinophil-derived cytokines in human allergic
diseases and it is still not clear if mediators located in the granules are activated upon
release, or are inactivated and degraded (Desreumaux and Capron, 1996). Very recently
eosinophils were shown to synthetise biologically active 11-12 (Crewe et ah, 1998).
Heinz they may be involved in the activation of ThO and Thl type cells seen in the late




It has long been appreciated that exposure of an allergic individual to an antigen
produces an immediate response, often followed by a LPR. In man this late reaction
occurs within 6 to 24 hours of allergen challenge, peaks after 4 to 12 hours, and is
characterised clinically by oedema and erythema of the skin and by increased resistance
to air flow in the nose and lung (Atkins et ah, 1988).
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However, in contrast, the spontaneous human AD lesions are not characterised by
an immediate reaction and differ from the LPR by the lack of persistent neutrophilic
infiltration, activation and degranulation (Ott et ah, 1994).
3.4.8.1.2. Cells involved in the LPR
Histopathological examination of LPRs reveal a mixed cellular infiltrate of
predominantly mononuclear cells but also of eosinophils, basophils, and neutrophils.
The size of the LPR appears to be correlated with the number of activated eosinophils.
Activated T cells are also present and there is a strong correlation between the number of
CD4+ T cells and the number of activated eosinophils (Frew and Kay, 1988).
3.4.8.1.3. Mediators and cytokines involved in the late-phase reaction
Leukotrienes and cyclooxygenase products, such as PGD2, are more likely to be
active during the LPR than the early-phase reaction (Bousquet and Michel, 1993).
Cytokines, such as IFN-y, II-1, 11-3, 11-4, 11-5 and GM-CSF are likely to have a
role in the generation of LPR (Frew and Kay, 1988; Kay et ah, 1991). HRFs which
activate all basophils and eosinophils from allergic donors and which are found in the
LPR fluids, are believed to play a major role in perpetuating the LPR and the chronic
inflammation, in allergic asthma (MacDonald, 1996).
3.4.8.1.4. Mechanisms of the late-phase reaction
The exact mechanisms of the erythematous inflammation seen in LPR are not
completely understood. Mast cells appear to be the trigger cell of the reaction as the LPR
rarely appears without an immediate reaction. Antigen cross-linking of mast cell bound
IgE is ultimately responsible for the involvement of eosinophils, neutrophils, basophils
and lymphocytes. Lymphocytes may play a key role in the generation of the late-phase
inflammation by their production of cytokines (Frew et ah, 1991). Neutrophils represent
the first cell type seen in the inflammatory infiltrate following the immediate reaction.
The eosinophil appears to be critical to the development of the LPR by the production of
cytokines and eosinophil cationic proteins (particularly the major basic protein) which
may play a role in enhancing basophil and mast cell activation (Charlesworth et ah,
1989). Basophils may be the source of late-phase histamine release and thus be




The existence of the LPR in dogs was first demonstrated by Becker et al. (1988).
The LPR in the dog is similar to the LPR in humans (Becker et al., 1988; Thomsen et al.,
1993). Following intradermal injection of antigen and/or histamine in experimentally
sensitised dogs, neutrophils and eosinophils were the first cells seen in the dermis. They
were followed by mononuclear cells. LTB4 was found to be increased prior the
infiltration by neutrophils. However, the influx of basophils was not significant (Becker
et al., 1988). Nevertheless, as in human AD, neutrophils were reported to be rare in
spontaneous lesional skin (Olivry et al., 1997a).
However, the decrease of clinical symptoms shown in some atopic dogs treated
with misoprostol, a PGEj analogue, is in favour of a clinical relevance of allergen
induced LPR (Olivry et al., 1997b).
3.4.9. Disregulation of the fatty acid metabolism
Therapeutic fatty acid supplementation and absorption studies in atopic and
normal dogs have recently been undertaken. In one study, levels of plasma essential fatty
acid (EFA) were measured in normal humans and normal dogs. They were then
compared to the levels in subjects with allergic skin disease. The study concluded that
normal humans and dogs have slightly lower concentrations of plasma linoleic acid (LA)
and slightly higher concentrations of dihomo-gamma-linoleic acid (DGLA) and
arachidonic acid (AA) than do subjects with allergic skin disease. A slight increase in
DGLA and a marked increase in AA after evening primrose oil supplementation was
seen in dogs but not in humans. These results point to a possible enzyme defect in
humans with atopic dermatitis but argue against such a defect in dogs (Horrobbin et al.,
1990).
In another study, no significant difference was found in serum n-6 fatty acids
between normal, atopic, and seborrhoeic dogs (White, 1990). In a further report there
was no difference in resting triglyceride levels between atopic dogs and normal dogs;
however triglyceride levels were significantly lower in atopic dogs than in normal dogs
after feeding corn oil (van den Broek and Simpson, 1990).
All these studies tend to imply that atopic dogs have either impaired fat
absorption or altered triglyceride metabolism.
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3.4.10. Importance of food sensitivity in atopic disease
The importance of food sensitivity in atopic disease will be discussed in the
section on food hypersensitivity.
4. Immunoglobulin G in atopic disease
In most species, antibodies of one or more IgG subclasses are cytotropic and can
bind to mast cells or basophils. These IgG antibodies are heat stable and were called
"short term sensitising IgG" according to their sensitisation time which is maximal after
2 hours and persists only for a few hours (Parish, 1970).
The evidence of the involvement of IgG4 in some anaphylactic reactions and
allergic diseases was first proposed by Parish in 1974. Since then, several authors have
demonstrated that anti-IgG4 antibodies are able to cause histamine release from human
basophils (Vijay and Perelmuter, 1977; Fagan et al., 1982).
However, allergen-specific IgG has also been shown to block the binding of
allergen to cell-bound IgE (Lichtenstein et ah, 1968), and IgG4 has been shown to
significantly increase in patients undergoing hyposensitisation (Devey et ah, 1976).
Therefore, the role of IgG4 in atopic disease appears to be paradoxical and a protective
role as well as a potentially harmful role have been attributed to it (van der Zee and
Aalberse, 1987).
The heterogeneity of IgG4 antibodies was suggested as an explanation for this
paradox by Stanworth (1987). The author postulated that the majority of IgG4 myeloma
proteins which he found were unable to bind to human mast cells, represent protective
antibodies and the 25% that do seem to bind were effector types.
5. Diagnosis
5.1. Introduction
Atopy should be diagnosed on the basis of the history and the clinical findings.
Allergy tests should only be used to confirm the diagnosis and to identify the specific
allergens involved to enable hyposensitisation therapy. Both, in vitro and in vivo tests




5.2.1. In vivo testing
5.2.1.1. Man
5.2.1.1.1. General introduction
Skin tests have represented the primary diagnostic tool in human allergy since
their introduction. The intracutaneous test developed by Mentoux in 1908 was applied to
immediate hypersensitivity by Schloss (1912). Some years later Lewis and Grant (1924)
described the prick test. These methods have been used for decades without major
modifications, but in the recent years they have been refined, and a number of
standardised devices have been developed for prick testing (Pepys, 1975).
5.2.1.1.2. Interpretation of in vivo tests
In vivo allergy testing is generally not used in people with atopic dermatitis
because it is not helpful. Whereas negative tests are very reliable, most of the positive
results are false-positives, lacking clinical correlation (Sampson and Albergo, 1984).
However, skin tests can provide useful confirmatory evidence for a diagnosis of allergic
asthma that has been made on clinical grounds.
The occurrence of a positive skin test does not necessarily imply that the patient
is clinically allergic to that allergen. Many have shown that ST can be positive in
nonallergic individuals (Bousquet and Michel, 1993). These positive results are usually
attributed to the presence of impurities, contaminants or non-specific mast cell
secretagogues in the allergen extract. However studies have shown that such reactions
were not all irritant reactions since, in some patients, positive PK tests were obtained
using their serum (Roane et al, 1968). It has also been proposed that the presence of
positive skin tests in non allergic subjects may predict the onset of allergic symptoms
since these reactions seems principally to occur in subjects who are first-degree relatives
of atopic patients (Hagy and Settipane, 1976).
5.2.1.2. Dogs
5.2.1.2.1. General introduction
In dogs IDSTs are used rather than prick tests. In the UK the use of the IDST in
the dog was first described by Baker (1971). The test is reported to be a useful diagnostic
aid if performed properly with good allergenic extracts and if interpreted with caution
(Halliwell and Gorman, 1989).
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IDSTs can detect allergen- specific anaphylactic antibodies bound to mast cells,
which belong predominantly, if not exclusively, to the IgE isotype. The degranulation of
mast cells and the release of inflammatory mediators produce an erythematous wheal.
The factors influencing the skin sensitivity to an antigen include the amount of allergen
injected, the degree of sensitisation and releasability to the mediators, as well as the
reactivity of the skin to the mediators released from the mast cells. A positive control
such as histamine should be included (Halliwell and Gorman, 1989). The negative
control is the diluent of the allergenic extract. The skin test is read after 15 to 20
minutes. The reactions are graded either by using an arbitrary scale rating +1 to +4
where +4 approximates the histamine wheal size and a +1 is a wheal that is just
discemibly greater than the size of the negative control. The result should also take into
account the degree of erythema and the elevation above the surface. Alternatively, one
can measure the diameter of the wheals and a positive test is defined as >50% of the sum
of the diameter of the positive and the negative controls (Halliwell and Gorman, 1989).
Although it seems easy to perform such tests, adequate interpretation requires trained
individuals who are aware of all factors that might modify the results.
The simplicity, rapidity of performance, low cost and high sensitivity explain the
popularity of the IDST in atopy.
5.2.1.2.2. Causes of false-positive and false-negative results
There are a number of factors which can lead to either false-positive or false-
negative results. Discussion of this is beyond the scope of this chapter.
5.2.1.2.3. Interpretation of in vivo tests
It is important to emphasise that a positive IDST is merely an indicator that the
patient has skin-sensitising antibody, mast cells that degranulate on antigen exposure,
and target tissue that responds to the released mediators. It does not necessarily mean
that the patient has clinical allergy to the allergen(s) injected and results have to be
interpreted in the light of the patient's history and exposure to allergen (Halliwell and
Gorman, 1989; Scott et ah, 1995a). On the other hand, the IDST does not appear to be
100% sensitive and a negative test does not always mean that the dog is not sensitised to
this allergen (DeBoer, 1997).
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5.2.2. In vitro testing
5.2.2.1. Man
5.2.2.1.1. General introduction
An immediate consequence of the discovery of IgE antibody in man was the
development of assays to measure total and allergen-specific IgE. A radioimmunoassay
(RIA) was first developed in 1967 and adapted to demonstrate the antibody activity of
IgE to particular allergens (Wide et ah, 1967). This sandwich RIA was called the
radioallergosorbent test (RAST) (Wide et ah, 1967). More recent methods for the
detection of IgE antibody include the enzyme-linked immunosorbent assay (ELISA)
(Donohue et ah, 1989) and AlaSTAT or liquid phase assay (El Shami and Alaba, 1989).
5.2.2.1.2. Current methods
The principle of the ELISA and RAST is identical and both detect the same
antibody. Both tests use allergens bound to a solid phase and the only difference is that
RAST uses radiolabelled antibody whereas ELISA uses an antibody coupled to a
suitable enzyme.
The liquid phase assay measures IgE antibody activity to allergens in the liquid
phase. One of the advantages is that non-specific IgE binding to a solid phase can be
virtually eliminated. Another advantage claimed by proponents over the solid-phase
assays is that no potentially dominant epitope is masked in the coupling procedure,
because the different coupling agents can react with different parts of the molecule.
Also, the test is usually performed with undiluted serum. However, several studies in
which AlaSTAT and RAST were evaluated in man showed that both correlated well
with each other and had good sensitivity and specificity (McSharry et al., 1993).
5.2.2.2. Dogs
RAST was first described in the dog by Halliwell and Kunkle in 1978. More
recently the development of ELISA has been reported (Kleinbeck et al., 1989). Those are
the two most commonly used in vitro tests that detect relative levels of allergen-specific
IgE in serum (Halliwell, 1994).
The principle of the test is the same as it is in man. Results are compared to a
standard curve established by the laboratory. The standard is usually a serum or a pool of
sera which are known to contain a high level of allergen-specific IgE. Results are
expressed in OD or reported in relative antibody units (RAU) by comparison to the
standard.
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In vitro tests have now become available through commercial laboratories in both
the USA and Europe and have been the subject of several studies, with variable results
(Sousa and Norton, 1990; Miller et ah, 1992; Bond et al., 1994; Plant, 1994; Bunde et
al., 1997).
The replacement of anti-canine IgE by the use of the human FcsRIa receptor to
detect allergen-specific IgE by ELISA has been introduced recently (McCall et al.,
1997). A study performed on a group of artificially sensitised flea allergic dogs showed
an excellent correlation between the skin tests results to flea saliva and the biotinylated
FcsRIa based assay. Another study has been recently performed on normal dogs, atopic
dogs and dogs with naturally occurring dermatitis (McCall et al., 1997). Results were
found to be encouraging with a sensitivity of the assay of 83.3% as compared to the
IDST.
VARL Liquid Gold allergen-specific IgE test (liquid-phase) was reported to have
a good concordance with western blots in two blinded studies which used the latter as a
standard (Griffin, 1993a).
In vitro tests have the great advantage that they are not influenced by
antihistamines and probably not by low doses of corticosteroids, although this has yet to
be proved. However levels of birch pollen-specific IgE were shown to be decreased in
asthmatic individuals following treatment with intranasal glucorticoids (Pulleritis et al.,
1997). Levels of allergen-specific IgE were also reported to double in some dogs after
discontinuation of corticosteroids and therefore some authors recommended that they are
withdrawn before in vitro testing (Griffin, 1989). A recent study using the FceRIa-based
test Allercept® showed that although many dogs may be tested successfully while
undergoing treatment with corticosteroids, other may be immunosuppressed sufficiently
to affect IgE serum levels (McCall, 1998). In vitro tests can, of course, also be used on
dogs with inflamed, lichenified skin, which may be inappropriate for the IDST
(Halliwell and Gorman, 1989).
5.2.3. Correlation between in vivo and in vitro testing
5.2.3.1. Man
Comparisons between the titration of specific IgE by IDST and by immunoassay
in man depend upon the quality and standardisation of allergens used in both tests. The
worst correlations are obtained with HD, mold, and unstandardised dander extracts,
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whereas the correlation ranges between 70 and 80% with extracts such as pollens, mites,
or standardised dander extracts (Bousquet et ah, 1988).
There is a generally good correlation between a strongly positive IDST and a
positive in vitro test, and also between a negative IDST and a negative in vitro test in
atopic individuals (Bousquet et ah, 1988). In > 80% of cases where discordant results
were obtained positive IDSTs were found in the absence of detectable allergen-specific
IgE. The discrepancies observed in some studies could be due to the heterogeneity of the
atopic population since the level of total IgE was shown to influence the relationship
between skin test and RAST (Eriksson, 1989).
5.2.3.2. Dogs
Many studies have compared results of in vitro and in vivo tests in the dog and
have shown varying correlations which are dependent upon the allergen employed. In
general the correlation appears to be best in the case of pollens, and worst for HD
(Halliwell and Kunkle, 1978; Willemse et ah, 1985b; Kleinbeck et ah, 1989; Codner and
Lessard, 1993; Miller et ah, 1993a; Bond et ah, 1994; Plant, 1994; Bunde et ah, 1997;
Lian and Halliwell, 1998). Interestingly, in one study, discordant results usually
consisted of a negative skin test associated with positive or strongly positive ELISA
(Kleinbeck et al;, 1989). In another study, ELISA was found to be of limited value due
to low specificity and a high incidence of false positives (Codner and Lessard, 1993). It
has been suggested that positive results seen in clinically normal dogs with negative
IDSTs may result from the high level of total IgE present in dog serum (Griffin et al.,
1990).
The results of hyposensitisation based upon skin tests and in vitro tests have been
compared and results appear to be broadly similar (Willemse et al., 1984; Sousa and
Norton, 1990; Griffin and Rosenkrantz, 1991; Miller et ah, 1993a). However Griffin and
Rosenkrantz (1991) showed that only 22% of dogs treated with hyposensitisation based
on the results ofELISA in animals with negative skin tests showed improvement.
Nevertheless, it is important to ask whether in vitro tests should correlate with
skin testing. Since skin tests have always been considered as the "gold standard", when
the in vitro test and skin testing do not correlate it has always been assumed that in vitro
tests must be wrong (Halliwell, 1994). The IDST can also be prone to error. The
percentage of concordance between skin testing and in vitro tests can be considerably
decreased when dogs with weak IDST reactions and questionable clinical histories are
included (Esch and Grier, 1997). The possible heterogeneity of IgE antibody may also be
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an explanation for the poor correlation often observed between in vivo and in vitro tests.
Therefore so called false-positive reactions in in vitro tests may be due in some cases to
the fact that non-pathogenic IgE is being detected (Jackson et ah, 1996; Lian and
Halliwell, 1998).
5.3. Conclusion
In conclusion, there is clearly a place for both tests in the diagnosis of atopic
disease and the practice of both tests on the same animal can help the dermatologist to
learn more about allergic disease.
It must be emphasised once more that a positive allergy test is an indication that
the animal has allergen-specific IgE but is not of itself a diagnosis, and that the use of
these tests must be regarded as an adjunct in confirming the diagnosis when supported
by appropriate clinical signs and after elimination of other possible diagnoses.
If it is clear that there is room for technological improvement of diagnostic tests
it is also clear that there is more to allergy than the mere presence of allergen-specific
IgE (DeBoer, 1996).
III. Adverse reaction to foods in man
1. Introduction
Adverse food reaction is a generic term that includes any reaction following the
ingestion of a food or a food additive. It can be secondary to a food allergic reaction or
food intolerance. An examination of the host immune response at the level of the
intestinal mucosa is prerequisite since the intestinal mucosa is the site where food
antigens first interact with cells of the immune system.
Under the ideal situation, ingestion of food in normal individual results in the
development of immunologic tolerance to food antigens. However, in addition, food
antigen-specific antibodies are formed, which play a role in blocking penetration of food
antigens across the gastrointestinal barrier and in rapidly clearing minute quantities of
food antigens that gain systemic access. Failure to develop oral tolerance in genetically
predisposed individuals may result in food hypersensitivity that may be responsible for a
variety of clinical illnesses. IgE-mediated disorders account for the majority of well-
characterised food allergic reactions and have been studied most extensively. However
other mechanisms are believed to be involved in some food allergic disorders.
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2. Control of antigen absorption
Food antigens, obtained in part from heterologous animal species and from
vegetable sources, are capable of eliciting immune responses. Therefore the individual
must digest and absorb these substances without developing an adverse immune
response whilst at the same time being able to recognise and respond to infectious
organisms gaining access via the same route.
2.1. Nonspecific-regulation of antigen uptake
Digestive enzymes, gastric acidity, mucous glycoproteins, and peristalsis are
important factors that both protect the host from infectious agents and direct the
degradation of foods.
Glycoproteins in the mucous covering of the gastrointestinal surface provide an
important nonspecific defence mechanism against parasitic, bacterial and viral
attachment to the epithelium. However the mucous glycoprotein responses are not
entirely non-specific and a relationship between immunological reactions and
glycoprotein synthesis and release has been suggested (Lake et al., 1980; Miller et al,
1979).
The epithelial layer of the gastrointestinal tract is the final barrier to antigen
passage. Its permeability is discussed in a following section.
Immaturity of these mechanisms in infants reduces the efficiency of the infant
mucosal barrier (Hyman et al., 1985). Basal acid output, proteolytic activity in the small
intestine, mucin composition and microvillus mucous membranes have all been shown
to be immature and less functional in the young animal (Shub et ah, 1983).
2.2. Specific regulation of antigen uptake
The humoral immune system of the gastrointestinal tract is capable of specific
responses to intact infectious organisms and to solubilised antigens. The "gut-associated
lymphoid tissue" (GALT) is composed of four distinct lymphoid compartments. These
are the Peyer's patches, lymphocytes and plasma cells scattered throughout the lamina
propria, intraepithelial lymphocytes, and mesenteric lymph nodes. Macrophages and
dendritic cells located in Peyer's patches transport macromolecules from the lumen to
resident precuisor B and T cells.
IgA-producing cells predominate in the intestinal mucosa. IgM B cell precursors
are the next most common (6-18%), followed by IgG-producing cells (3-4%) and,
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finally, by IgE and IgD isotypes (<1%) (Cornell et al., 1971; Owen and Jones, 1974;
Baklien and Brandtzaeg, 1975).
The function of IgA is to trap undesirable molecules such as dietary and
microbial antigens and infectious agents and block their access to the absorbing surface
of the gastrointestinal tract by preventing binding to the surface cells (Walker et al.,
1975).
The newborn lacks IgA in exocrine secretions (Seiner et al., 1968). The relatively
low concentration of IgA in the intestine in young infants together with the enormous
quantity of ingested proteins, contributes to the large amount of food antigen confronting
the immature GALT. These antigens may stimulate excessive production of IgE
antibodies in genetically predisposed infants (Taylor et al., 1973; Soothill et al., 1976).
2.3. Antigen uptake, gastrointestinal tract permeability, development of oral
tolerance and normal systemic immune response to food antigen
Oral tolerance is the phenomena whereby prior exposure to an antigen by the
enteric route induces a specific immunological unresponsiveness on subsequent systemic
exposure to the same antigen (Sanderson and Walker, 1993).
The integrity of the intestinal barrier is important in preventing inappropriate and
uncontrolled antigen transport. However, under normal conditions, a small fraction of
the potential antigenic load bypasses this barrier and will be absorbed. This fraction is
crucial for antigen-specific immune response (Walker, 1988). There are 2 different
modes of absorption of food molecules across the intestinal mucosa. In order to reduce
their immunogenicity, a major part of the proteins (90%) are degraded before absorption
as smaller non-immunogenic peptide fragments. These molecules penetrate through the
enterocyte membrane (Fordtran et al., 1965). A minor part of the protein is however
absorbed intact or at least in an immunologic form and leads to the induction of antigen-
specific immune responses (Sampson, 1991). The absorption of intact food antigens,
which are thought to permeate aqueous channels between adjacent enterocytes
(Smulders and Wright, 1971) occurs as a natural consequence of the design of the
defence systems. This mechanism generates a systemic hyporesponsivness, or oral
tolerance (Sanderson and Walker, 1993).
The means by which tolerance develops is not well understood. Three principal
immunological mechanisms have been implicated: clonal deletion, clonal anergy and
antigen-driven suppression (Strobel and Mowat, 1998). Lymphoid cells appear to be
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important in the development of oral tolerance since irradiated mice lose the ability to
develop oral tolerance (Bruce et al., 1987). Murine studies have shown that CD8+ cell
activation along with antigen presenting cells in the reticuloendothelial system may play
a key role in the development of oral tolerance (Sampson, 1991). However Garside et al.
(1995) were able to induce oral tolerance in mice depleted of CD8+ cells. Therefore
these cells appear not to be prerequisites for the induction of oral tolerance and CD4+
rather than CD8+ T cells may be implicated (Garside et ah, 1995).
The presence of detectable serum IgG, IgM, and IgA antibodies to food antigens
is a common phenomenon in normal individuals, at least in low levels, and thus
everyone has some detectable antibody to various food proteins (Sampson, 1991). Food-
specific IgE can also be detected in the sera of normal children (Burgin-Wolff et ah,
1980). High levels of food specific non-IgE antibodies found in some patients seem to be
secondary to increased gastrointestinal permeability associated with a variety of
inflammatory disorders (Sampson, 1991).
Also, in a relatively few individuals who are genetically predisposed, a
breakdown or a failure in the development of oral tolerance may result in a
hypersensitivity response to the ingested antigen. This may occur if the gut permeability
is altered and one or both modes of absorption is affected (Isolauri et ah, 1990). In the
newborn, the gut barrier is incompletely developed and the antigen may not be
transformed into a tolerogenic form (Strobel and Ferguson, 1984). This may explain the
peak of prevalence of food allergy in young children. Increased intestinal permeability
has also been demonstrated in patients with atopic eczema (see section on food induced
eczema/atopy). However, it seems that the inability to induce tolerance is not merely a
result of the immaturity of the digestive system or antigen-handling capacity of the
neonatal gut, but is more likely to be due to a regulatory imbalance that can be partially
restored with adult spleen cells (Peng et ah, 1989).
3. Classification of adverse reactions to food antigens
As mentioned earlier, adverse reaction to food is a general term for any clinically
abnormal response attributed to the ingestion of a food or food additive. Such reactions
can be divided in two broad categories; those which are immune-mediated (food
hypersensitivity) and those without an immunological basis (food intolerance). The





The true prevalence of adverse food reactions is controversial. Many authorities
suggest that it is less than 1% of the population (Sampson, 1993a). However most
studies suggest that true allergy, at least in young children, may be more prevalent that
the medical society thought (U.S. Department of Agriculture, 1983; Bock, 1987). Food
hypersensitivity may affect 3 to 8% of the population with a peak prevalence at about
one year of age (Bock, 1987; Host and Halken, 1990; Sampson, 1992). As
approximately 70 to 80% of infants outgrow their food hypersensitivity, by the end of
the first decade of life the prevalence drops, and then appears to remain at about 1% of
the population (Sampson, 1992).
4.2. Etiopathogenesis
Although type I, IgE mediated reactions, are most frequently implicated, food
allergic reactions may also involve type II, type III and type IV hypersensitivities. More
than one hypersensitivity reaction may be involved (Sampson, 1991).
Reactions to food antigens can be immediate and occur within minutes after
exposure or can be delayed, requiring repeated antigen exposure and occurring hours or
days after exposure.
In some situations, although immunological mechanisms are believed to be
involved, the precise pathogenesis is unknown (Sampson, 1993a).
4.2.1. IgE-mediated reactions
The majority of immediate reactions to food are reported to be due to IgE-
mediated hypersensitivity (Sampson, 1991) and appear to result from the production of
food-specific IgE in predisposed individuals. Interaction between food antigen and
specific IgE leads to a pathological process mediated by mast cells and basophils.
Involvement of food-specific IgE has been demonstrated by the use of PK tests
(Prausnitz and Ktistner, 1921; Bock et al., 1978). Following oral challenge of the
recipient with food antigens, to which the donor was allergic, cutaneous reactions similar
to those presented by the patient were induced (Ratner and Gruehls, 1934). Mast cell
degranulation was also reported following in vitro and in vivo passive sensitisation of
intestinal mucosal mast cells (Gray et al., 1940; Selbekk et al., 1978). Local
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degranulation of intestinal mast cells has been demonstrated to increase the permeability
and the passage of food antigen through the gastrointestinal barrier into the body where
it may be distributed to other target organs (Brostoff et al., 1979).
The liberation of a variety of cytokines by activated mast cells and basophils may
also induce an IgE-mediated late-phase response (see chapters I and II).
Moreover, repeated ingestion of food allergen stimulates mononuclear cells to
secrete HRF (Sampson et al., 1989). This phenomena has been associated with increased
bronchial hypersensitivity in patients with asthma (Alam et al., 1987) and increased
cutaneous irritability in children with atopic dermatitis (Sampson et al., 1989) (see
chapter II). Individuals with atopic dermatitis and food allergy sometimes show
spontaneous basophil histamine release (May and Remigio, 1982; Sampson et al., 1989).
The level of histamine release in vitro has been demonstrated to return to normal levels
over a 4-6 month period when the patient is not fed the offending food allergen and
therefore appears to depend on continued ingestion of the allergen (Sampson et al.,
1989).
4.2.2. Non IgE-mediated food hypersensitivity
Although type II , antigen-antibody - dependent cytotoxic reactions, type III,
antigen-antibody complex-mediated hypersensitivity and type IV, cell-mediated
hypersensitivity (Paganelli et al., 1984; Paganelli et al., 1987; Sampson, 1993a) have
been reported to be implicated in patients with food hypersensitivity, there is little
support for any significant role.
4.3. Diagnosis
The lack of definitive laboratory tests to confirm food allergy and implicate the
responsible allergens is a major cause of concern. Adverse reactions may result from a
variety of known and unknown immunologic responses, may occur in minutes to days
following ingestion and may involve a wide variety of objective and subjective
complaints as well as the development of symptoms which may be variable, intermittent
or cumulative (Sampson, 1988).
History, diet diary, performance of elimination diets, open challenges, single-
blind challenges and double-blind placebo-controlled food challenges (DRPCFC's) may
all be utilised as diagnostic approaches in the establishment of a diagnosis of food
allergy. However, the DBPCFC is the only test which can control for psychogenic
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factors and patient and physician bias and thus is the only way to accurately diagnose
food hypersensitivity (Sampson, 1988). Therefore the DBPCFC represents the gold
standard for diagnosing adverse reactions to food but does not necessarily implicate
hypersensitivity.
Non IgE-mediated gastrointestinal disorders generally require laboratory or
endoscopic studies to arrive at the correct diagnosis whereas when an IgE-mediated
disorder is suspected, selective IDST or radioallergosorbent tests (RASTs) can be very
helpful in the establishment of the diagnosis.
There is no evidence of any diagnostic value for food-specific IgG or IgG4
antibody levels, food immune complexes or lymphocyte activation tests.
4.3.1. In vivo tests
Prick skin tests are frequently used to screen patients with suspected IgE-
mediated food allergies. The positive predictive accuracy of skin tests was reported to
vary from 17% to 78% for the 6 major food antigens (egg, milk, peanut, fish, soy and
wheat), whereas the negative predictive value was reported to vary from 87% to 100%
(Sampson, 1984&1988). Therefore the prick skin test may be considered an excellent
means of excluding IgE-mediated food allergies, but is only suggestive of the presence
of clinically relevant food allergies. However there are some exceptions to this general
statement. IgE-mediated sensitivity to fruits and vegetables is frequently not detected,
probably because of the lability of these commercially prepared allergens (Ortoloni et
al., 1989). On the other hand, children less than 2 years old may have food
hypersensitivity in the absence of positive skin test presumably because of lack of skin
reactivity (Menardo et ah, 1985).
4.3.2. In vitro tests
It is important to remember that a local immune response in the gastrointestinal
tract is not necessarily reflected in the systemic circulation, and findings based on the
analysis of blood samples are not necessarily relevant for local immunity. Also, the
ingested food may not be the relevant antigen, with the true offending allergen possibly
appearing only during digestion.
In vitro tests include ELISA and RAST, basophil histamine release assay,
intestinal mast cell histamine release and intragastral provocation under endoscopy
(Selbekk, 1985; Nolte et ah, 1989; Sampson, 1993b)
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4.3.2.1. ELISA and RAST
The diagnostic value of in vitro tests reported in the literature is very variable and
dependent on the criteria used to make the diagnosis, the population investigated and the
food antigen evaluated (Ownby, 1991). Because processing proteins does influence their
potential allergenicity, in vitro measurement of food-specific IgE antibodies raises
certain issues. Commercially available food extracts are often unreliable, especially
some allergens such as of vegetable origin which are labile and may lack allergenicity.
Conversely, vegetable allergens may be very rich in lectins, which can bind IgE and
reduce the specificity of the assay (Barnett et al., 1987).
Although RASTs and ELISAs are considered slightly less sensitive than skin
tests, prick skin tests and RASTs were found to have similar sensitivity and specificity in
a study which was comparing RAST with DBPCFC (Sampson, 1988). In another recent
study in which the skin prick test and specific IgE for milk, egg and nut were compared
with the oral challenge test, the prick test was found to be the most sensitive technique
whereas RAST had the highest specificity (Roger et al., 1994). ELISA appears to be
useful for predicting the probability that a food allergic patient may later develop
immunological tolerance with resolution of clinical signs and low levels of antigen-
specific IgE are thus useful prognostic indicators (Sampson, 1993b).
IV. Allergic skin diseases in cats
Allergic skin diseases comprise up to 30% of cases of skin disease in cats
(Chalmers and Medleau, 1989; Carlotti, 1992). The most common causes are flea and
other insect bite hypersensitivities, atopy and food hypersensitivity. Some patients are
presented with more than one type. The reported incidence varies in different studies
(O'Dair et al., 1996, Prost, 1996a). In a report of 88 cats which showed clinical signs
compatible with allergic skin disease, a diagnosis of flea allergy was made in 45.5% of
cases, atopy in 73% of cases and food allergy in 23% of cases (Prost, 1996a). However,
O'Dair et al. (1996) reported that of 20 cats suspected of allergic skin disease, 10 were
atopic (50%), 14 were flea allergic (70%) whereas none were diagnosed with food
allergy.
Allergic skin diseases occur most commonly in young cats although cats from all
ages can be affected.
The clinical presentation of the different allergic diseases can be
indistinguishable. Whereas some symptoms are similar to those in the dog, the cat is not
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a small dog and has its own clinical entities such as the eosinophilic granuloma complex,
miliary dermatitis, self-induced alopecia and facial pruritus. Some cats can manifest
various combinations of those 4 patterns (Prost, 1996a&b; Halliwell, 1997). In a recently
published report of 88 confirmed cases of allergic skin disease, 24 cases were presented
with self-induced alopecia, 20 were presented with eosinophilic granuloma complex
(eosinophilic plaque, eosinophilic ulcer and/or linear granuloma), 13 cats had miliary
dermatitis and 12 cats had facial dermatitis (Prost, 1996a). Various combinations of 2 of
the 4 patterns were seen in 24 of the 88 cats (Prost, 1996a). Also, cats appear to suffer
from a true allergic asthma (Moise and Spaulding, 1981; Halliwell and Gorman, 1989;
Corcoran et ah, 1995; Prost, 1996a&b; Halliwell, 1997) and can be presented with both
cutaneous and respiratory signs resulting from exposure to the same allergen(s)
(Halliwell and Gorman, 1989; Halliwell, 1997).
Although much progress has been made in the past decade in the field of allergic
skin diseases in man and in dogs, little is still known about these diseases in cats despite
a number of recent studies.
1. Feline atopy
1.1. Introduction
Atopy was first described in the cat in 1982 by Reedy who reported positive skin
tests in 15 of 20 cats presented with miliary dermatitis, extensive alopecia and/or
manifestations of the eosinophilic granuloma complex. Eleven out of these 15 cats
showed a good response to hyposensitisation. Currently there is increasing interest in
feline atopy but reports are still few in comparison to those of canine atopy.
Although recent studies have shown the existence of an IgE-like antibody in cat
serum (Walton et ah, 1968; Powell et ah, 1980; DeBoer et ah, 1993; Baldwin, 1993;
Foster, 1995; Foster et ah, 1995), this immunoglobulin has not yet been fully
characterised. Also, while anecdotal reports of familial involvement in feline atopy
suggest a genetic component (Scott, 1987), an inherited predisposition has not yet been
fully demonstrated (Halliwell and Gorman, 1989). Thus one may still argue whether the
term atopy should be used in cats.
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1.2. Pathogenesis
The pathogenesis of feline atopy is still poorly understood. No study has been
performed on the production and the regulation of feline IgE. The clinical relevance of
this antibody is also unknown.
On the other hand atopic cats tend to respond well to immunotherapy based on
the detection of allergens involved by either IDST (Reedy, 1982; Bettenay, 1996; Prost,
1992) or in vitro tests (Halliwell, 1997). This suggests a role for reaginic antibody in the
pathogenesis of feline atopy.
Recently, the level of allergen-specific IgG in atopic cats has been studied. Foster
et al. (1997) demonstrated that the level of IgG antibody against some, but not all
environmental allergens, was significantly higher in the serum from cats with confirmed
allergic disease than in the serum from normal cats, cats with non-dermatologic disease
and cats with undiagnosed pruritis. They suggested that allergic cats may therefore
develop a Th2 lymphocyte-directed immune response characterised by the production of
both allergen-specific IgG and IgE (Foster et al., 1997). Which of the three IgG
subclasses is involved in this response was not addressed, and the importance of this
isotype in the pathogenesis of feline atopy is speculative.
Cells found in skin biopsies from allergic cats vary according to the clinical
lesion sampled. In non-inflammatory skin, lymphocytes and mast cells are prominent
whereas in inflammatory skin, eosinophils are usually the predominant inflammatory
cell (Scott et al., 1995b).
Roosje et al. (1995) have demonstrated that lesional skin of atopic cats with
miliary dermatitis contains a predominantly CD4+ infiltrate. A recent study has
investigated MHC class II+ and CDla+ cells in the skin of normal cats and in lesional
skin of atopic cats (Roosje et al., 1997). The authors showed that the number of MHC
class II+/CDla+ cells were increased in the epidermis and the dermis of the lesional skin.
The marked increase ofMHC class II+ dendritic cells seen in the epidermis is consistent
with the upregulation of MHC class II after cytokine-mediated Langerhans' cells
activation. These cells could have an active role in the immunopathogenesis of skin
lesions in atopic cats.
Mast cells have been studied in normal cats and cats suffering from skin diseases.
They weie found in the epidermis of cats with eosinophilic granuloma complex whereas
they were not detected in the epidermis of normal cats (Scott, 1990) or of cats suffering
from non-dermatologic diseases (Foster, 1994). A study performed on cats with miliary
"eczema" showed a higher number of mast cells in the dermis of these cats than in
normal cats (Scott, 1980). Dermal mast cells were also shown to be more numerous in
some cats suffering from pemphigus foliaceus (Greek, 1993). On the other hand, feline
mast cells vary in number with the site of the skin biopsy (Foster, 1994).
A recent study (O'Dair et ah, 1996) has evaluated intestinal permeability ratios to
lactulose and mannitol in 14 cats which were diagnosed as atopic and/or allergic to fleas
but not allergic to food. An elevated ratio suggestive of increased intestinal permeability
was found in only one cat. This cat also showed clinical signs of concurrent
gastrointestinal disease.
The immunopathogenesis of feline asthma is still not clear. It has been shown to
share some features with human asthma. One is an eosinophilic inflammation of central
airways, a bronchoconstriction that is reversible with p-adrenergic agonists, and
histologic changes in airways including epithelial erosion, globlet-cell and submucosal-
gland hyperplasia and hypertrophy, and increased smooth-muscle mass (Howard and
Ryan, 1982; Moise et al., 1989; McKiernan and Johnson, 1993). A model of feline
asthma has been induced in ascaris naive cats by repeated immune stimulation with
ascaris antigen. The histological appearance of the airway inflammation was similar to
that noted in both feline and human asthma (Padrid et al., 1995). This data suggests that
immune sensitisation alone could be a salient factor in the histologic changes that are
observed in the asthmatic cat. On the other hand, asthmatic cats can exhibit positive skin
tests and in vitro tests, can show a good response to hyposensitisation (Halliwell, 1997)
or to the removal of the allergen (Corcoran et al., 1995).
1.3. Incidence, breed and sex predisposition, and age of onset
Reports of the incidence of feline atopy vary considerably. Chalmers and
Medleau (1989) reported that atopy accounted for less than 1% of the cats presented for
investigation of presumed allergic dermatitis at Purdue University and for 15% at the
New York state College of Veterinary Medicine. However, European studies suggest a
higher incidence. In the UK, 50% of cats with allergic skin disease had positive skin
reactions to aeroallergens (O'Dair et al., 1996), whereas in a study in France, 73% of
presumed allergic cats gave positive skin tests (Prost, 1996a). These differences
probably reflect the lack of defined criteria for feline atopy and also practice bias.
No breed and sex predisposition has been reported (Prost, 1992). Age of onset
ranges from 6 months to 7 years (Reedy, 1982; Scott et al., 1986; Halliwell and Gorman;
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1989; Prost, 1996b). Most cases seem to commence in the young cat between the age of
6 months and three years (Scott et al., 1995b; Halliwell and Gorman; 1989; Prost,
1996a&b). In one study performed on 16 atopic cats with miliary dermatitis, 75% started
to show clinical signs between 6 months and 2 years of age (Scott et ah, 1986). Prost
(1996b) reported an age of onset ranging from one to three years of age in 65% of cases,
with 15% commencing their disease at less than one year of age.
1.4. Clinical signs
1.4.1. Cutaneous signs
As noted in the dog, pruritus is always present (Carlotti, 1992; Prost, 1992; Scott
and Miller, 1993). However this is not always obvious to the owner because grooming is
part of the normal behaviour of cats and also because they are secretive and can spend
hours hidden, grooming or traumatising themselves. Also, pruritus is not always obvious
to the practitioner when the cat is presented for a non-inflammatory alopecia without any
other clinical signs. It can be seasonal or non seasonal (Scott, 1987; Carlotti and Prost,
1988). In a report of 16 cats with symptoms consistent with atopy, 11 had seasonal
disease, three showed non seasonal symptoms and 2 progressed from seasonal to non
seasonal (Scott, 1987). Carlotti and Prost (1988) reported non seasonal pruritus in 6 cats
out of 7.
The clinical signs attributed to atopy are extremely variable. The most common
signs are self-induced alopecia (also called extensive alopecia or symmetrical alopecia),
miliary dermatitis, eosinophilic granuloma complex and facial and neck pruritus (Reedy,
1992; Scott, 1984&1987; Moriello, 1994; Prost, 1996a&b; Halliwell, 1997). Some cats
can manifest various combinations of those 4 patterns (Carlotti and Prost, 1988; Prost,
1992; Halliwell, 1997). In a study of cats with symptoms compatible with atopy, 8 cases
were presented with extensive alopecia, 11 were presented with eosinophilic granuloma
complex (eosinophilic plaque, eosinophilic ulcer and/or linear granuloma), 5 cats had
miliary dermatitis, 2 cats had facial pruritus and one cat had seborrhea (Prost, 1992). An
association of the eosinophilic granuloma complex with one of the other syndromes was
seen in three cases whereas one cat with extensive alopecia showed also some lesions of
miliary dermatitis (Prost, 1992). Recurrent swelling of the chin or lower lip (eosinophilic
or collagenolytic granuloma) may also be seen (Scott et al., 1995b). Cats may exhibit
seborrhea as the only symptom (Prost, 1992) or foot/nail chewing (Moriello, 1994). One
53
case of feline atopy was reported in association with a sterile eosinophilic folliculitis and
showed an excellent response to hyposensitisation (Scott and Shanley, 1989).
Both lesions and pruritus may be localised or generalised. Primary skin lesions
may or may not be present and many cats start to scratch or to lick at apparently normal
skin (Carlotti, 1992). The typical chronic "eczematous " lesions (excoriation and
lichenification) seen in man and the dog with AD are not reported in atopic cats. It is
also very uncommon for cats to develop secondary staphylococcal infection, however
secondary pyoderma may occur in some atopic cats (Scott et ah, 1995b).
Atopic cats can manifest recurrent ceruminous otitis externa (Carlotti and Prost,
1988; Prost, 1992; Moriello, 1994; Halliwell, 1997).
Lymphadenopathy may be seen in some cats, especially in chronic cases that
have miliary dermatitis, excoriations or eosinophilic plaques (Bettenay, 1991; Moriello,
1994; Scott et al., 1995b). Because of the excessive grooming in some animals, there
may be a history of vomiting hair balls (Bettenay, 1991), or constipation (Moriello,
1994).
1.4.2. Respiratory signs
Cats with allergic respiratory disease can show a chronic cough suggestive of
allergic bronchitis, respiratory difficulty accompanied by an expiratory wheeze
compatible with asthma, rhinitis and/or conjunctivitis (Halliwell and Gorman, 1989).
Carlotti and Prost (1988) reported sneezing in 5 cats and chronic conjunctivitis in one of
10 atopic cats which had cutaneous lesions.
In a recent study of 29 cats exhibiting feline asthma syndrome without cutaneous
signs, the most common presentations were recurrent bouts of coughing (26 cats) and
dyspnea (21 cats) while sneezing was seen in 10 cats and nasal discharge in 6 cats
(Corcoran et ah, 1995).
1.5. Diagnosis
The extreme variability of the clinical signs and the fact that the associated
reaction patterns can have many other causes necessitates the consideration of a lengthy
list of differential diagnoses. Therefore a careful history and clinical evaluation should
first identify other possible causes of the skin or respiratory diseases under investigation
(Halliwell and Gorman, 1989). In addition, atopic cats may have other concurrent
allergic diseases (Foster and O'Dair, 1993; O'Dair et ah, 1996; Prost, 1996a, Halliwell,
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1997). Flea allergy was reported to be associated with atopy in 3 out of 9 cats cases
(33% of cases) (Foster and O'Dair, 1993), 33 out of 66 cats (50% of cases) (Prost,
1996a), and 7 out of 10 cats (70% of cases) (O'Dair et al., 1996). Although it is much
less common, food hypersensitivity may also be seen with atopy (Halliwell, 1997).
Therefore, the common differential diagnoses include other hypersensitivities,
ectoparasitism (cheyletiellosis, otodectic and feline notoedric acariasis), dermatophyte
infection and psychogenic alopecia (Scott et al., 1995b). Other less frequent diseases to
be considered in the differential diagnosis include bacterial folliculitis, telogen
effluvium, idiopathic symmetrical alopecia, mycosis fungoides and mastocytosis
(Bettenay, 1991; Thoday, 1990; Carlotti, 1992). The term idiopathic symmetrical
alopecia is also used to describe the previously named feline endocrine alopecia which
has been shown in some cats to be the result of low thyroid function (Thoday, 1990).
Although haematology and histopathology can help in the diagnosis of the
pathological entities, they cannot be used to establish a diagnosis of feline atopy (Foster
and O'Dair, 1993). The presence of eosinophilia is very variable, and of little diagnostic
significance (Scott, 1987; Foster and O'Dair, 1993; O'Dair et al., 1996).
1.5.1. Allergy testing
After careful and complete elimination of other diagnoses, confirmation of the
diagnosis and the identification of the allergens involved may be made with the IDST
and/or in vitro tests.
1.5.1.1. IDSTs
Until recently, the IDST has been the only test available for allergy testing in the
cat. It is assumed, as in the dog, that it is the gold standard and the diagnosis of atopy has
thus been based on IDST results and response to hyposensitisation (Reedy, 1982; Scott,
1984; McDougal, 1986; Prost, 1992).
Allergen concentrations used in dogs were shown to be appropriate for use in cats
(Bevier, 1990).
Withdrawal times for corticosteroids and antihistamines recommended are the
same as those established for the dog (Halliwell and Gorman, 1989; Carlotti, 1992).
Megestrol acetate has also been shown to suppress the pituitary/adrenal axis for at least
as long as do corticosteroids (Chastain et al., 1981). It could therefore be expected to
suppress skin reactivity in the IDST, although this has yet to be critically addressed.
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Skin tests are technically more difficult than in dogs since cat skin is thinner and
has also denser collagen bundles (Carlotti, 1992). Also, weal reactions in cats tend to be
subtle, flat, with minimal erythema and difficult to interpret (Reedy, 1982; Prost 1996b).
Restraint for skin testing in cats, with or without preceding anaesthesia, were shown in a
study to induce significant increases in plasma Cortisol, corticotropin, and a-melanocyte-
stimulating hormone concentrations (Willemse et ah, 1993). The authors suggested that
this Cortisol response may explain the typical weak response to the IDST observed in
cats (Willemse et ah, 1993). However, some atopic cats can be as reactive as any dog.
Nonetheless sedation or anaesthesia with low doses of either xylazine,
medetomidine, ketamine, ketamine-diazepam, glycopyrrolate, tiletamine- diazepam, or a
general gas anaesthetic are recommended (Mueller et ah, 1991; Carlotti, 1992; O'Dair
and Foster, 1995; Scott et ah, 1995b; Prost, 1996b).
The technique of injection is the same as described for the dog but great care
must be taken to ensure that the injection is truly intradermal (Halliwell and Gorman,
1989). The reading and scoring of the reaction are also critical. In order to help the
visualisation of the reaction, the IDST should be read in the dark with an indirect light
source. Sometimes, feline skin test reactions develop and fade rapidly, within 10
minutes. Therefore some authors observe the site of injection continuously over 20
minutes (Carlotti, 1992), whereas others recommend reading the reaction between 5 and
15 minutes (Bettenay, 1991) or after 15 to 20 minutes (Prost, 1996b). A recent study
demonstrated that degranulation following in vivo allergen challenge occurred after 5
minutes in 20 % of mast cells and, after 10 to 15 minutes in nearly two-thirds of them
(Bevier and Dunston, 1996). In addition to immediate reactions, delayed reactions may
also occur. Their significance is unknown (Halliwell and Gorman, 1989).
Non-seasonal allergens appear to be the most commonly involved in feline atopy.
Of 66 cats with positive IDSTs, 38 cats (57.6%) were positive to non seasonal allergens
and 25 cats (38.5%) were positive to seasonal and non seasonal allergens while only
three cats were reactive to pollens alone (Prost, 1996a). In another report, non seasonal
and seasonal allergens gave positive reactions in 77% and 23% of the cats respectively
(Foster and O'Dair, 1993). Several studies have shown that positive reactions occur most
frequently to HDM antigens. DF has been reported to be involved in 80% (Prost, 1996a)
and 100% (Carlotti and Prost, 1988) of the cases, whereas DP was involved in 10%
(Carlotti and Prost, 1988) and 46% of the cases (Prost, 1996a). Foster and O'Dair (1993)
reported positive reactions to house dust and Dermatophagoides spp in 77% of cats.
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Human dander, dog dander and moulds were reported to be positive in 22.5%, 17.7%
and 8% respectively (Prost, 1996a).
Some allergens, such as house dust (HD), firebush and flea, were shown to
induce positive skin reactions at low dilutions in normal cats. It was proposed that those
reactions may be not always false-positive irritant reactions but rather true positive
reactions and that a possible interpretation could be the dissociation of positive skin test
reactivity and clinical sensitivity (Bevier, 1990).
1.5.1.2. In vitro tests
Recently, ELISAs for the establishment of the diagnosis of atopic disease in cats
have become available in the USA and in Europe. One of them uses for the detection of
allergen-specific IgE an antiserum that was raised against a chimaeric feline/murine IgE
antibody. These commercial tests have not been adequately evaluated. The only report
which compared the results of this assay to skin testing, assuming the latter as the gold
standard in the diagnosis of feline atopy, showed a very poor correlation between the
two tests (Foster and O'Dair, 1993). The specificity and sensitivity of the ELISA were
reported as 57% and 11% respectively with positive and negative predictive values of
10% and 40% (Foster and O'Dair, 1993). However, in a recent study in which 81 cats
received hyposensitisation based on results of ELISA using a polyclonal antiserum, the
response was shown to be broadly similar to that obtained when hyposensitisation was
based upon skin testing (Prost, 1992; Halliwell, 1997). Although these studies were not
placebo controlled, the results raised the same question in the cat as has been asked in
the dog: namely "should results of in vitro tests correlate with those of skin testing?".
1.6. Treatment
The optimal treatment of feline atopy varies with the severity of the disease and
its duration. Avoidance is the ideal form of therapy (Prost, 1993), but unfortunately is
not easily undertaken. Corticosteroids, antihistamines and essential fatty acids, used
alone or in combination as symptomatic therapy, can be very useful (Carlotti, 1992).
Hyposensitisation is often effective and could represent the most appropriate long-term
control method for a cat which has non seasonal atopic disease (Reedy, 1982,
McDougal, 1986; Scott et ah, 1986; Carlotti and Prost, 1988; Prost, 1992; O'Dair and
Foster, 1995; Bettenay, 1996; Halliwell, 1997). Topical therapy is uncommonly used in
cats but can however be very effective (Scott et ah, 1995b).
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1.6.1. Symptomatic therapy
Corticosteroids are well tolerated by cats and represent the treatment of choice
for controlling clinical signs. They are widely used with good results, in the early stage
of the disease. Oral prednisolone (2.2 mg/kg/day for 5 to 10 days and then every other
day) and injectable repositol methylprednisolone acetate (5.5 mg/kg or 20 mg/cat SC or
IM at intervals of not less than 8 weeks and preferably every 12 weeks) or triamcinolone
acetonide (5 mg/cat SQ) can all be used (Scott et al., 1995b). However after a few years,
response to the therapy can decrease and side effects may occur. Thus in these cases
another form of therapy should be tried.
The antihistamine most commonly recommended is chlorpheniramine
hydrochloride (2-4 mg/cat b.i.d.). It was reported to be very effective in atopic cats with
improvement in 73% of cases (Miller and Scott, 1990). Alternatively clemastine (0.67
mg/cat b.i.d.) can also be used and was shown to give good results in 50% of cases
(Miller and Scott, 1994).
Fatty acid preparations containing n-3/n-6 have also been reported to be of help
and seem to give a good response in 50 to 75% of cats with inflammatory skin disease
(Harvey , 1991; Harvey, 1993a&b; Miller et al., 1993b). When given with either
corticosteroids and/or antihistamines, they appear to have synergistic effects. The cats
which improved when treated with EFA also showed abnormalities of their serum fatty
acid before treatment (Harvey, 1991).
1.6.2. Hyposensitisation
1.6.2.1. Introduction and mechanisms of action
The concept that protective or blocking antibodies are induced by
hyposensitisation has long been favoured since it was reported that sera from
hyposensitised patients could block the PK reaction (Cooke et al., 1935). However,
although allergen-specific IgG antibodies increase in hyposensitised patients, there are
few studies that have shown a convincingly direct relationship between allergen-specific
IgG levels and clinical efficacy (Aalberse et al., 1983; Djurup, 1985).
A rise in allergen-specific IgE is often seen early in the course of the therapy and
despite this rise in the first year, patients often report considerable therapeutic benefits.
IgE antibody then falls gradually over several years (Irons et al., 1977; Foucard and
Johansson, 1978). The induction of autologous anti-IgE antibody, particularly
antiidiotype antibodies, could be of potential benefit (Wheeler et al., 1990). Autologous
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antigen/antibody complexes were demonstrated under experimental conditions to inhibit
the specific response directed against the antigen contained in the complex (Saint-Remy,
1994). Injection of such complexes have been reported to be of particular benefit in
patients with AD (Leroy et al., 1993).
A potential aim of hyposensitisation is the reversal of the activity of allergen-
specific T-cell activity from Th2>Thl to Thl>Th2. The current view is that allergen-
specific immunotherapy is believed to switch the allergen-specific immune response
toward the production of a higher Thl cytokine profile (Durham et al., 1991). It appears
that immunotherapy leads to an upregulation of Thl-type cytokines rather than to a
downregulation of Th2-type cytokines. However decreased production of 11-4 and 11-5 by
Th2-like cells have been demonstrated in recent studies involving long term
administration of immunotherapy (Briner et al., 1993; Secrist et al., 1993).
Recently, a study has shown a long-lived reduction in the induction of CD23 on
peripheral B cells by grass-pollen-extract, in patients given allergen-specific
immunotherapy. This was associated with reduced symptoms. No such reduction in
CD23 was observed in patients treated symptomatically without allergen-specific
immunotherapy (Jung et al., 1995).
Basophils of patients hyposensitised often show a reduced histamine release in
response to allergen challenge in vitro (Swineford, 1972). A reduced level of IgE
receptors on the cells has also been proposed as a mechanism in hyposensitisation
(Bonifazi et al., 1991).
1.6.2.2. Assessment of hyposensitisation in cats
Either aqueous or alum-precipitated allergens have been used with similar results.
The protocol used is the same as for the dog.
Hyposensitisation in cats was first described by Reedy (1982) who used alum-
precipitated allergens to hyposensitise 15 cats who showed positive reactions on IDST.
A favourable response was seen in 11 cats (73%). Favourable results were also reported
in 69% of cases by McDougal (1986), 100% of cases by Scott et al. (1986), 67% of cases
by Carlotti and Prost (1988) and 73% of cases by Prost (1992). However some studies
have also showed less favourable results (O'Dair and Foster, 1995; Bettenay, 1996) with
efficacy rates of 45% and 50% respectively. Most of the reports on hyposensitisation
were based upon follow-up periods of 6 to 10 months and the lower success rate reported
by Bettenay (1996) may be due to the longer study period which involved a 12 month to
three year follow-up. Indeed their results at 12 months were comparable to those in
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previous publications (McDougal, 1986; Scott et al., 1986; Carlotti and Prost, 1988;
Prost, 1992). This is supported by the data from O'Dair and Foster (1995) who found a
success rate of only 45% in a 2 year study involving 12 cats. On the other hand none of
them were placebo-controlled and thus, the apparent efficacy may be overstated.
Interestingly, O'Dair and Foster (1995) reported no success with advanced lesions of
eosinophilic granuloma complex. A recent study showed that the different dermatologic
conditions exhibit differences in their response to hyposensitisation (Halliwell, 1997)
(see below). Therefore the interpretation of the success rate of some studies is difficult as
all are based on numbers of cats with different reaction patterns.
Comparisons of the reported response rates to immunotherapy are difficult.
Firstly, there are no standardised regimens. There is variation in protocols regarding
frequency, the dose of antigen and the recommended duration of therapy. In addition, the
allergens used come from different sources, and there are no universally accepted
protocols for allergen standardisation. The definition of a good response can vary from
one author to another. The patients may be on a variety of concurrent symptomatic
medications and the clinical assessment procedures may vary from study to study.
Despite these problems, hyposensitisation is widely recommended and most writers
report a good clinical response, with adverse reactions being rare.
The efficacy of hyposensitisation based upon in vitro test results has been
assessed for the first time very recently in a survey of 81 cases (Halliwell, 1997).
Response to hyposensitisation and a diet change and to hyposensitisation alone was
studied for each of the specific signs of atopy. The follow-up ranged from 4 to 37
months (mean of 18.5 months). Results were broadly similar for both groups
(hyposensitisation and a diet change and to hyposensitisation alone). An improvement of
at least 50% was noted in 75.3% of all cases to a combination of hyposensitisation and
dietary change. Forty eight percent of all cases showed an improvement of 75% to 100%
and 12.3% of them, an improvement of 100%. The improvement of the individual
dermatological conditions ranged from 93.6% in cases of linear granuloma to 60% in
cases with self-induced alopecia. A 62.6 % improvement was reported in cases of otitis




The term food hypersensitivity is used inappropriately in veterinary medicine to
describe any adverse reactions to ingested food. However, as mentioned previously,
some adverse reactions can be the result of intolerance rather than allergy.
2.1.Etiopathogenesis
As in the dog, the pathogenesis of food hypersensitivity in cats has not been
established. Type I but also type III and type IV hypersensitivities are believed to be
involved (Scott, 1980; Kunkle, 1984; Halliwell and Gorman, 1989).
Walton et al. (1968) studied a cat suffering from both gastrointestinal and
dermatological signs due to allergy to cows milk. Positive PK tests were obtained and
the PK reactivity was destroyed by heating the serum at 56°C for 30 minutes.
Dietary antigens most commonly incriminated in food allergy in cats are fish,
dairy products and beef (Walton, 1967; Dakin, 1988; White and Sequoia, 1989;
Guaguere, 1993). Other foods reported to be involved are pork, chicken, rabbit, horse,
lamb and mutton, eggs, clam juice and cod liver oil (Walton, 1967; Stogdale et al., 1982;
White and Sequoia, 1989; Carlotti et al., 1990; Guaguere, 1993; Rosser, 1993; Reedy,
1994; Scott et al., 1995b). Some cats react to all commercial foods, but are
asymptomatic when fed any home prepared diet. This would appear to implicate some
commonly used food additive (White and Sequoia, 1989).
There is no age, breed or sex predilection. The age of onset varies from three
months to 13 years with a mean age of 4 to 5 years (Walton, 1967; White and Sequoia,
1989; Carlotti et al., 1990; Guaguere, 1993; Rosser, 1993; Denis and Paradis, 1994). It
has been reported that in 70% of cases, the cat was fed with the offending diet for 2
years or longer (Scott, 1980). Recently Reedy (1994) reported a case of a cat with
diagnosed food allergy that was maintained on a diet of lamb but became sensitive to
lamb two years later.
2.2. Incidence
Although food hypersensitivity represents the third most common
hypersensitivity in the cat after flea allergy dermatitis and atopy, its incidence is rare and
it has been reported to comprise up to only 6% of all feline dermatologic cases (Walton,
1967; Carlotti et al., 1990; Denis and Paradis , 1994; O'Dair et al., 1996). The diagnosis
was made at two Universities in the USA and one in Canada, only 2 to 4 times per year
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(White and Sequoia, 1989; Rosser, 1993; Denis and Paradis , 1994). The incidence was
similar in a French referral practice which reported an average of three cases per year
(Guaguere, 1993). Reports of the prevalence of food allergy vary from 0% (O'Dair et al.,
1996), 4% (Foster and O'Dair, 1993) to 23% (Prost, 1996a) of allergic skin diseases. Up
to 15% of cats with miliary dermatitis were reported to have food hypersensitivity
(Scott, 1987).
2.3. Clinical signs
Cats suffering from food allergy can show dermatologic and/or gastrointestinal
signs, and respiratory and neurologic signs are rare (Wills, 1992). The disease is usually
nonseasonal.
Pruritus is always present and can be localised or generalised (White and
Sequoia, 1989; Carlotti et al., 1990; Guaguere, 1993; Rosser, 1993). Clinical signs vary
widely and can be indistinguishable from other cutaneous hypersensitivities. They may
include focal or symmetrical alopecia, facial and neck pruritus, miliary dermatitis,
excessive hair grooming, eosinophilic granuloma complex and otitis externa. The
anterior one-third of the body has been reported to be the most common region involved
(White and Sequoia, 1989; Guaguere, 1993; Rosser, 1993). Angiodema, urticaria and
conjunctivitis have also been reported (Halliwell and Gorman, 1989; Rosser, 1993).
Gastrointestinal signs were reported in 10 to 15% of the cases (Scott et al.,
1995b). They can occur with or without skin lesions and may include vomiting, profuse
watery diarrhea and inflammatory bowel disease such as lymphocytic-plasmacytic colitis
(Walton et al., 1968; Stogdale et al., 1982; Nelson et al., 1984; Dakin, 1988; Dennis et
al., 1992; Guaguere, 1993; Denis and Paradis, 1994).
2.4. Diagnosis
In the cat, as in man and the dog, the definitive diagnosis is based on a favourable
response to an "elimination" diet followed by a provocative test (Walton, 1967). The
animal is fed with foods to which it has either not been exposed previously or to which it
has been exposed infrequently. Some clinicians attempt this by feeding the cat with a
commercial hypoallergenic diet (Medleau et al., 1986; Dakin, 1988; White and Sequoia,
1989; Guaguere, 1993; Roudebush and McKeever, 1993). However in one study, an
improvement was seen in only 79% of cats with confirmed food hypersensitivity using a
commercial hypoallergenic diet (Roudebush and McKeever, 1993). Because of these
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findings homemade diets are usually recommended as the initial test diet (White and
Sequoia, 1989; Carlotti et ah, 1990; Roudebush and McKeever, 1993; Reedy, 1994).
While most of the cats usually improve within three weeks of instituting the
hypoallergenic diet (Scott, 1980; Stogdale et ah, 1982; Kunkle, 1983; White and
Sequoia, 1989; Carlotti et ah, 1990), some cats improve only after 8 to 13 weeks
(Carlotti et ah, 1990; Guaguere, 1993; Rosser, 1993; Denis and Paradis, 1994). Indeed it
was reported in a recent study that three cats of 17 cats suffering from food allergy
responded to the restriction diet only after 8 weeks (Guaguere, 1993), whereas in 2 other
studies, both performed on 13 cats, one cat improved after 9 weeks and one improved
after only 13 weeks (Rosser, 1993; Denis and Paradis, 1994). Therefore, the restriction
diet should be maintained for at least 10 weeks in order to ensure a response in all food
allergic cats.
Although most of the cats relapse within 8 days of a challenge with their previous
diet (Medleau et ah, 1986; Dakin, 1988; Guaguere, 1993; Reedy, 1994), some of them
may take longer (Rosser, 1993). Indeed, Rosser (1993) showed that symptoms could
reappear at any time from 15-30 minutes to 10 days. Thus to confirm the diagnosis, cats
should be fed their previous diet until a relapse is noticed, or for at least 10 to 14 days.
2.5. Clinical management
The clinical management is the avoidance of the offending food. It is also
important to bear in mind that the cat can become sensitised to a component of its new
diet (Reedy, 1994).
However, in some cases avoidance may be difficult, especially when the cat is
outdoors and can find other sources of food. In such cases, the use of corticosteroid
therapy can be of benefit to the cat. In cases of extreme pruritus, the administration of
oral corticosteroids can also be justified during the first few weeks of the diet trial.
Although food allergy in cats has been reported by some authors to be refractory to
corticosteroids (Scott, 1980; Carlotti et ah, 1990), these drugs were shown to have
reasonable efficacy in the management of pruritus in 2 studies that incorporated
rechallenge to confirm the diagnosis. A good response was shown in approximately 35%
of cases in one study (Guaguere, 1993) and in 64% of cases in the other (Rosser, 1993).
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Aims of the studies
Details of the current state of knowledge regarding IgE mediated
hypersensitivities in man and the dog and cat have been reviewed. There is a paucity of
information regarding the latter species. The aims of this study, therefore, were:
* To purify feline IgE, to assess further its physicochemical characteristics, and
to raise polyclonal antisera against the isotype.
* To assay the levels of IgE specific for Dermatophagoides farinae in the sera of
atopic and normal cats, both household and laboratory reared.
* To induce IgE in normal cats using low dose antigenic challenge in aluminium
hydroxide, and to compare the induced antibody with the spontaneous antibody of
hypersensitive cats.
* To assess the effects of infection with Toxocara cati and of
immunoprophylaxis with the standard battery of feline viral vaccines on the immune
response of the IgE and other isotypes to an orally administered antigen.
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CHAPTER 2.
PRODUCTION AND CHARACTERISATION OF
POLYCLONAL ANTISERA AGAINST FELINE IgE
2.1. Introduction
IgE antibodies in animals share many physicochemical properties with IgE
antibody of man. They are characterised by a relatively fast electrophoretic mobility, a
sedimentation coefficient of approximately 8 S, a molecular weight of approximately
200 KDa, the capacity to fix to tissue following injection for > 3 weeks and a high
sensitivity to heat and reducing agents.
Several studies have already shown that cat serum contains a protein with IgE-
like properties (Walton et al., 1968; Powell et al., 1980; Baldwin et al., 1993; DeBoer et
al., 1993; Foster, 1995; Foster et al., 1995). DeBoer et al. (1993) showed that cats have a
reaginic antibody that is antigenically cross-reactive with canine IgE and has an apparent
molecular weight similar to that of IgE from other species. Foster et al. (1995)
demonstrated that the passive cutaneous anaphylaxis (PCA) reactivity was eluted
following chromatography using Sephadex G200 in a position similar to that of other
species, and that feline reaginic antibodies are bound by protein A.
In man (Johansson and Bennich, 1967) as in the rat and the mouse (Bazin et al.,
1974; Bottscher and Hammerling, 1978) myelomas have permitted the ready purification
of IgE for the subsequent production ofmonoclonal antibodies. However, in the cat, the
lack of myelomas secreting IgE, the presumably low level of serum IgE and the small
amount of serum obtainable make the isolation of IgE very difficult.
The further characterisation of feline IgE and the development of specific
antisera are prerequisites for the elucidation of the role of IgE and of immediate type
hypersensitivity in a number of common feline diseases. The goal of this study was thus
to produce polyclonal antisera against the immunoglobulin to permit quantification of





Normal cats and cats infected with Toxocara cati (T. cati) were obtained from a
colony of experimental cats at the University of Liege (Belgium).
Normal adult (ex-breeder) parasite free cats for Prausnitz-Kiistner (PK) tests and
reversed cutaneous anaphylaxis (RCA) were obtained from Hill Grove Family Farm Ltd
(Oxford, England).
New Zealand white rabbits were obtained from Interfauna UK limited
(Cambridge, England).
All experimental protocols were in accordance with the requirements of the
Animal Care and Ethics Committee and/or the UK Home Office as appropriate.
2.2.2. Infection of cats with T. cati
Three 10 month old cats (#5,#6,#7) and three 12 to 16 week old kittens
(#1,#2,#3) were found to be naturally infected with T. cati. All were secreting ova in
their faeces.
Three additional normal 10 week old kittens (#4,#8,#9) were experimentally
infected with T. cati. Eggs were isolated from faeces of naturally infected cats. They
were washed 3 times in 1% sodium chloride and centrifuged at 1500 rpm for 5 minutes.
After discarding the final rinse, eggs were resuspended in 0.5% formalin (Sigma, Poole,
UK) and kept, under oxygen, in a dark room, at 27°C. Infective 2nd stage larvae were
obtained after 3 weeks. The cats were dosed with 10 embryonated ova daily for 3 days.
Development of a patent infection was indicated by the appearance of the ova in the
faeces within 60 to 75 days.
2.2.3. Ascaris antigens
Purified antigen from Ascaris suum (Asc-1) was purchased from Greer
Laboratories (Lenoir, North Carolina).
Adult T. cati were obtained post mortem from naturally infected cats and
antigens from body fluid were partially purified by gel filtration on Sephadex G100
(Pharmacia, Uppsala, Sweden) to remove the low molecular weight histamine releasing
fractions. Two adult T. cati were washed with PBS, and ground with a mortar and pestle.
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The worm mixture was incubated at 4°C for 48 hr. The pellet was discarded and the
supernatant was centrifuged at 49000x g for 1 hr in order to remove the fine particles.
The resultant solution was passed through a Sephadex G100 (Pharmacia) column and
material from the first peak (the major protein peak) was concentrated to 1 mg/ml.
2.2.4. Preparation of dinitrophenylated antigens
Asc-1 and bovine serum albumin (BSA) (Sigma) were dinitrophenylated
according to the method of Eisen (1964).
2.2.5. Induction of feline anti-DNP and anti-Ascaris antibodies
Cats were immunised with DNP-Asc in aluminium hydroxide (Imject Alum®;
Pierce, Rockford, Illinois, U.S.A.) at a final ratio of alum to immunogen-alum mixture
1:4 (1 volume of alum for 3 volumes of immunogen fraction) in order to induce anti-
DNP reaginic antibody as described for the dog (Schultz & Halliwell, 1985). Each cat
received two biweekly injections of 10 pg of DNP-Asc subcutaneously over the lateral
thorax at two sites on either side of the body.
2.2.6. Performance of intradermal skin tests (IDSTs)
Ten days after the last immunisation, cats were anaesthetised with 1 mg/kg
xylazine (Virbaxyl®, Virbac limited, Cambridge, UK) and 10 mg/kg ketamine
hydrochloride (Vetalar®, Parke-Davis, Pontypool, Gwent, UK) intramuscularly. The
lateral chest was clipped and 0.05 ml of a solution of 10 pg/ml of DNP-BSA was
injected intradermally. Phosphate buffered saline (PBS) and 1/100,000 w/v solution of
histamine phosphate (ARTU Biologicals N.V., Lelystad, Holland) were used as negative
and positive controls respectively. Reactions were scored on a +1 to +4 scale,
incorporating both diameter and elevation above the surface. A +1 reaction was just
discernibly greater than the PBS weal, and a +4 reaction approximated the size of the
histamine weal.
2.2.7. Fractionation of sera
2.2.7.1. Preparation of IgE rich fractions (Fr-R)
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T. cati infected cats were bled by cardiac puncture ten days after the last
immunisation with DNP-Asc. Sera were harvested by centrifugation after clot retraction
and were stored at -30°C.
The 3-in-series 4x60 cm column set of Sephacryl S-200 (Pharmacia) was firstly
carefully calibrated by filtration of normal cat serum equilibrated with 0.75M PBS, pH
7.0, containing 0.05% tween 20 (Sigma) to prevent aggregate formation.
Sera from bleedings of 4 infected cats (sera #1, #2, #7 and #8) were fractionated
by the same three-step procedure that was employed to prepare IgE rich fractions of
canine sera (Halliwell, 1973). A volume of 30 to 40 ml of each serum was precipitated at
33.33% saturation with ammonium sulphate and after centrifugation, further ammonium
sulphate was added to the supernatant to bring the degree of saturation up to 45%. The
resultant precipitate was resuspended in 0.15 M sodium phosphate buffered pH 7.2
(PBS) to the original volume and dialysed against a 10 fold volume of the same buffer
for 48 hr at 4°C with 3 buffer changes, to remove the ammonium sulphate.
The resultant fraction that precipitated between 33.33% and 45% saturation with
ammonium sulphate was then dialysed against 0.05 M phosphate buffer, pH 8.0, and
applied to a column of diethylaminoethyl cellulose (DEAE; Whatman, Maidstone, Kent,
England) equilibrated with the same buffer.
The excluded protein was concentrated and then applied to a 3-in-series 4x60 cm
column set of Sephacryl S-200 (Pharmacia) and eluted using PBS. The protein eluting
immediately prior to the 7S peak and the first one third of that peak was pooled and
concentrated using centripet -10 concentrators (Amicon, Gloucester, UK) as fraction R
(Fr-R) (fig. 2.1). The second third of the peak was pooled and concentrated as fraction
R+G (Fr-R+G) (fig. 2.1).
Columns were attached to a LKB uvicord UV monitor, 2211 Superrac fraction
collector and chromatogram recorder (Pharmacia).
2.2.7.2. Preparation of IgG fractions
Feline sera were fractionated using a 2 step procedure. Following precipitation
with 33.33% saturated (NH4)2S04 (SASS) and centrifugation, the supernatant was
discarded and the protein pellet was resuspended in PBS, pFI 7.2 to the starting volume.
A second precipitation with 33.33% SASS was carried on and the resuspended pellet
was dialysed against a 10 fold volume of PBS at 4°C for 72h, with 3 changes.
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(1)
Fig. 2.1. Elution profile of the 7S peak (1), Fr-R (2) and Fr-R+G (3) from the
3-in-series column set of Sephacryl S-200.
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The protein was then dialysed against 0.01M phosphate buffer at 4°C overnight
and applied to a column of DEAE (DE52; Whatman, Maidstone, UK) equilibrated with
the same buffer. The excluded protein was collected and concentrated. The molarity of
the phosphate buffer was then increased to 0.025 and to 0.035M and the respective
eluted proteins were concentrated.
2.2.7.3. Preparation of IgG (Fab) 2
The IgG fraction excluded from DEAE using 0.01M phosphate, pH 8 was
adjusted to a concentration of 20 mg/ml and dialysed against a 0.1M sodium acetate
buffer, pH 4.5, for 3 hr. Then the pH was decreased to pH 4.5 using glacial acetic acid
(Sigma). Two mg of pepsin were added to 100 mg of protein and the solution was
incubated at 37°C for 24 hr. After centrifugation, the precipitate was discarded. The
resultant solution was dialysed against PBS in order to raise the pH to 7.4 before
filtration through a column of Sephadex G-100 (Pharmacia) (Hudson and Hay, 1980).
Five protein peaks eluted from the column. The peak containing the (Fab)2 fraction (peak
2) was collected, concentrated and coupled to CNBr activated Sepharose 4B.
2.2.8. Preparation of antisera
2.2.8.1. Preparation of polyclonal anti-feline IgE
All fractions were sterilised by filtration through a 0.45pm nitro-cellulose filter
(BDH, Luterworth, UK) prior to their injection into the rabbits.
2.2.8.1.1. Antisera against fraction-R
Three New Zealand white rabbits were immunised with 3 biweekly injections of
100 to 200 pg of Fr-R in 2 ml of complete Freund's adjuvant (Sigma, Poole, UK)
subcutaneously at 4 sites (table 2.2).
The resultant antisera were passed over an immunoabsorbent column of
Sepharose 4B (Sigma) to which was coupled serum from a parasite free cat that had been
heated to 56°C for 4 hr. This column removed any activity against all immunoglobulins
other than IgE and also against other heat stable serum proteins (Vaerman and
Heremans, 1968). One to 2 ml of antisera were loaded on the immunoabsorbent column
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Table 2.1. Protocols for experiments in chapter 2.
Manipulations of cats
Infection with T. cati (table 2.4)
Immunisation with DNP-Asc
Intradermal skin tests (table 2.5)
Assessment of cat sera
PK tests (table 2.5)
Fractionation of cat sera
IgE rich fraction: IgG fractions: IgG (Fab)2
- SASS (33.33%followed - SASS (33.33%)
by 45% or 55%) - DEAE (0.01M,
- DEAE (0.05M) 0.025M and 0.035M)
- Filtration on S-200: Fr-R
Production of antisera
Anti-feline IgE Anti-feline IgG Anti-feline light chain
(table 2.2) (table 2.3)
-Fr-R
- IgE eluted from putative
anti-IgE column
- Gel band cut from SDS-page
Assessment of antisera
Reversed cutaneous anaphylaxis (table 2.2)
Neutralisation ofPK reactivity (fig. 2.4)
Immunoelectrophoresis (fig. 2.5)
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Table 2.2. RCA titres of polyclonal anti-feline IgE raised against IgE preparations














R294 Fr-R from sera of parasitised cats


















R794 IgE preparation eluted from the
putative anti-IgE column (after
multiple passages of serum #6)
0.5 mg #3 400
R894 IgE preparation eluted from the
putative anti-IgE column (after
multiple passages of whole cat
sera)
0.3 mg Negative
R994 IgE preparation eluted from the
putative anti-IgE column (after
multiple passages of whole cat
sera)
0.5 mg #4 400
R1094 IgE preparation eluted from the
putative anti-IgE column (after








R195 Fr-R from pool of stray* cat sera 1 mg #2 400
R295 Fr-R from pool of stray* cat sera 1 mg #2 200
R395 Gel band cut from SDS-PAGE Negative
R196 Fr-R from pool of stray* cat sera 1 mg Negative
R197 Fr-R (55% SASS**) from pool
of sera from parasitised cats
immunised with HSA
1.5 mg Negative
R297 Fr-R (55% SASS**) from pool
of sera from parasitised cats
immunised with HSA
1 mg Negative
*: Stray cats from a cat home in Liege (Belgium).
**: IgE rich fraction resulting from a 33% SASS precipitation followed by a 55% SASS
precipitation instead of 45%.
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of heated normal feline serum equilibrated with PBS and the flow through (FT)
collected. Bound proteins were eluted using 0.1M glycine HC1, pH 2.8 and discarded.
This process was repeated several times until no protein could be eluted by glycine HC1.
The last FT collected was then concentrated to the starting volume.
2.2.8.1.2. Other anti-IgE sera
The antiserum which had the best apparent anti-IgE activity as assessed by reversed
cutaneous anaphylaxis (RCA) (R294-7) was then used to prepare an immunoabsorbent
column. A 45% ammonium sulphate precipitate of the antiserum was dissolved in PBS
and then coupled to Sepharose 4B. Two ml of sera from parasitised cats were applied to
the immunoabsorbent column equilibrated with PBS. The bound protein was eluted
using 0.1M glycine HC1, pH 2.8. The eluate was collected in 1M tris-HCL, pFI 8 to
avoid prolonged exposure to low pH, and the resulting eluate was concentrated. The
putative IgE from sera of parasitised cats that was eluted from the column was then used
to immunise 4 further rabbits using the same procedure as above (table 2.5).
Aliquots of 5 ml of sera from cats with patent infections with T. cati that had
been immunised orally with HSA were then applied to the Sephacryl S-200 columns (see
chapter 6). The first half of the 7S peak (Fr-R and Fr-R+G) was collected, concentrated
and pooled. Ammonium sulphate was added to the pool to give a final concentration of
33.33%. The supernatant was kept and precipitated a second time at 55% saturation. The
pellet obtained was resuspended with and dialysed against 0.15M PBS, pH 7.2 at 4°C for
24 hr with 3 changes. Two New Zealand white rabbits (R197 and R297) were
immunised with the resultant solution in CFA as described above.
One rabbit was also immunised with a protein band cut from a SDS-PAGE. This
protein had a MW similar to the canine IgE heavy chain (see chapter 5).
2.2.8.2. Preparation of polyclonal anti-feline IgG
All fractions were sterilised by filtration through a 0.45pm nitro-cellulose filter
(BDH) prior to injection into rabbits.
Anti-feline IgG was prepared by immunising 3 New Zealand White rabbits with
3 biweekly injections of 0.5 ml of 1 mg aliquots ofpurified IgG fractions (table 2.3). The
first immunisation was given in 2 ml of CFA whereas other 2 were given in 2 ml of
incomplete Freund's adjuvant (IFA). Rabbits were bled every 2 weeks by venepuncture.
Resulting antisera were assessed by IEP.
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Table 2.3. Polyclonal antisera raised against feline IgG preparations
Rabbit Fraction of IgG used for Immunoabsorbent column to
immunisation which the antiserum was applied
R494 0.01M (Fab) 2 column
R594 0.025M 0.01M column
R694 0.035M 0.01M column
2.2.8.3. Preparation of anti-feline light chain serum
Anti-feline light chain serum was prepared by adsorption and elution of two ml of
anti-feline IgG R4#94 from an immunoabsorbent column of Sepharose 4B coupled to
feline (Fab)2.
2.2.9. Induction of reversed cutaneous anaphylaxis (RCA)
Antisera were assessed for activity against IgE by their ability to induce reversed
cutaneous anaphylaxis (RCA) on intradermal injection in healthy parasite-free cats. Cats
were anaesthetised with 10 mg/kg ketamine hydrochloride intramuscularly. The hair of
the lateral chest area was clipped and 0.05 ml of each dilution was injected
intradermally. Antisera were tested at 1:10 and 1:100 and then at doubling dilutions.
Normal rabbit serum (1/10, 1/100 and 1/1000) and PBS were included as negative
controls and histamine phosphate 1/100,000 w/v as a positive control.
Immediate skin reactions were recorded 15 to 20 minutes after the injection as
above for IDST.
2.2.10. Homologous PK tests
Homologous PK tests were performed to assess the DNP specific IgE and the
Asc specific IgE in the sera from 9 infected cats. Healthy parasite-free cats were
anaesthetised with 10 mg/kg ketamine hydrochloride intramuscularly. The hair of the
lateral chest area was clipped. One tenth ml of ten fold dilutions in PBS (1 -1/10,000) of
each serum, sterilised beforehand by filhalion through a 0.45pm nitro-cellulose filter
(BDH), was injected intradermally. Injection sites were challenged 48 hr later by
intradermal injection of 0.05 ml of a 10 pg/ml solution of DNP-BSA , 100 pg/ml ofAsc-
74
1 and 100 pg/ml of T. cati antigen respectively. The antigens were injected into
unsensitised sites as negative controls with histamine phosphate 1/100,000 w/v as a
positive control. Skin reactions were recorded 15 to 20 minutes after the injection as
above.
2.2.11. Neutralisation ofPK reactivity
Antisera were also assessed for activity against IgE by their ability to remove PK
reactivity from feline sera. PK tests were performed as above with sera that gave positive
reactions before and after 2 and 4 passages through the anti-IgE immunoabsorbent
column (R294). Two ml of the same serum was also assessed by PK test before and after
4 passages through a column of Sepharose 4B coupled to normal rabbit serum as a
control.
2.2.12. Immunoelectrophoresis (IEP) on agar gel
IEP was performed using 1.5% agar in 0.03 M sodium barbital buffer pH 8.6.
Electrophoresis was carried out for 60 min at 50 mA in 0.03 M sodium barbital buffer
pH 8.6. After application of antisera, the slides were incubated at room temperature for
48 hr in a humidity chamber. Precipitates were washed and dried before being stained
with amido black (Sigma).
2.3. Results
2.3.1. Parasitological findings
All cats developed a patent infection with T. cati with ova appearing in the faeces
within 60 to 75 days. Adult T. cati were found in the duodenum of cats #1 - #4 at
autopsy 4 weeks to 12 months later. No T. cati were recovered in the other cats.
However Dypilidium caninum (D. caninum ) was found in the large intestine of cats #4 -
#7 (table 2.4).
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Table 2.4. Parasitological findings in 9 cats naturally* or experimentally** infected with T.
cati.
Cat Parasitological findings
Ova in faeces At autopsy
#1* yes T. cati
#2* yes T. cati
#3* yes T. cati
fj/j ^ H4 yes T. cati and D. caninum
#5* yes D. caninum
#6* yes D. caninum




All cats had a positive IDST to DNP-BSA with 4 cats (cats 1, 3, 6 and 7)
showing a +3 reaction; 4 cats (cats 2, 4, 8 and 9), a +2 reaction; and one cat (cat 5), only
a +1 reaction (table 2.5).
Table 2.5. DNP-specific IDST and PK test results in 9 cats immunised with DNP-Asc.










*: Strength of skin test to 10~2 mg/ml DNP/BSA.
* *: Highest dilution (10 fold) to which a positive test resulted using 10"2 mg/ml
DNP-BSA.
2.3.3. Homologous PK tests
Ten-fold dilutions of seia from immunised cats were assessed for PK reactivity.
Positive results were recorded with dilutions out to 1/100 (3 cats), 1/10 (5 cats), with one
cat reacting only with undiluted serum when challenged by DNP-BSA (table 2.5).
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Serum from only one cat (cat #4) gave a positive reaction to T. cati antigen (with a PK
reactivity of 1/64), and no sera showed PK reactivity against Asc-1.
2.3.4. RCA tests
The 3 antisera raised against Fr-R of the sera from cats immunised with DNP-
Asc (R194-R394) and 3 out of the 4 antisera raised against the putative IgE fraction
eluted from the putative anti-IgE column (R794-R994 and R1094) were able to induce
RCA at a dilution of >1/100 (table 2.2). Although 2 antisera (R294 and R394) were able
to induce a weal on intradermal injection at 1/3200 dilution, the largest wheal at that
dilution was obtained with R294. Reactions were not seen with normal rabbit serum. Of
the 6 last antisera produced, four were always negative on RCA, and a further two (R195
and R295) only induced positive reactions in the first two bleedings.
2.3.5. Neutralisation ofPK reactivity of reactive sera
PK reactivity to DNP and T. cati respectively in sera #6 and #4 decreased
progressively following each passage through the putative anti-IgE immunoabsorbent
column (R294) (fig. 2.2). Although the diminution in PK reactivity was evident in both
cases, it was most significant in case of serum #6 (fig. 2.2). In contrast, passage of the
sera through a column of normal rabbit serum coupled to cyanogen bromide activated
Sepharose 4B produced only a small decrease ofPK reactivity (fig. 2.2). Heating at 56°C
for 4 hr removed all PK reactivity (fig. 2.2) The eluate from the R294 anti-IgE
immunoabsorbent column following application of serum from cat #4 was assessed for
PK reactivity to DNP. A +4 result was obtained following injection of 0.1 ml of a 375
fig/ml preparation of pooled eluates.
2.3.6. IEP on agar gel
2.3.6.1. Specificity of the putative anti-feline IgE.
The absorbed antisera which had the best apparent anti-IgE activity were assayed
for their capacity to precipitate with reaginic antibodies on IEP against a range of both
heated and unheated feline sera.
Rabbit antiserum R294 from the 9th bleeding and R1094 from the 5th bleeding
were able to precipitate with a protein which had y-1 electrophoretic mobility in the 9
sera from infected cats and in the serum from a parasite free cat. This protein was not
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10 20 40 80 160 320
Titre
B Serum #6
□ Serum #6 after 2 passages through the putative anti-IgE column
□ Serum #6 after 4 passages through the putative anti-IgE column
□ Serum #6 after 4 passages through a normal rabbit serum column
■ Serum #6 heated at 56° for 4 hr
Fig. 2.2. Effect on the PK titre to DNP of the passage of feline reagin-containing
serum #6 through a putative anti-IgE immunoabsorbent column (R294)
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detectable in heated sera (fig. 2.3). The same antisera failed to detect purified feline IgG.
This protein was also no longer detectable after 4 passages of the serum through the anti-
IgE immunoabsorbent column.
2.3.6.2. Immunoelectrophoretic analysis of the eluate from the putative anti-IgE column.
Rabbit anti-feline light chain serum was tested for its ability to precipitate with
the reaginic antibody eluted from the column R294-7 coupled to cyanogen bromide
activated Sepharose 4B.
Rabbit antiserum against feline light chains detected a single protein which had y-
1 electrophoretic mobility in the putative IgE preparation eluted from the column R294-7
(fig. 2.3). However R294 was not able to precipitate with this protein, and equally the
protein was not detected by anti-feline IgG (Fc-specific).
2.4. Discussion
Foster et al. (1995) have demonstrated that reaginic activity in cat sera eluted
between the IgM and IgG peaks upon Sephadex G 200, as has been shown in other
species (Fireman et al., 1963; Zvaifler and Becker, 1966; Patterson et al., 1969; Hammer
et al., 1971; Isersky et al, 1974; Halliwell, 1975b; Fehrer, 1976; Ovary et al., 1976; Suter
and Fey, 1981; Roe et al., 1993; Yilmaz et al., 1993). Nevertheless, contrary to the dog
(Peng et al., 1991 &1997), feline immunoglobulins fail to bind to protein G (Reis et al.,
1986; Lew et al., 1991; Foster et al., 1995) which therefore cannot be used to remove
contaminating IgG from an IgE preparation. In the present study, feline reaginic
antibodies were isolated from cat sera by salt precipitation followed by anion-exchange
chromatography on DEAE and by Sephacryl 200 gel filtration to produce fraction-R.
This fraction was shown to contain reaginic antibody by its ability to produce antisera,
following immunisation of rabbits, which had activity against feline IgE as judged by
neutralisation ofPK reactivity and induction ofRCA.
On IEP on agar gel, antisera R294 and R1094 were able to precipitate with a heat
labile immunoglobulin which had y-1 electrophoretic mobility. The protein eluted from
the anti-IgE column was shown to be immunoglobulin by its detection by a rabbit anti-
feline light chain serum, but it was not detected by the anti-IgE sera R294 and R1094.
Neither was it detected by Fc-specific anti-feline IgG. It has been shown that canine IgE
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(a) Top well: cat serum #4.
Bottom well: cat serum #4 heated at 56° for 4 hr.
Trough: antiserum R294.
(b) Top trough: antiserum R294.
Bottom trough: anti-feline light chain immunoglobulin.
Well: eluate from R294 immunoabsorbent column.
Fig. 2.3. (a and b) Antibody activity of putative anti-feline IgE serum (R294) as revealed by
immunoelectrophoresis.
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is sensitive to acid treatment (Halliwell, 1975b) and the same is likely to hold true for
the feline isotype. Since 0.1M glycine-HCl pH 2,7 was used to eluate the solution from
the putative anti-IgE affinity column, the Fc portion of the reaginic antibody may have
been denatured although it was immediately neutralised with 1M Tris-HCl to pH 8.0.
This could explain why R294 failed to precipitate with the immunoglobulin in the
putative IgE eluted from the anti-IgE column. It could also explain why the antisera
produced against this eluate were weaker in terms of RCA activity. Therefore it may
have been of benefit to eluate the proteins bound to the column using a neutral buffer
such as immunopure gentle antigen/antibody elution buffer (Pierce and Warriner, UK
Ltd). However, it was surprising that the last 6 antisera produced, although also raised
against Fr-R from parasitised cats or stray cats, were either negative, or were able to
induce RCA only in the early bleedings and rapidly became negative in later bleedings.
The fractions were mixed with CFA as was the immunogen in the case of the previous
antisera but the protein concentration injected was higher, although similar to the
concentration recommended for the production of polyclonal antisera (Harlow and Lane,
1988). Nevertheless, it is possible that the fractions contained more contaminant proteins
and that the IgE antibodies were present in too small concentrations. The first bleeding
(2 weeks after immunisation) of the antisera was often able to induce a strong RCA
which rapidly decreased in the subsequent bleedings. This may be the result of the
presence of IgM antibody in high concentrations.
Although many researchers recommend that CFA should only be used for the
first injection in antisera production for humane reasons, it was used in these studies on
three occasions with full permission of the Home Office. This was done because
previous experience in our laboratory has shown that the induction of antisera against
IgE of animal origin, which is likely to be present in very small quantities, is
exceedingly difficult using any other protocol. Painless granulomatous swellings which
did not ulcerate, were the only adverse effects observed, and the rabbits were not
affected systematically.
The PK test has proved to be a sensitive method to detect the presence of reaginic
antibody (Prausnitz and Kiistner, 1921). The sensitivity of the test has been shown to be
0.2 ng/ml in human sera and 2-3 ng/ml in mouse sera (Ishizaka, 1988). The optimal
period after sensitisation for the detection of IgE using PK or PCA tests is 24 to 48 hr
while for IgG, this period is 1 to 6 hr. Moreover, the sensitisation induced by IgG
persists only for a short time of 1 to 2 days while the IgE binds to mast cells for about 3
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weeks (Ovary, 1986). Those characteristics as well as the heat sensitivity permit
distinction between IgE and IgG homocytotropic antibodies. In cats as in other species,
PCA tests have also been used extensively to establish the presence of allergen specific
IgE (Walton et al., 1968; Powell et al., 1980; Baldwin, 1993; Foster et al., 1995).
The life cycle of T. cati is complex and may include a variety of developmental
stages and several hosts. Cats can become infected by 3 different routes, namely the
ingestion of embryonated eggs, the transmammary passage of larvae from the queen and
the ingestion of larvae in paratenic hosts (rodents, birds or insects) (Swerczek et al.,
1971). The mode of infection of the cat determines the relative proportion of larvae that
migrate via the tracheal versus the somatic route. When infection occurs by the ingestion
of embryonated eggs, second-stage larvae (L2) hatch in the stomach and migrate through
the liver and the lungs to the small intestine, where they mature into the adult stage
(Hendrix and Blagburn, 1983; Swerczek et al., 1971). The migration is accomplished by
larvae in the second-stage and the third-stage does not develop until larvae have returned
to the digestive tract. Third-stage larvae develop in the stomach wall while the fourth
stage is found in the stomach contents, the intestinal wall and intestinal contents. The
patent period is about 50 days (Glickman and Schantz, 1981). In this mode of infection,
some of the larvae that reach the lung also penetrate the pulmonary vein to undergo
somatic migration and encyst in an arrested state in the tissues of the cat where they can
survive for some years.
Therefore, in order to induce a somatic migration, kittens were infected orally
with embryonated eggs. Eggs were found in the faeces 63 days after oral infection in two
cats (cats #7 and #8), and 75 days in one cat (cat #4). This is in accord with the patent
period reported by Glickman and Schantz (1981). Six months later, 2 of the cats (cats #7
and #8) were found to be negative whereas the third cat (cat #4) remained positive for
more than 12 months. The 2 cats which became negative presumably had some larvae
encysted in their tissues stimulating specific IgE against T. cati. However Bowman and
Lynn (1995) reported that in the cat there is not the age related protection seen in dogs
against T. canis, and this is why mature ascarids are not uncommon in cats. On the other
hand, faeces were assessed for T. cati eggs before the experimental infection when the
kittens were 7 weeks old. Although no eggs were found in their faeces, 7 weeks may not
have been long enough to obtain a patent infection and the kittens may still have already
been infected by the transmammary route before experimental infection. In contrast to
infection by ingestion of embryonated eggs, in the latter mode of infection, larvae
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acquired by the kitten do not undergo migration and develop in the stomach wall and
stomach contents (Hendrix and Blagburn, 1983). If so, the 2 cats which became negative
could have cleared their adult worm burden and may not have had any encysted larvae in
their tissues. It is not impossible that the mother of the kittens had encysted larvae which
were reactivated during her pregnancy. However this is unlikely since they were wormed
before mating. In a recent survey performed in Ireland, T. canis were still found in faeces
from 3.6% of pet dogs (4 dogs out of 112) which were afforded high level of care
(O'Sullivan, 1997).
The dosage of 10 embryonated eggs for 3 days was suggested by the Department
of Parasitology in Liege, Belgium in order to avoid the development of an immune
response that could have led to the clearing of the larvae.
Sera from all 9 of the cats were able to give a positive PK test to DNP at 1/10
dilution with 3 sera reacting out to 1/100. However, results of PK tests when challenged
by Asc-1 or T. cati antigen were surprising in that only one serum gave a positive test
when challenged with T. cati antigen despite the fact that all the cats had previous patent
infections with T. cati. It is also difficult to understand why the immunisation of the cats
with DNP-Asc-1 failed to induce detectable Asc-1-specific IgE. It has been shown by
Strejan et al (1973) that Asc-1 allergen is strongly immunogenic and when coupled to
DNP, was far more effective in inducing DNP-specific IgE than when coupled to other
proteins (Strejan and Marsh, 1971). A lower dose of Asc-1 could have been more
effective since Strejan et al (1973) found that Asc-1 was more immunogenic at a dose of
1 pg than at 10 jag.
Also, in some systems, the potentiation of reagins by helminth antigens seems to
require active infection and is usually transient and ceases when most of the parasites
have been expelled (Orr et al., 1971). In this study, the IgE response to DNP does not
appear to be related to the potentiation by helminth infection but may still have resulted
from immunisation of the cats with DNP coupled to Asc-1. It is also possible that the
differences seen in the IgE response could reflect differing genetic backgrounds (Tada,
1975).
Antigenic cross-reactivity between stages of Toxocara and other ascarid species
has been described (Page et al., 1991). Rabbits, rats and mice infected with T. canis gave
a heterogeneous response to the antigens of different stages and the different hosts
recognised different and cross-reacting antigens (Kennedy and Qureshi, 1986). Also,
human infection with A. suum may be associated with cross-reacting antibodies to
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antigens from A. suum and N. brasiliensis (McWilliams et al., 1987; Kennedy et al,
1987). However, in one study, Foster (1995) used crude A. suum and T. canis antigens in
PCA tests using sera from cats infected with T. canis, with negative results. The author
hypothesised that the antigens responsible for PCA activity may have been present in
different quantities at different stages of the parasite life cycle (Foster, 1995). Cox
(1993) has shown that the various immune responses are stage specific and that
immunity elicited by larval stages is effective against subsequent invading larvae giving
rise to the situation in which the host harbours a population of adult worms but is
immune to reinfestation. In the case of the cats infected by ingestion of embryonated
eggs, the cats with negative PK activity to antigens of the adult worm may still have had
some IgE activity against larval stages of T. cati.
The production of specific IgE has been linked with host-protection against
helminth infection. Hagan et al (1991) showed that resistance to reinfection with
Schistosoma haematobium in man is associated with high levels of parasite-specific IgE
antibodies with specificity for adult worm and schistosomulum membrane antigens.
Baldwin et al (1993) showed a strong correlation between the production of filarial-
specific IgE and the death of adult Brugia pahangi in cats. The majority of cats with
high levels of circulating microfilaria or live adults in the lymphatics did not produce
significant levels of IgE. However helminths are also able to elicit extremely high levels
of blocking IgG4 antibodies (Allen and Maizels, 1996). If so, such a level of specific
IgG4 may have interfered with the IgE binding to the mast cells.
The reasons for the failure of most of the cats to develop a detectable IgE
response to the parasite antigens studied using the PK test are thus obscure. However,
since the detection of specific-IgE was not performed by enzyme-linked
immunoabsorbent assay we should not exclude the possibility of the existence of another
Asc-1 or T. cah-specific IgE isoform which was either less efficient in binding to mast
cells or in inducing degranulation. It is also quite possible that antibodies of other
isotypes were produced.
In conclusion, the claim of the specificity of the antisera for feline IgE is
supported by a number of results. Firstly, the DNP-specific PK reactivity was removed
by passage through the putative anti-IgE immunoabsorbent column. Secondly, PK
reactivity was recovered in the eluate. Thirdly, this eluate contained immunoglobulin
which was not IgG. Furthermore, the antisera were able to induce RCA in high dilutions
and finally, they were able to detect a heat labile protein in the sera of parasitised cats
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INDUCTION OF ANTIGEN-SPECIFIC IgE
IN NORMAL CATS
3.1. Introduction
Although enzyme-linked immunosorbant assays (ELISAs) are marketed for the
detection of allergen-specific feline IgE, details supporting the specificity of these
antisera have not yet been published in the scientific literature. In a study of one of these
assays, Foster and O'Dair (1993) found that the correlation with intradermal skin tests
was very poor. Both the specificity and the sensitivity of the ELISA as compared with
the intradermal skin test results were low with a positive and negative predictive value of
0.1 and 0.4 respectively.
The previous chapter has documented the production of polyclonal antisera
specific for feline IgE. It was important therefore to ensure that the antisera could detect
IgE antibodies in the sera of cats in which allergen specific IgE was induced
experimentally under controlled conditions. As house dust mites are the most common
allergens involved in atopic disease in dogs and cats in Europe (Foster and O'Dair, 1993;
Carlotti and Costargent, 1994; Sture et al., 1995) Dermatophcigoides farinae (DF) was
chosen as the antigen. The kinetics of IgE and IgG responses specific for DF were
followed during the 8 weeks of the study. In addition, IgE antibodies specific for the
dinitrophenyl group (DNP) were induced in another group of cats (see chapter 2). In all




Nine cats, either naturally or experimentally infected with Toxocara cati (71 cati)
were described in the previous chapter.
Fifteen healthy adult cats were obtained from Hill Grove Family Farm Ltd, of
which 10 were used for immunisation with DF and 5 as recipients for PK tests.
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3.2.2. Allergen extracts
DF extract (1/100 w/v) was purchased from Greer Laboratories.
3.2.3. Dinitrophenylation of antigen
Cat serum albumin (CSA, Sigma) and Ascaris suum antigen (Asc-1, Greer) were
dinitrophenylated by mixing with a solution of 2 % dinitrofluorobenzene (DNFB) in
ethanol (Hudson and Hay, 1980). Dinitrophenylated protein was separated from
unbound DNFB by filtration through a Sephadex G-25 column (Pharmacia).
3.2.4. Immunisation of cats
1. The 9 cats, naturally or experimentally infected with T. cati, were given two
subcutaneous injections at 2 week intervals of 10 pg of DNP-Asc in aluminium
hydroxide (Imject™ Alum®, Pierce), and were the same cats as described in the
previous chapter. Serum was harvested from blood taken prior to immunisation and 2
weeks after the second immunisation.
2. Ten cats from a parasite free colony were given 3 subcutaneous injections of
50 pg ofDF in aluminium hydroxide at weeks 0, 2 and 5. Five cats (U49, B85, 46L, D09
and 794), in addition, were given at the same time, 50 pg of Asc-1 mixed with the DF
antigen in the same adjuvant. All cats were bled prior to immunisation and at weekly
intervals thereafter for 7 weeks.
3.2.5. Performance of intradermal skin tests (IDSTs)
IDSTs were performed weekly as before (chapter 2). Two fold dilutions of a
1/1000 w/v dilution ofDF was injected intradermally.
3.2.6. PK tests
PK tests were performed as before (chapter 2). Briefly, 0.1 ml of doubling
dilutions of sera were injected intradermally. Injection sites were challenged 48 hr later
by intradermal injection of 0.05 ml of a 1/1000 w/v dilution of DF. For standardisation
of responses between PK tests in recipient cats, a reference serum from a cat which had a
strong positive skin test to a high dilution ofDF was used in each test.
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3.2.7. Antisera
The antiserum R294 (chapter 2) was passed through an affinity chromatography
column containing DF coupled to cyanogen bromide activated Sepharose 4B
(Pharmacia) to remove possible naturally occurring antibodies with activity against DF.
Rabbit anti-feline IgG, heavy chain (HC) specific, was purchased from Nordic
Immunology (Tilburg, the Netherlands).
Monoclonal alkaline phosphatase-conjugated mouse anti-rabbit immunoglobulin
was purchased from Sigma.
3.2.8. ELISA
3.2.8.1. Assay optimisation
Preliminary assays were performed to determine optimal dilutions of reagents
and sera. The concentrations of coating antigen and conjugated antibody were evaluated
by use of checkerboard titrations.
3.2.8.2. Detection ofDF-specific IgE
DF-specific IgE in feline sera from sensitised cats was assessed by indirect
ELISA. Polystyrene microtitre plates (Immulon 4®, Dynatech Laboratories,
Billingshurst, UK) were coated overnight at 4°C with 100 pl/well of 1/5000 W/V
dilution of DF extract in 0.1M sodium carbonate buffer, pH 9.6 (coating buffer). Plates
were washed three times with washing buffer which was 0.05% tween 20 (Sigma) in
0.015M PBS, pH 7.2 and blocked overnight at 4°C with 0.5% human serum albumin
(FISA) in washing buffer (150 pl/well). After further washing, 50 pi of each sample
diluted in ELISA buffer (0.05% tween 20, 0.1% of HSA in 0.015M PBS, pH 7.2) was
added to duplicate wells. After incubation at 37°C for 2 hr and further washing, 50 pi of
the polyclonal anti-feline IgE diluted in ELISA buffer (1/50) was added to each well.
After incubation for 2 hr at 37°C, the plates were washed and 50 pi of the alkaline
phosphatase-conjugated second antibody diluted in ELISA buffer (1/2000) was added to
each well and plates were incubated for a further hour at 37°C. After a last wash, 50 pi
of alkaline phosphatase substrate, namely 5 mg of PNP substrate tablets (Sigma) in 5.5
ml of MgCl2 in diethanolamine buffer, pFI 9.8, was added to each well. Plates were
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incubated at 37°C for 30 minutes and the optical density (OD) at 405 nm read using an
automated microtitre plate reader after subtraction of the mean blank well values.
3.2.8.3. Detection ofDF-specific IgG
DF-specific IgG was assayed by indirect ELISA as performed for allergen-
specific IgE. Incubation times with the serum samples were reduced from 2 hr to 1.5 hr
for the serum samples and from 2hr to 1 hr for both the polyclonal rabbit anti-feline IgG
and the alkaline phosphatase conjugated monoclonal mouse anti-rabbit immunoglobulin.
Rabbit anti-feline IgG was used at 1/5000 and conjugated antibody at 1/2000.
3.2.8.4. Detection ofDNP-specific IgE and IgG
The same method as above was used to assess the DNP-specific antibody except
that plates were coated with 10 pg/ml of a solution of DNP-CSA for the measurement of
DNP-specific IgE and 1 pg/ml in the case ofDNP-specific IgG.
3.2.8.5. Standardisation of results
A serum containing a high level of allergen-specific IgE or IgG antibody was
selected as the standard and assigned a value of 1000 relative antibody unit (RAU) value
when undiluted. Doubling dilutions of the standard were included in each plate, and the
results were recorded in RAU by reference to the standard curve. Preimmunisation sera
were used as negative control sera in each plate.
3.2.8.6. Assessment of serum-samples
Serum samples were initially assessed at a dilution of 1/2 in ELISA buffer for the
detection of DNP-specific IgE and DF-specific IgE in preimmunisation bleedings and
1/5 in postimmunisation bleedings. For the detection of DNP-specific IgG and DF-
specific IgG, preimmunisation and postimmunisation bleedings were initially assessed at
a dilution of 1/10 and 1/100 respectively. The assay was then repeated in lower or higher
dilutions as appropriate. A serum sample whose resultant OD fell below the end point of
the standard curve (EPSC) was deemed to be negative. For statistical analyses, these sera
were given a value halfway between the RAU of the EPSC and zero.
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3.2.8.7. Determination of the standard curve
A programmable ELISA reader indicated the % error for each point on the
standard curve. Since these errors tended to be higher at the lower and higher end of the
curve, these points were deleted, leaving a minimum of 3 or 4 points to the standard
curve for the detection of DNP and DF-specific IgE, and 4 to 5 points for the detection
of allergen-specific IgG. The standard curve was generated by plotting the OD against
log 10 reference serum concentration.
Using linear regression analysis, the correlation coefficient of each standard




X represents concentration whereas Y denotes optical density
2 ... 2 •
When R = 1, all data points lie along the line the best fit, whereas when R is
very small, data points are highly scattered.
3.2.8.8. Validation of the assay
Allergen-specific IgE and IgG were measured in sera before and after heating to
56°C for 4 hr. In the case of both DNP and DF-specific antibody, IgE was no longer
detected after heating, whereas IgG levels were substantially unaffected (figs 3.1 (a and
b) and 3.2 (a and b)). This supports the isotype specificity of the anti-IgE antiserum.
3.2.9. Statistical analysis
Correlation of IgE and IgG were calculated using a Pearson's rank coefficient
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Fig. 3.1. DNP-specific IgE (a) and IgG (b) in cat sera before and after heating
at 56 °C for 4 hr (h = sera after heating). IgE and IgG levels reported as
















Fig. 3.2. DF-specific IgE (a) and IgG (b) in cat sera before and after heating
at 56 °C for 4 hr (h = sera after heating). IgE and IgG levels reported as




No DNP-specific antibody was detected in the sera of cats prior to their
immunisation with DNP-Asc. Six out of the 9 cats developed an IgE response against
DNP as assessed by ELISA (fig. 3.3). However all the cats were positive to the IDST
and all showed positive PK tests. Serum from 8 of the cats gave positive PK tests at 1/10
with 3 sera reacting out to 1/100. One cat had PK reactivity only to undiluted serum.
All cats developed a DNP-specific IgG response (fig. 3.3).
3.3.2. DF-specific response
3.3.2.1. IDSTs
The 10 cats immunised with DF were skin tested weekly commencing
immediately prior to the first injection. Assessment of the level of serum DF-specific
IgE by ELISA and of the highest dilution of DF antigen to induce a positive skin test
following intradermal injection revealed some striking anomalies and little evident
correlation. Firstly, DF-specific IgE was in general, detectable in sera prior to the time at
which the cat showed positive skin tests. Indeed, 4 cats failed to develop positive skin
tests during the 8 weeks of the experiment despite developing some of the highest levels
of serum allergen-specific IgE. In general, strongly positive skin tests to high dilutions
of antigen were always accompanied by high levels of detectable allergen-specific IgE.
However the reverse was not the case. The individual responses are noted in fig. 3.4 (a-
j))-
3.3.2.2. ELISA
OD values slightly greater than the blanks were detected in some of the
preimmunisation sera. These values were unchanged in sera after passage through an
immunoabsorbent column of DF coupled to Sepharose 4B (data not shown) which
implied non-specific binding. These OD values were therefore subtracted from the
results in each case before expression in RAU following reference to the standard curve.
All cats developed both an IgG and an IgE response to DF following
immunisation (fig. 3.5 (a and b)). The kinetics appeared different, in that a detectable
IgE response appeared earlier, and had fallen by week 5 prior to the third immunisation.
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Fig. 3.3. DNP-specific IgE and IgG responses, and PK reactivity to DNP











Fig. 3.4. The relationship between the DF-specific IgE and IgG (in RAU) , and the
highest dilution of antigen to gave positive IDST (skin reaction titre) in 10 cats
immunised with DF.
= immunisation. IgG results are divided by 1000.
(a) cat A60 and (b) cat U49
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Fig. 3.4. (continued) The relationship between the DF-specitic IgE and IgG (in
RAU) , and the highest dilution of antigen to gave positive IDST (skin reaction
titre) in 10 cats immunised with DF.
^ = immunisation. IgG results are divided by 1000.






































Fig. 3.4. (continued) The relationship between the DF-specific IgE and IgG (in
RAU), and the highest dilution of antigen to gave positive IDST (skin reaction
titre) in 10 cats immunised with DF.
^ = immunisation. IgG results are divided by 1000.






Fig. 3.4. (continued) The relationship between the DF-specific IgE and IgG (in
RAU), and the highest dilution of antigen to gave positive IDST (skin reaction
titre) in 10 cats immunised with DF.
^ = immunisation. IgG results are divided by 1000.



























































Fig. 3.4. (continued) The relationship between the DF-specific IgE and IgG (in
RAU), and the highest dilution of antigen to gave positive IDST (skin reaction
titre) in 10 cats immunised with DF
^ = immunisation. IgG results are divided by 1000.




























Fig. 3.5. Mean and standard error of the DF-specific IgE (a) and DF-specific
IgG (b) responses in 10 cats immunised with DF. Antibody expressed in RAU.
^ = immunisation.
w. 0 w. 1 w. 2 w. 3 w. 4 w. 5 w. 6 w. 7
Time (weeks)
w. 5
A Time (weeks) ^
w. 6 w.7
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In contrast, a detectable IgG antibody response commenced later and rose gradually
through the 8 weeks (fig. 3.5 (a and b)). Assessment of both isotypes in all serum
samples in each cat revealed no significant correlation between them (Pearson's rank
correlation coefficient). However, when all the ELISA values for DF were considered
together, there was a significant correlation between Log DF-specific IgE and IgG
antibodies at weeks 2, 4 and 5 (r=0.499, 0.396 and -0.504 respectively, p<0.05, fig. 3.6)
although some samples had very high IgG and low IgE levels and vice versa (fig. 3.4 (a-
j)). The levels of both isotypes were not correlated at weeks 3, 6 and 7 (r=0.120, 0.010
and 0.026 respectively, p>0.05, fig. 3.6). The correlation between Log DF-specific IgE
and IgG antibodies was also significant when all the data were considered together over
the 8 week period (weeks 0 to 7, 10 cats, r=0.790, p<0.01, fig.3.7). The 5 cats
immunised with DF alone (A71, 60T, 81P, A60 and 735) in alum produced responses
that did not differ noticeably from those immunised with both DF and Asc-1 in alum
(U49, B85, 46L, D09 and 794).
3.3.2.3. PK tests
Positive PK tests were only obtained using sera from cats with positive IDSTs
and the IDST reactivity tended to parallel the PK titre. Thus the strongest PK test results
were in general obtained with postimmunisation sera from cats which had strong
positive skin tests to high dilutions ofDF (up to 1/320). On the other hand sera from cats
which had positive IDSTs to low dilutions of DF, gave either negative or only weakly
positive PK reactions. Furthermore postimmunisation sera from the 4 cats which failed
to develop positive skin tests but had high levels of serum allergen-specific IgE as
assessed by ELISA showed no PK reactivity. On the other hand, allergen-specific IgE
was detected by ELISA in cats which had PK reactivity as well as in cats which had no
such reactivity. In both situations the IgE was heat labile and was not detected by the
ELISA after the serum was heated at 56°C for 4 hr. Heating the sera also completely
abolished the PK reactivity.
3.4. Discussion
One of the classical characters lie properties of reaginic antibody is its sensitivity
to heating (Coca and Grove, 1925). Ishizaka et al. (1967) observed that reaginic antibody
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Fig. 3.6. DF-speciflc IgE and IgG in RAU in sera from cats immunised with DF at week 2
(a), week 3 (b), week 4 (c), week 5 (d), week 6 (e) and week 7 (f).
The levels of the two isotypes are significantly correlated at week 2 ((a) r =0.499, p < 0.05),
week 4 ((c) r =0.396, p < 0.05) and week 5 ((d) r =-0.504, p < 0.05). The correlation was not
significant at week 3 ((b) r =0.120, p > 0.05), week 6 ((e) r = 0.010, p > 0.05) and week 7 ((f)
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Fig. 3.7. DF-specific IgE and IgG in RAU in sera from cats immunised with
DF. The levels of the two isotypes are significantly correlated (r = 0.790, p <
0.01).
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56°C for 2 to 4 hr. Schwartzman and Rockey (1967) demonstrated that canine reaginic
antibody is comparable to human reaginic antibody in many characteristics including
heat sensitivity. Powell et al. (1980) demonstrated the heat sensitivity of reaginic
antibody in cats. Such treatment does not inactivate other classes of antibody and thus
allows the differentiation between IgE and other isotypes. In the present study, the
complete abolition of detectable allergen-specific IgE in postimmunisation sera heated to
56°C for 4 hr demonstrated the specificity of the rabbit anti-feline IgE. It was
noteworthy that in the case of the ELISA for DF-specific IgE, above background OD
values were obtained in preimmunisation sera. The fact that the OD values were
unchanged after passage through a DF immunoabsorbent column, and that the rabbit
anti-feline IgE had also been passed over such a column indicated non-specific binding.
It has been shown in dogs that the high background levels of IgE antibody, associated
with parasitism, may interfere with the ELISA and lead to a higher incidence of false
positive results. In one study, Griffin et al. (1990) demonstrated that different types of
antigens were affected differently by the serum IgE concentration. It is important
therefore, that true controls are identified in the case of each allergen system to obviate
false positive results. Although the cats used in the DF study were parasite free at the
time of the experiment, the possibility of previous parasitism cannot be excluded.
Only duplicates of a single dilution were performed in the ELISA in the present
study. Bullock and Walls (1977) found that reactivity curves showed an extremely steep
slope at the end point. The antibody affinities of various sera may differ, leading to many
possible dose-response curves (de Savigny and Voller, 1980). In this respect, testing a
whole range of serum dilutions would have been more accurate. However the amount of
antiserum available was too low to allow such procedure.
In the T. cati infected cats, immunisation with DNP-Asc produced a DNP-
specific IgE response (assessed either by ELISA or PK tests) in all cases. Surprisingly,
ELISA results did not correlate with PK test results. Indeed, the antiserum was not able
to detect any DNP-specific IgE in the sera of 3 cats although all of these cats had good
PK reactivity. The PK test is considered a sensitive test with an estimated minimum
concentration of human IgE required for sensitising human skin for a positive reaction of
0.2 ng/ml (Ishizaka and Ishizaka, 1975). Therefore this finding could be related to the
lower sensitivity of the ELISA in comparison with the PK test. However, since the PK
tests were performed almost 2 years before the ELISA tests and samples had been
thawed and refrozen a number of times, the IgE may have been denatured in those cats
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by freezing and thawing or storage conditions. On the other hand, this is unlikely since
in dogs, as in man, IgE appears to be remarkably stable in serum stored at room
temperature for short durations and limited freeze/thaw cycles are unlikely to
substantially alter quantitative results (Bazaral and Hamburger, 1972; Halliwell, 1975;
Hill and DeBoer, 1994). Another explanation could be that the high level of DNP-
specific IgG in cats 1 and 9 could have interfered with the binding of allergen-specific
IgE to the antigen in the ELISA. However cat 6 showed a high level of IgE and a good
PK reactivity in spite of a high level of IgG. Also the cats that showed positive PK tests
and no detectable IgE on ELISA may have had higher levels of DNP-specific
immunoglobulins other than IgG and IgE. It has been shown that dogs sensitised to
ragweed not only develop ragweed-specific IgE and IgG level but also ragweed-specific
IgA, IgM and IgD-like antibody (Peng et al, 1991; Yang et al., 1995). The reasons for
this discrepancy are thus obscure.
Injections of Asc-1 together with DF in 5 parasite free cats failed to stimulate a
higher DF-specific IgE than in cats given DF alone. It is well-known that helminths are
particularly adept at stimulating IgE synthesis. Helminth infection has the ability to
potentiate IgE responses to unrelated antigens and therefore to disproportionately elevate
serum levels of total non-parasite-specific IgE (Ogilvie, 1964; Jarrett and Bazin, 1974;
Turner et al., 1979; Zakroff et al., 1989). Halliwell (1973) showed that subcutaneous
injections in dogs of A. suum antigen alone or coupled to haptens was able not only to
stimulate the production of reagin to haptens to which the antigen was coupled but also
to any protein with which it was simultaneously administered. However the parasite
status of the dogs was not known, although in those days T. canis infection in dogs was
almost universal. The apparent disparity in the ability of ascaris antigens to stimulate
allergen-specific IgE production in the 2 experiments may thus merely relate to the
parasite status.
In the DF immunised cats, the IgE response commenced early, being detectable 2
weeks after immunisation whereas IgG was essentially undetectable until week 3.
Furthermore, the IgE level tended to fall off after the second immunisation in 5 cats
whereas the IgG antibody continued to rise. IgE thus appears to be an early antibody in
the cat, as has been shown in the rat (Tada, 1975). The decrease in DF-specific IgE after
5 weeks, as contrasted with the IgG response, could, of course merely be reflective of the
shorter half-life of the former isotype, rather than an actual lowering of the production
relative to IgG. The IgE antibody level depends not only on the dose of the antigen and
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the adjuvant used but also on the interaction of genetic background and environmental
factors (Levine et Vaz, 1970; Vaz et al., 1971). It has been demonstrated that the IgE
response to an allergen in mice depends on the strain immunised (Levine et Vaz, 1970).
The marked variations of the antibody response seen in these cats are most probably the
result of the genetic differences between them as it was suggested for the outbred dogs in
the study of Schultz and Halliwell (1985).
The cats immunised with DF showed no clinical signs of allergy in spite of the
strongly positive IDST developed by some of them. It is possible that this resulted from
the limited exposure to DF in the laboratory conditions. However the subcutaneous route
used for antigen administration, both for the induction of IgE and for antigen challenge,
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is different to the natural disease in which the percutaneous route is believed to be
responsible for clinical signs (Halliwell, 1990; Olivry et al., 1996). On the other hand it
is noteworthy that no species in which IgE was experimentally induced, including man,
have shown any clinical signs of allergic disease (Marsh et al., 1972). The only study
that came close to inducing spontaneous disease involved a study of basenji-greyhound
crosses who developed not only bronchospasm, but also dermatitis upon repeated
nebulisation with Ascaris antigen (Butler et al., 1983). However these dogs were either
natively allergic to A. suum or had become sensitised by repeated aerosol challenge with
a purified Ascaris antigen. This emphasises the fact that it is not merely the presence of
IgE that distinguishes atopic individuals from normals. It has been suggested that this
might be because the reaginic response can be accompanied by high levels of blocking
antibodies (Marsh et al., 1972) but another reason could be the heterogeneity of the
reaginic antibody response as discussed below.
In the present study, circulating levels of DF-specific IgE did not correlate with
tissue-bound IgE as assessed by IDSTs. In particular, 4 cats with high levels of IgE
never developed a positive IDST. Moreover, it was noteworthy that there was a marked
lack of correlation between the level of IgE as assessed by ELISA and by PK tests. Also,
positive PK tests were never obtained using sera from cats which were IDST negative,
although such sera had high levels of IgE as assessed by ELISA. On the other hand, sera
from the cats which were only IDST positive to a low dilution of DF showed only a
weak PK reactivity whereas sera from cats which had a positive IDST to high dilutions
of DF showed much greater reactivity. It is, of course, possible that the cats which
developed a high level of DF-specific IgE without a positive IDST may have developed
a high level of blocking IgG. However, the level of IgG measured in these cats was not
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higher than in the cats with a positive IDST to a high dilution ofDF that showed strong
PK reactivity. Therefore the DF system appears to be different than the DNP system, in
that sera from all the 9 cats immunised with DNP showed PK reactivity.
It could also be hypothesised that the negative IDSTs in the face of the positive
ELISAs could be due to a delay in circulating IgE fixing to mast cells. Such a
phenomena is believed to occur clinically in some cases of canine atopic disease in
which the positive in vitro tests develop weeks or months before a positive IDST.
However this possibility could be excluded as the sera from these cats failed to give
positive PK tests.
The most rational explanation for this finding would be the existence of
heterogeneity of IgE in cats. Theoretically, a number of possibilities exist by which
subclasses of IgE could differ. Firstly, the IgE antibody could be heterogeneous in terms
of its ability to respond to histamine releasing factors (HRF), which are cytokines
derived from macrophages, lymphocytes, mononuclear cells, platelets and vascular
endothelial cells. It has been hypothesised that it is not the production of IgE but, rather
the ability of the IgE to interact with the HRF which differentiates atopics from non
atopic individuals (Lichtenstein, 1988). The basis of this heterogeneity is not yet
understood but has been speculated to be due to differential glycosylation of the IgE
molecule (MacDonald, 1996). Thus the type of IgE produced by the cats experimentally
immunised with DF, in contrast to that produced by atopic cats, may not be reactive with
HRF. In cats which become positive to the IDST, this first IgE antibody response (IgE-)
could have been followed by the production (switching) to the second type of IgE
antibody (IgE+). The cats which stayed negative to the IDST would never have
developed the second IgE isotype and such animals would have positive ELISA results
without positive IDST or PK reactivity. However in man, HRF's appear to be involved
only in the late phase reaction resulting from the activation of basophils, and the reaction
is seen in only a subpopulation of allergic individuals (MacDonald, 1996). Therefore it is
unlikely that, in the present study, the interaction of IgE with HRF would explain why
some of the cats in which DF-specific IgE was experimentally induced did not develop
an immediate response to the IDST.
Secondly it is possible is that the IgE antibody experimentally induced in the
normal cats may be less effective at inducing degranulation, as is the case with IgG
homocytotropic antibody which requires larger amounts of antigen to elicit positive
IDSTs or passive transfer tests. In this regard it has been shown in man that anti-IgG4
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appears to be less effective than anti-IgE in eliciting basophil histamine release and that
the amount of anti-IgG4 required to induce a response is very high (Valent and
Bettelheim, 1992). It could also be that the IgE experimentally induced in the normal
cats may have a low affinity for mast cell receptors and therefore not be able to interact
with them in order to sensitise mast cells. In a recent study, Lyczack et al. (1996)
demonstrated the existence of 4 human IgE isoforms They suggested that this could be
an additional possible explanation for the functional heterogeneity of IgE and that IgE
may differ in its primary protein structure as well as glycosylation. Each isotope may
have some unique properties as circulating, cytophilic immunoglobulins, and may differ
in their ability to carry out IgE-mediated functions through binding to their different
receptors. One of those isoforms is secreted as half-molecules (heavy-light chain) and
therefore could be less able to arm mast cells and basophils for antigen-triggered release
and may indeed inhibit such release (Lyczack et al., 1996). Interestingly, it has been also
shown that the relative levels ofmRNAs encoding various isoforms appears to be altered
in allergic and parasitic diseases (Diaz-Sanchez et al., 1995). These findings suggest that
the existence of more than one type of IgE in cats is not unexpected and that the IgE
antibody experimentally induced in normal cats may be different from the IgE produced
in allergic cats. Moreover, it is not impossible that the cats which developed a positive
IDST were genetically predetermined to be atopic.
Findings of recent studies in dogs are also strongly suggestive of a heterogeneity
of canine IgE. Lian and Halliwell (1998) skin tested and blood sampled both normal and
atopic dogs for the detection of allergen-specific IgE and found positive IDSTs and
ELISAs in most of the normal dogs.
Jackson et al. (1996) studied leucocyte histamine release in atopic dogs, normal
dogs and artificially sensitised dogs and found comparable results to those found in that
study, in that histamine release induced by antigen or anti-IgE was generally found only
in atopic dogs.
Using a monoclonal and polyclonal antibodies specific for canine IgE, Peng et al.
(1993b) found that the ELISA values measured by the monoclonal antibody correlated
less well with PCA titres when compared to the ELISA values measured by the
polyclonal antibody. They were able to isolate 2 different isotypes of canine IgE (IgEl
and IgE2) which differed from each other by their charge, their affinity for protein A and
their antigenicity (Peng et al., 1997). Carbonhydrate moieties appeared not to be
involved in the differences between the 2 types of IgE. In spite of these differences, both
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exhibited typical IgE characteristics, such as heat sensitivity, identical molecular weight
and capacity to induce 48-hr PK tests.
Since PK test results can be influenced by the recipient (Augustin, 1978), the PK
tests in these studies were performed with a positive serum included in each assay as a
control. This serum was used a total of 9 times on 5 recipients with an identical titre
(1/320) on every occasion although the reaction size varied from one cat to another. This
supports the validity of the test as used in this study. The use of Evans blue and the PCA
test could have been more sensitive and resulted in higher observed titres, but such an
approach limits the repeated use of the cats. Interestingly PK tests have been found to
have limitations in dogs as the titre of a given serum may vary widely when assessed in
different recipient animals (Peng et al., 1993a).
In conclusion, the present study showed that normal cats developed a reaginic
antibody response to both a hapten (DNP) and an environmental allergen (DF) which
was readily detected by use of the polyclonal anti-IgE in an ELISA. There was a
significant overall correlation between allergen-specific IgE and IgG responses.
However, the level of allergen-specific IgE was not correlated with either skin test or PK
reactivity, whereas the positive PK reactivity was generally correlated with positive skin




MEASUREMENT OF DF-SPECIFIC IgE IN THE SERA
FROM SPONTANEOUSLY ALLERGIC CATS
4.1. Introduction
Feline atopy was first described in 1982 by Reedy who reported positive skin
tests and a good response to immunotherapy in cats presented with miliary dermatitis,
self-induced alopecia and/or eosinophilic granuloma complex (Reedy, 1982).
IgE immunoglobulin has been shown to be involved in the pathogenesis of atopy
although its clinical relevance remains unknown. Because the intradermal skin test
(IDST) has been the only test available for allergy testing in the cat, the diagnosis of
atopy has been based on this test and response to hyposensitisation for many years
(Reedy, 1982; Scott, 1984; Prost, 1992). Recently, ELISA for feline IgE has become
commercially available in the USA and in Europe. However these tests have not been
adequately evaluated. The only study which compared the results of ELISA to the IDST,
which was assumed to be the gold standard in the diagnosis of feline atopy, reported a
very poor correlation between the two. The authors concluded that the ELISA used was
unreliable in establishing a diagnosis of feline atopic disease (Foster and O'Dair, 1993).
Nevertheless, in a recent study in which 81 cats received hyposensitisation based on the
results of radioallergosorbent tests (RAST), the response was shown to be broadly
similar to that obtained when hyposensitisation was based upon the results of skin
testing (Halliwell, 1997).
In the previous chapter (chapter 3), it was demonstrated that allergen-specific IgE
could be induced in normal cats by immunisation with Dermatophagoides farinae (DF)
in aluminium hydroxide. The allergen-specific IgE response was shown not to be
correlated with the skin reactivity, which raised the question of a possible heterogeneity
of IgE in this species. It was therefore of interest to know if cats suffering from atopy
had higher levels ofDF-specific IgE than normal cats. The level of DF-specific IgG was
also assayed.
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4.2. Materials and methods
4.2.1. Cat sera
Cats were presented to the Royal (Dick) School of Veterinary Studies at the
University of Edinburgh and to the Faculte de Medecine Veterinaire at the Universite de
Liege in Belgium. Three groups of cats were represented in the study:
Atopic cats. The 10 cats comprising this group had a mean of age of 6.5 years
(range 3 years to 12 years). Six of the cases were spayed females and the 4 males were
castrated. The diagnosis of atopic disease was made by the combination of clinical signs,
absence of any other dermatological disease that could account for their disease, and the
presence of at least one positive reaction to the IDSTs using a panel of 57 allergens. A
hypoallergenic food trial and strict flea control were performed in each case to exclude
those diseases. One cat had also a concomitant adverse reaction to food, and responded
partially to a hypoallergenic diet.
Control group 1. This group comprised 15 normal healthy household cats that
were presented to the University of Liege for routine examination. The average age of
the group was 4.5 years (range 9 months to 13 years). The group was composed of 7
females (2 spayed) and 8 males of whom 6 were castrated. All were free of skin disease
and ectoparasites.
Control group 2. This group comprised 11 normal healthy laboratory reared cats
that were obtained from Hill Grove Family Farm Ltd. The mean age was 9 years (range
4 to 12 years). All cats were entire females. The cats had been raised under laboratory
conditions and presumably exposed at best to only low levels ofDF.
4.2.2. Allergen extracts
DF extract (1/100 w/v) was purchased from Greer Laboratories.
Fifty three additional allergens were selected for intradermal skin tests of which
42 were obtained from Greer laboratories whereas 12 were obtained from ARTU
(Artuverin Allergens; ARTU Biologicals, Lelystad, The Nederlands) (table 4.1).
Allergens were used at appropriate dilutions which were believed to be non-irritant for
the dog (August, 1982) and therefore non-irritant for the cat (Bevier, 1990).
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Table 4.1. Allergens and concentration used for the IDST
Number Allergens Units Concentration Source
Mites/Dusts
1 Dermatophagoides pteronyssinus w/v 1:10000 Greer
2 Acaris siro NE 100 ARTU
3 Dermatophagoides farinae w/v 1:10000 Greer
4 Tyrophagus putresceantiae NE 100 ARTU
5 House dust PNU 1000 Greer
Epithelial group
6 Human epithelium mg 10 ARTU
7 Cat epithelium PNU 500 Greer
8 Horse dander PNU 500 Greer
9 Sheep epithelium PNU 500 Greer
10 Mixed feathers mg 100 ARTU
11 Cotton linters w/v 1:1000 Greer
Insects
12 American/German cockroach PNU 500 Greer
13 Flea w/v 1000 Greer
Trees
14 White ash PNU 1000 Greer
15 Ash NE 1000 ARTU
16 Tag alder PNU 1000 Greer
17 Alder NE 1000 ARTU
18 American beech PNU 1000 Greer
19 Beech NE 1000 ARTU
20 White oak PNU 1000 Greer
21 White birch PNU 1000 Greer
22 Birch NE 1000 ARTU
23 American elm PNU 1000 Greer
24 Elm NE 1000 ARTU
25 Box elder PNU 1000 Greer
26 Elder NE 1000 ARTU
27 Plane NE 1000 ARTU
28 White pine PNU 1000 Greer
29 Hawthorn PNU 1000 Greer
Weeds
30 Yellow dock 1000 Greer
31 Jerusalem oak 1000 Greer
32 Lambs quater 1000 Greer
33 Commun mugwort 1000 Greer
34 Nettle 1000 Greer
35 English plantain 1000 Greer
36 Brassica spp 1000 Greer
37 Chrysanthemum spp 1000 Greer
38 Red clover 1000 Greer
39 Heather 1000 ARTU
40 Kentucky blue 1000 Greer
41 Meadow fescue 1000 Greer
42 Orchard/Cocksfoot 1000 Greer
43 Perrenial rye 1000 Greer
44 Sweet vernal 1000 Greer
45 Timothy 1000 Greer
46 Velvet/Yorkshire fog 1000 Greer
47 Red top/Bent 1000 Greer
48 Couch 1000 Greer
Moulds/Smuts
49 Aspergillus mix 1000 Greer
50 Alternaria tenius 1000 Greer
51 Botryttis cinerea 1000 Greer
52 Penicillium mix 1000 Greer
53 Barley smut 1000 Greer
54 Oat smut 1000 Greer
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4.2.3. Antisera
The production of polyclonal rabbit anti-feline IgE used in this study was
described in chapter 2. The antiserum was passed through an affinity chromatography
column containing DF coupled to cyanogen bromide activated Sepharose 4B
(Pharmacia) to remove possible naturally occurring antibodies with activity against DF.
Goat anti-feline IgG, Fc specific, alkaline phosphatase-conjugated, was obtained
from Bethyl Laboratories Inc. (Montgomery, Alabama, USA).
4.2.4. IDSTs
Prior to the IDST, all antiinflammatory drug therapy was discontinued for at least
4 weeks in the case of oral and topical medications or at least 8 weeks in the case of
injectable glucocorticoids or progestagen therapy (Barbet and Halliwell, 1989; Halliwell
and Gorman, 1989).
IDSTs were performed as in the previous chapters.
4.2.5. In vitro enzyme-linked immunoabsorbent assays (ELISAs)
4.2.5.1. Detection ofDF-specific IgE
Assay conditions were optimised in preliminary experiments (chapter 3). Results
were expressed in RAU by reference to the standard which was included in each plate.
Serum samples were initially assessed at a dilution of 1/5 and repeated at higher or lower
dilutions if the results did not fall in the sensitive part of the curve. Plates were read from
30 minutes to 45 minutes.
4.2.5.2. Detection ofDF-specific IgG
Serum samples were assayed for DF-specific IgG by direct ELISA. They were
initially assessed at a dilution of 1/100. Incubation time with the serum samples was
reduced from 2 hr to 1.5 hr and, from 2 hr to 1 hr with the alkaline phosphatase-
conjugated goat anti-feline IgG. Polyclonal anti-feline IgG was used at 1/100. Plates
were read from 30 minutes to 45 minutes.
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4.2.5.3. Statistical analysis
Nonparametric Mann Whitney tests were used to perform the statistical analysis
and to compare the IgE and IgG levels in the 3 groups of sera. Differences were
considered significant at p<0.05.
Correlations between IgE and IgG were calculated using Pearson's rank




All the 10 cats showed skin test reactivity to at least one of the house dust mite
(HDM) and/or house dust (HD) antigens (table 4.2). The most common allergens
implicated by the IDST were DF and HD which both gave positive reactions in 8 cats
(table 4.2). Six cats were positive to Dermatophagoid.es pteronyssinus (DP) and four cats
were also positive to flea antigen (table 4.2). Other allergens to which positive reactions
were seen were Tyrophagus putresceantiae (n=2), mixed moth (n=T), cockroach (n=l),
white ash (n=l), birch (n=l), american elm (n=l), Brassica spp (n=l), Chrysanthemum
spp (n=2), red clover (n=2), Heather (n=T), velvet/Yorkshire fog (n=l), red top/bent
(n=1), and couch (n=1).
Table 4.2. Levels of DF-specific IgE and IgG, and IDST results for DF, DP and HD
antigens in the 10 atopic cats
Atopic cats IDST DF-specific DF-specific
DF DP HD IgE (RAU) IgG (RAU)
166324 +3 +4 +3 953 295793
165767 neg. neg. +3 576 15259
166349 +3 neg. +2 282 1722
166064 neg. +1 + 1 657 31170
161640 +3 neg. neg. 97 14456
165841 +2 +1 +2 447 1317
166735 +3 neg. +2 680 5543
8317 +4 neg. +3 421 26031
640 +2 +2 neg. 327 17644
Noirfa +3 +3 +2 468 21177
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4.3.2. ELISA results
Although the median level of antibody to DF in the atopic cats of both isotypes
was higher than that of control group 1 (457.5 vs 330 RAU for IgE and 16451 vs 9860
RAU for IgG) in neither case was the difference significant (table 4.3, fig. 4.1(a) and
4.1(b). However, in the control group 2 (laboratory reared cats) the median levels (37
RAU for IgE and 343 RAU for IgG) were significantly lower than both the atopic cats
and the cats in control group 1 (p<0.001). The levels of DF-specific IgE and IgG were
significantly correlated (r = 0.629, p<0.01) (fig. 4.2).
Table 4.3. Median and range of levels of DF-specific IgE and DF-specific IgG in RAU in
the atopic, normal household (control group 1) and laboratory raired cats (control
group 2).
Atopic cats Control Control
n= 10 group 1 n=15 group 2 n=ll
DF-specific IgE
Median 457 330 37
Range 97-953 108-478 31-87
DF-specific IgG
Median 16451 9860 343
Range 1317-295493 78-38539 78-8367
4.4. Discussion
Only one cat out of the 10 cats which showed positive IDST results had an
adverse reaction to food. This is in accord with the other reports on food allergy in cats
in which the incidence is reported to be rare (Walton, 1967; White and Sequoia, 1989;
Carlotti et al., 1990; Foster and O'Dair, 1993; Rosser, 1993; Denis and Paradis, 1994;
O'Dair et al., 1996).
DF is believed to be the most common allergen implicated in feline atopy.
Positive reactions to DF have been reported in 77 to 100% of atopic cats (Carlotti and
Prost, 1988, Foster and O'Dair, 1993; Prost, 1996a). The results of the IDST in the
present study were thus in agreement with other reports, with 80% of the cats showing



























































Fig. 4.1. Levels of DF-specific IgE (a) and IgG (b) in RAU in serum from
atopic, normal pet (group 1) and laboratory reared cats (control group 2).
Bar represents the median for each group.
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Fig. 4.2. Df-specific IgE and IgG in RAU in sera from atopic and normal cats.
The levels of the two isotypes are significantly correlated (r=0.617, p<0.01).
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In human allergic patients, a good correlation has been reported between a
strongly positive IDST and a positive in vitro test and also between a negative prick-
puncture test and a negative in vitro test (Bousquet and Michel, 1993). In dogs, the
correlation depends upon the allergen employed and appears to be good for ragweed and
poor for HD (Halliwell and Kunkle, 1978; Willemse et al, 1985b; Lian and Halliwell,
1998). Contrary to man, in the dog discordant results were reported to usually consist of
negative skin tests associated with positive ELISA results (Kleinbeck et al., 1989;
Codner and Lessard, 1993).
The ELISA has only been introduced recently for confirmation of the diagnosis
of atopic disease in cats (Foster and O'Dair, 1993). The antiserum used in the latter
assay was raised against a chimaeric feline/murine IgE antibody and there is no
published data supporting its specificity. A comparison of this test with results of IDSTs,
assuming the latter as the gold standard, showed a poor correlation between the two and
it was concluded that ELISA was unreliable in establishing a diagnosis of feline atopy.
In the present study also the IDST did not always correlate well with the in vitro test. Of
the 10 atopic cats, 2 cats were IDST negative to DF but had high levels of DF-specific
IgE as assessed by ELISA whereas one had a very low level of DF-specific IgE but
showed a strong skin test reactivity to DF. Although DF antigen at 1/10,000 dilution is
believed to be non-irritant, it is possible that it was close to an irritant concentration in
one cat and therefore the result could have represented a true false positive reaction in
this case.
All the normal pet cats had detectable levels of DF-specific IgE, and high levels
were found in 2 of them. However the median level of DF-specific IgE in sera from
these cats was not significantly different from the median of that in the atopic cats. But it
should be emphasised that the normal pet cats were not skin tested and some of the cats
may have had a positive IDST to this antigen, as was recently reported in normal dogs
(Lian and Halliwell, 1998). Although none of the cats showed otitis externa, some of
them may have been asymptomatic carriers of Otodectes cynotis. Therefore, in such a
case the positive ELISA tests seen in normal pet cats could have been the result of
antigenic cross-reactivity between DF and Otodectes. Indeed cross-reactivity between
HDM and Sarcoptes has been reported in man using both skin tests and RAST (Falk and
Bolle, 1980). Because Sarcoptes and Otodectes are antigenically very close, it would not
be surprising that HDM would also cross-react with Otodectes (Saridomichelakis et al.,
1997). It was noteworthy that levels of both DF-specific IgE and IgG in the laboratory
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reared cats were significantly lower than that in both the other groups. Also, the rabbits
which produced the antisera were shown to have antitibodies that reacted with DF.
Therefore those rabbits may have been infected with Psoroptes and contain Psoroptes-
specific IgE antibodies in their sera. For this reason, the antisera were passed through an
immunoaffmity column coupled to DF prior to be used in ELISA.
The fact that not only is DF the most frequently implicated allergen in feline
atopy, but also that DF-specific IgE is found in normal cats is of great interest. It has
been suggested in man that the powerful allergic immune response commonly provoked
by Dermatophagoides pteronyssinus (DP) could result from its ability to cleave the low
affinity IgE Fc receptor (CD23) from the surface of IgE-secreting B cells (Hewitt et al.,
1995). This could ablate an important feedback inhibitory mechanism that normally
limits IgE synthesis. Furthermore, fragments of CD23 released by HDM have been
reported to promote IgE production (Sutton and Gould, 1993).
The level of specific IgG to some aeroallergens has been shown to be higher in
cats with either atopy, food and/or flea allergy than in normal cats or cats with pruritic
skin disease but negative IDSTs (Foster et al., 1997). However this was not so in the
case of HDM-specific IgG levels which were not significantly greater in allergic cats as
compared to normal cats (Foster et al., 1997). In both the clinical and the experimental
studies (chapter 3) the levels of DF-specific IgE and IgG were significantly correlated.
This is not surprising since both isotypes are under the control of a Th-2 type response.
In conclusion, this antiserum also detected allergen-specific IgE in atopic cats
and in normal pet cats kept under normal household conditions, but significantly lower
levels were found in laboratory reared cats. In both the experimental and clinical studies
there was a significant overall correlation between allergen-specific IgE and IgG
responses. However, the level of allergen-specific IgE was not correlated with the skin
test results. This is also consistent with the results found in normal cats in which DF-
specific IgE was induced experimentally and supports the possible existence of
heterogeneity of IgE antibodies in cats.
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CHAPTER 5.
PHYSICOCHEMICAL STUDIES ON FELINE IgE AND
CROSS-REACTIVITY OF FELINE IgE WITH CANINE
AND HUMAN IgE
5.1. Introduction
Although a number of recent studies have been performed on IgE in cats, it has
not been possible to purify this immunoglobulin by conventional chromatographic
techniques. Recently Foster (1995) has attempted to isolate and determine feline Ce gene
sequences using a nested polymerase chain reaction technique with primers based on the
established sequences for sheep, rat, mouse and human homologues. He was able to
establish a partial sequence for the feline Cs gene. However the antisera raised against
the synthetic peptide recognised epitopes only in the peptide and not in the native
molecule.
Semi-purified feline IgE has been examined by sodium dodecyl sulphate-
polyacrylamide gel electrophoresis (SDS-PAGE) and the MW of putative feline IgE was
reported to be approximately 80 kDa (DeBoer et al., 1993). However the amino acid
sequence of this molecule has never been established.
Cross-reactivity has been demonstrated between feline IgE and canine IgE using
a monoclonal anti-canine IgE (DeBoer et al., 1993). However the existence of a cross-
reactivity has never been shown between human and feline IgE.
The aims of this study were to assess by SDS-PAGE different fractions of
partially purified IgE using conventional chromatographic techniques, and to assess the
antigenic cross-reactivity of feline reaginic antibody with canine IgE and human IgE
using polyclonal anti-human and anti- canine IgE of different origins.
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5.2. Materials and methods
5.2.1. Physicochemical studies on feline IgE
5.2.1.1. Experimental animals
Stray kittens and adult cats were provided by the Dog and Cat Home (Societe
Protectrice des Animaux, SPA) of Vervier, Belgium.
One New Zealand white rabbit was obtained from Interfauna UK limited.
All experimental protocols were in accordance with the requirements of the
Animal Care and Ethics Committee and/or the UK Home Office as appropriate.
5.2.1.2. Sera and IgE antibodies
The stray cats were anaesthetised with 20 qg/kg medetomidine hydrochloride
(Domitor®, Smithkline Beecham, Louvain-La-Neuve, Belgium) and 10 mg/kg ketamine
hydrochloride (Imalgene 1000®, Rhone Merieux, Brussels, Belgium) and bled by
cardiac puncture. Blood was centrifuged and approximately 45 ml (kittens) to 90 ml
(adults) of sera were collected from each cat. They were then euthanised with 5 ml of
pentobarbital sodium (Natriumpentobarbital 20%®, Kela, Hoosgraten, Belgium) and
their gastrointestinal (GI) tract opened to check for the presence of adult Toxocara cati
(T. Cati).
Sera from cats parasitised with T. cati were those from the cats immunised with
DNP-Asc (see chapter 2).
Sera with a high level of Dermatophagoides farinae (DF)-specific IgE were the
sera from the cats B85 and A71 experimentally sensitised to DF (bleeding 8), which
showed a strong intradermal skin test (IDST) to this antigen (see chapter 3).
Partially purified canine IgE was kindly provided by Prof. R.E.W. Halliwell.
Monoclonal mouse IgE was purchased from Sigma (Sigma).
5.2.1.3. Antisera
Rabbit anti-feline IgE used were R294 and R1094 (chapter 2).
Rabbit anti-feline IgG, heavy chain (HC)-specific, was purchased from Nordic
Immunology.
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5.2.1.4. Immunoaffmity chromatography columns
DF antigen (Greer laboratories, Lenoir, North Carolina, USA) and polyclonal
antisera against feline IgE (R294 and R1094) and against feline IgG were conjugated to
cyanogen bromide activated Sepharose 4B (see appendix).
A protein A column (HiTrap affinity columns) was purchased from Pharmacia.
5.2.1.5. Preparation of feline IgE rich fractions
Different approaches were used to obtain feline IgE rich fractions in order to
assess these samples for their IgE content by SDS-PAGE.
(a) Sixty ml of a pool of sera from stray cats and cats parasitised with T. cati
were precipitated with ammonium sulphate. The protein that precipitated between 33%
and 45% saturation was equilibrated with 0.05M phosphate buffer, pH 8.0, and passed
over a column of DEAE equilibrated with the same buffer (see chapter 2). The excluded
protein was collected, concentrated and then passed over a 3-in-series column set of
Sephacryl S-200 in PBS. Fr-R and Fr-R+G were collected and concentrated to a protein
concentration of 1 mg/ml for Fr-R and 3.2 mg/ml for Fr-R+G (see chapter 2). These
fractions were assessed by SDS-PAGE.
(b) Fraction R+G obtained above (a) was passed through the putative anti-feline
IgE (R294 or R1094) affinity column equilibrated with PBS. The protein bound to the
column was eluted with 0.1M glycine HC1 buffer, pH 2.8. The eluate was neutralised
immediately with 1M Tris-HCl buffer, pH 8 and concentrated. It was then assessed by
SDS-PAGE.
(c) Five replicates of two ml each of serum from parasitised cats were passed
through the putative anti-feline IgE affinity column and the eluates were collected,
pooled together and concentrated to a protein concentration of 750 pg/ml. The resulting
fraction was assessed by SDS-PAGE.
(d) Three ml aliquots of sera from cats which had a high level ofDF-specific IgE
were passed 3 times through an immunoaffinity column of Sepharose 4B coupled to DF.
A total of 36 ml of sera were applied on the columns. Bound material was eluted and
neutralised as above. In order to remove contaminating IgG, the IgE-containing fraction
was repeatedly passed down to through an immunoaffinity column of anti-feline IgG,
which was heavy chain specific, equilibrated with PBS, until the eluate peak was
122
negligible (4 times). The fall-through (FT) was concentrated to 2 mg/ml and assessed by
SDS-PAGE.
(e) Sera from 2 stray cats were fractionated by the 3 step procedure (a). The
resulting Fr-R (1 mg/ml) was cross-adsorbed by successive passages through an
immunoaffinity column of anti-feline IgG and the FT concentrated to a final protein
concentration of 2.5 mg/ml. One ml of this solution was dialysed in PBS overnight at
4°C and filtered before application to the protein A column (HiTrap affinity columns,
Pharmacia, Biotech) equilibrated with 0.1M sodium phosphate buffer, pH 8.0. Material
bound to the column was eluted with 0.1M glycine HC1 buffer, pH 2.8 and neutralised
immediately with 1M Tris-FICl buffer, pFI 8.0. FT (400 pg/ml) and eluate (300 pg/ml)
were both assessed by SDS-PAGE. The FT peak was chosen to perform the terminal
amino-acid sequencing.
5.2.1.6. Assessment of the different fractions by SDS-PAGE
IgE containing fractions were analysed by SDS-PAGE using a 10%
polyacrylamide gel run under reducing conditions as described by Laemmli (1970).
Gels were cast and run using the mini-Protean system (82 x 73 x 0.75 mm) or the
large format gel (20 x 20 cm) (Bio-Rad Lab, Ltd., Flemel Hempstead, UK). To form the
mini-gel, 3.5 ml of 10% acrylamide resolving gel containing 0.33% N, N -
methylenebisacrylamide (acrylamide bis) and 0.5% sodium dodecylsulphate (SDS) in
0.375M Tris-HCl buffer pH 8.8 were polymerised by the addition of 50 pi of a freshly
prepared 10% ammonium persulphate solution and 10 pi of N, N, N, N' -
tetramethylethylene diamine (Temed, BDH, Poole, UK). The resolving gel was poured
into each gel sandwich and carefully overlaid with distilled water (dH20). After complete
polymerisation, the water was removed. The 4% acrylamide stacking gel containing
0.1% acrylamide bis, 0.25% SDS in 0.125M Tris-HCl buffer, pH 6.8, a 10% ammonium
persulphate solution and Temed was added and allowed to polymerise with a 10-well
comb in place.
Samples were diluted 1:1 in SDS-PAGE sample buffer containing 10% glycerol,
2% SDS, 5% 2-p-mercaptoethanol and 0.1% bromophenol blue in 62mM Tris-HCl, pH
6.8. Samples were then heated in a boiling water bath for at least 2 minutes before
immediate loading onto a gel. Twenty pi of each preparation were loaded and run for
approximately 55 minutes at room temperature at a constant 200 V. Power was supplied
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by a Pharmacia Power Supply EPS 500/400 power pack. Running buffer, 192mM
glycine, 25mM Tris and 1% SDS, pH 8.3, was freshly prepared before each run.
Gels were stained for 30 minutes with 0.25% Coomassie blue solution
(Coomassie brilliant blue, R-250, Biorad Laboratories Ltd, Hemel Hempstead, Herts) in
45% methanol, 7.5% alcohol, 45% H20 and destained in successive changes of 25%
methanol, 7.5% acetic acid, 67.5% H20.
When large format gels were used, they were cast and run following the same
method as used for the mini-gel. However the stacking gel (40 ml) and the resolving gel
(20 ml) were degassed under vacuum prior to the addition of the ammonium persulphate
solution and Temed.
Large format gels were cast using 15-lane combs and loaded with 80 to 100 pi of
sample. Gels were run for approximately 4 hours at room temperature at 50mA constant
current. Power was supplied by a Pharmacia Power Supply EPS 500/400 power pack.
Large format gels were stained in 0.25% Coomassie blue solution as the mini gel
and destained overnight in 25% methanols.5% acetic acid:75.5% H20.
In addition to the high molecular weight markers usually employed (Bio-Rad
Lab, Ltd., Hemel Hempstead, UK), partially purified canine IgE and/or purified mouse
monoclonal IgE were used as positive controls and feline IgG, as negative control
molecular weight markers.
5.2.1.7. Preparation of a gel band in order to immunise a rabbit
An IgE preparation resulting from the elution of serum #6 (see chapter 2) after
passages through the anti-IgE affinity column was applied to SDS-PAGE on a large-
format gel. Gel was polymerised with a comb composed of one large and 2 small wells
in place. Four hundred and fifty pi corresponding to 450 pg of the feline IgE sample
were diluted in the sample buffer 1:1 and loaded on the large well without being heated.
A sample of 50 pi of canine IgE and the molecular weight standard were loaded on the
small wells. After electrophoresis, the gel was washed in several changes of deionized
water and transferred to 0.3M CuCl2 for 10 minutes. The relevant band of the gel
corresponding to the molecular weight (MW) of the IgE heavy chain was excised using a
scalpel, and destained by incubation in 0.25M EDTA, 0.25M Tris, pH 9.0 with 3
changes of 5 minutes each. The gel was pestled in 0.5 ml of PBS and stored at -20°C
prior to immunisation. In order to obtain the 3 fractions necessary for the immunisation
of the rabbit, the procedure was performed 3 times. Each sample was mixed with
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Freund's complete adjuvant (CFA) prior to injection as for the production of the other
antisera (see chapter 2). This antiserum was assessed for its activity against feline IgE by
reversed cutaneous anaphylaxis (RCA) as described in chapter 2.
5.2.1.8. Immunoblot for terminal amino-acid sequencing of suspected feline IgE
In order to perform an amino (N)-terminal amino-acid sequencing, Tris-Tricine
SDS-PAGE (Schagger gel) was made (Schagger and von Jagow, 1987). Gels were cast
and run using the mini-Protean system as described above. To form the mini-gel, 10 ml
of Tris-Tricine gel mixture containing 10% acrylamide bis and 0.1% SDS in 1M Tris
buffer pH 8.45 were polymerised by the addition of 50 pi of a freshly prepared 10%
ammonium persulphate solution and 10 pi of Temed. Three and a half ml of the
resolving gel was poured into each gel sandwich and carefully overlaid with dH20. After
complete polymerisation, the water was removed. The 4% acrylamide stacking gel
containing 0.1% acrylamide bis, 0.25% SDS in 0.125M Tris-HCl buffer, pH 6.8, a 10%
ammonium persulphate solution and Temed was added and allowed to polymerise with a
10-well comb in place.
Samples (feline IgE rich fraction prepared as in (e) and partially purified canine
IgE) were diluted 3:2 in SDS-PAGE sample buffer and then heated, as described above.
Five pi ofhigh molecular weight markers (Bio-Rad Lab), 45 pi of feline IgE and 25 pi of
canine IgE preparations were loaded and run for approximately 1 hour 20 minutes at
room temperature at a constant 110 V. Running buffers used were in the upper tank
lOOmM Tris buffer, lOOmM Tricine and 0.1% SDS and the lower tank 1M Tris buffer,
pH 8.9.
The gel was transblotted onto "Immobilon P" soaked in 10 mM (3-
(cyclohexylamino)-l-propanesulfonic acid) (CAPS) in 10% methanol using a semi-dry
blotter.
Briefly, 6 sheets of Whatman chromatography paper number 3 (Whatman,
Maidstone, UK) and a sheet of PVDF membrane with 0.2 mm pore size (Immobilon P,
Millipore Corporation, Bedford, Massachussetts, USA) were trimmed to the appropriate
size. Three sheets of chromatography paper were soaked in CAPS buffer and placed on
the anode graphite plate. The immobilon P membrane was soaked in methanol and in
dH20 and then placed on top of the 3 layers of paper. The gel was placed carefully on the
immobilon P membrane and the sandwich was completed by the addition of 3 further
sheets of paper soaked in CAPS buffer. The transfer cell was completed by placing the
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cathode plate on the top and the constant current of 80 mA was applied from a Bio-Rad
power pack (model 160/1.6) for 1 hour 30 minutes.
The blot was immediately stained for 10 seconds with 0.25% Coomassie blue
solution as for the gel and destained in methanokacetic acid:H20 5:1:5.
The band on the resulting blot that corresponded to the MW of IgE heavy chain
was cut and sent to Mr Pat Baker at the Microchemical Facilities of Brabaham Institute
in Cambridge for a terminal amino acid sequencing.
5.2.2. Assessment of antigenic cross-reactivity of feline IgE with canine and human IgE
5.2.2.1. Experimental animals
Recipients were normal adult parasite free cats (ex-breeder) obtained from Hill
Grove Family Farm Ltd.
5.2.2.2. Sera
Sera from cats parasitised with T. cati were the sera from the cats #6 and #4
which were immunised with DNP-Asc (see chapter 2).
Sera B85 and 735, bleeding 8 were from the cats experimentally sensitised to DF,
which showed a strong IDST and/or developed a good IgE response to DF antigen (see
chapter 3).
5.2.2.3. Antisera
Polyclonal rabbit, goat and sheep anti-human IgE, HC-specific were purchased
from Nordic Immunology.
Twelve polyclonal antisera, 3 from goats and 9 from rabbits specific for canine
IgE, were previously produced by Prof. R.E.W. Halliwell in his laboratory. One goat and
2 rabbit antisera were purified antibodies.
5.2.2.4. Immunoaffinity chromatography columns
Normal rabbit serum, polyclonal goat anti-canine IgE and rabbit anti-human IgE
were conjugated to cyanogen bromide activated Sepharose 4B.
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5.2.2.5. Induction of RCA
RCA was performed as before (see chapter 2). Antisera were tested at dilutions of
1:100 and 1:1000. The antisera which gave a strong reactions at 1/1000 dilution were
assessed at doubling dilutions from 1/100. A rabbit anti-feline IgE (R294 or R1094)
known for its ability to induce strong RCA was included as a positive control.
5.2.2.6. Immunoabsorption of feline sera rich in IgE by goat anti-canine IgE
Sera from 2 cats (#4 and #6) were fractionated by the 3 step procedure as
described above (a). The resulting Fr-R+G (1 mg/ml) was adsorbed by successive
passages through an immunoaffinity column of anti-canine IgE column. The proteins
bound were eluted, collected and the pH immediately neutralised as described above.
The eluate was concentrated up to a protein concentration of 620 pg/ml and assessed by
SDS-PAGE as described above.
5.2.2.7. Immunoabsorption of feline sera rich in IgE by rabbit anti-human IgE
Rabbit anti-human IgE was also assessed for activity against IgE by its ability to
remove ELISA reactivity from feline serum (B85 and 735) after passages through an
anti-human IgE immunoabsorbent column. ELISAs were performed as described in the
clinical study on atopic cats (chapter 4). All fractions were tested at a protein
concentration of 44 mg/ml, which corresponded at a serum dilution of approximately
1/2. Samples were tested in quadruplicate. Bleeding 8 of cat U49 was used as the
standard.
5.3. Results
5.3.1. Physicochemical studies on feline IgE
5.3.1.1. Fractions assessed by SDS-PAGE
(a) Fractions R and R+G
Multiple protein bands were seen in the gel (fig. 5.1). However the two major
bands were the IgG heavy chain and the light chain. A pale band corresponding to the
MW of canine IgE was present. This band had an apparent MW of 80 kDa. However the
MW of the protein bands were only estimated by reference to the marker and the
positive control and were not calculated.
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Fig. 5.1. SDS-gel electrophoresis. Assessment of Fr-R and R+G and of the feline proteins in
the fall through (FT) and eluate from the protein A affinity column
1 Canine IgE partially purified
2 Fr-R
3 Fr-R+G
4 Feline IgG eluted from the anti-IgG affinity column
5 FT from the anti-IgG affinity column
6 Eluate from the protein A affinity column
7 Eluate from the protein A affinity column
8 FT from the protein A affinity column
9 Molecular weight marker
10 Canine IgE partially purified
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(b and c) Eluates from the putative anti-feline IgE affinity column.
Multiple proteins were again present in the fractions eluted from the anti-feline
IgE affinity column (fig. 5.2). The two major protein bands seen on the gel were also the
IgG heavy chain and the light chain. In the Fr-R+G eluted from the anti-feline IgE
affinity column, a minor very thin and pale band corresponded to the canine IgE heavy
chain molecule with a MW of 80 kDa. In the sera of parasitised cats eluted from the
putative anti-feline IgE affinity column, two close protein bands seen on the gel were of
an approximate calculated MW of 83 and 87 kDa, whereas the approximate calculated
MW of the canine IgE was of 79 kDa.
(d) Eluates from the DF affinity column adsorbed by successive passages
through an affinity column of anti-feline IgG heavy chain.
The major protein bands corresponded to IgG heavy chain and to another protein
of approximately 66 to 70 kDa (fig. 5.3). A thin band corresponded to the MW of canine
IgE heavy chain and had an estimated MW of 80 kDa. Another paler, thin band of
slightly higher MW was seen. Because the gel was run for longer than normal, the light
chain was not visible.
(e) Eluate and FT from the protein A affinity column.
When run on the gel, the FT peak was found to contain only 3 protein bands (fig.
5.1). One band corresponded to the light chain and one had a molecular weight of
approximately 70 kDa. The last band was pale but relatively large and had a similar
molecular weight to the canine IgE heavy chain which was of approximately 80 kDa.
None of the bands corresponded to the heavy chain of IgG.
The eluate from the protein A affinity column was composed of 3 protein bands
(fig. 5.1). The major band corresponded to IgG heavy chain while another band
corresponded to the light chain. The third band was minor and had an approximate
molecular weight of 70 kDa.
5.3.1.2. RCA tests
The antiserum resulting from the immunisation of a rabbit with the gel bands was
not able to induce RCA in a recipient cat.
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Fig. 5.2. SDS-gel electrophoresis. Assessment of Fr-R+G eluate from the putative anti-
feline IgE affinity column
1 Molecular weight marker
2 Feline IgG
3 Eluate from the anti-feline IgE affinity column
4 Canine IgE partially purified
5 Mouse IgE
6 Feline IgG
7 Molecular weight marker
130
Fig. 5.3. SDS-gel electrophoresis. Assessment of serum from DF immunised cats eluted
from the HDM affinity column
1 Molecular weight marker
2 Canine IgE partially purified
3 Serum from parasitised cat eluted from the HDM affinity column
4 Feline IgG eluted from the anti-IgG affinity column
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5.3.1.3. Amino-terminal amino-acid sequencing
The N-terminal amino acid sequence of the protein sent for sequencing (see
section 5.1.8) shared more identity with the terminal amino acid sequence of a sheep
fibrinogen p-chain (50% identity) or a2-macroglobulin (25% identity) and was not of an
antibody (table 5.1). Only one residue (11) of this molecule was common to the human
IgE heavy chain (5% identity) (table 5.1).
Table 5.1. Terminal amino-acid sequence of the approximately 80 kDa feline protein, the
human IgE heavy chain, the fibrinogen p-chain and the a2-macro- globulin
1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19
Feline V L P L V E V P X L L D L P G V D D N
protein E K L G D V K A S? L G A
Human
IgE
A S T Q S P S V F P L T R C c K N I P
Fibrinogen
P-chain
G Y L D Y D E W D D N
a2-Macro-
globulin
P Q Y M V L V P S L L H T E T T E K G
5.3.2. Assessment of antigenic cross-reactivity of feline IgE with canine and human IgE
5.3.2.1. Induction of reversed cutaneous anaphylaxis
5.3.2.1.1. Rabbit and goat anti-canine IgE
Twelve polyclonal antisera were assessed for activity against IgE by their ability
to induce reversed cutaneous anaphylaxis (RCA) on intradermal injection in healthy
parasite-free cats
All rabbit and goat anti-canine IgE were able to induce RCA at a dilution of
1/100 (table 5.2). However 5 rabbit antisera had a RCA titre of 1000, 4 antisera (2
rabbits and 2 goats) had a RCA titre of 1600 and one antiserum (the purified goat
antiserum), a RCA titre of 4000 (table 5.2). Because of the small amount of specific
purified goat and rabbit antisera available, the goat antiserum GB was chosen to be
coupled to the cyanogen bromide activated Sepharose 4B.
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5.3.1.2. Rabbit, goat and sheep anti-human IgE
Rabbit anti-human IgE was the only antiserum which was able to induce a RCA
at a dilution of 1/10 and 1/100 although weak reactions only resulted. An
immunoaffinity column was made with this antiserum.
Table 5.2. RCA titres of polyclonal anti-canine and anti-human IgE
Anti-human IgE RCA titre* Anti-canine IgE RCA titre
R too R1 100
G Negative R2 100










R = rabbit antiserum, Rp = rabbit antiserum: purified antibody
G = goat antiserum, Gp = goat antiserum: purified antibody
S = sheep antiserum
* Highest dilution of antiserum to which a weal resulted following intradermal injection
5.3.2.2. Immunoabsorption of feline sera rich in IgE by goat anti-canine IgE
The eluted proteins consisted of three bands on the gel (fig. 5.4). The major band
corresponded to the heavy chain of IgG and the lowest band, to the light chain. The third
band was very pale and had a MW which was similar to the mouse IgE heavy chain and
was estimated to be of approximately 80 kDa. Elowever the MW was not calculated.
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Fig. 5.4. SDS-gel electrophoresis. Assessement of Fr-R+G eluted from the anti-canine IgE
affinity column
1 Molecular weight marker
2 Eluate from the anti-canine IgE affinity column
3 Mouse IgE
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5.3.2.3. Immunoabsorption of feline sera rich in IgE by rabbit anti-human IgE
Two ml of serum from 2 cats that developed a strong positive IDST to DF
antigen and/or that had a high level of DF-specific IgE (B85 and 735) was assessed by
ELISA before and after 4 passages through a rabbit anti-human IgE immunoabsorbent
column. Two ml of these feline sera rich in DF-specific IgE were also assessed by
ELISA before and after 4 passages through a column of Sepharose 4B coupled to normal
rabbit serum. The later fraction was used as a control.
The levels of DF-specific IgE were significantly different before and after 4
passages through the anti-human IgE immunoaffinity column. However, no significant
difference was seen between the results of the sera after the passages on the nonnal
rabbit serum immunoaffinity column and the passages on the anti-human IgE
immunoaffinity column.
5.4. Discussion
5.4.1. Physicochemical studies on feline IgE
The molecular weight of human monoclonal IgE heavy chains (s chain) have
been reported to vary from 69.8 kDa (Kochwa et al, 1972), 70 kDa (Peng et al., 1996),
72.3 kDa (Ishizaka, 1988), to 72.5 kDa (Bennich and Johansson, 1971). The MW of
canine s chains have also been estimated to vary and to range from 73 kDa (Peng et al.,
1993a), 75 kDa (Peng et al., 1996) to 77 kDa (DeBoer et al., 1993) whereas the MW of
mouse IgE heavy chain has been reported to be 75 KDa (Bose et al., 1984) and of sheep
and pig to be of 72 and 73 KDa respectively (Yilmaz et al., 1993; Roe et al., 1993).
In the present study a protein which had a similar MW to both canine and mouse
IgE was present in almost all fractions assessed. However, although different methods
were used to attempt to obtain an IgE rich fraction, resulting samples were always
contaminated by other proteins. Feline IgG heavy chain, with a calculated MW of 57
kDa was found to be the major protein present in all samples, except in the FT from the
protein A column. Even after 4 passages of the sample eluted from the HDM column,
through the feline anti-IgG column, IgG was still present in large amounts. Another band
of protein with a MW of approximately 70 kDa was visible on most of the gels. This
protein was believed to be albumin.
The protein which had an apparent MW of 80 kDa was not found in the eluate
from the protein A column. This could be because of the low protein content of the
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fraction. However further concentration of this fraction would have led to an overloading
of the gel with IgG. On the other hand, each concentration of the sample led to loss of
protein and therefore of IgE molecules, presumably already present in very small
quantities. The 80 kDa band was present in the FT of the protein A column, with 2 other
bands. One corresponded to the immunoglobulin light chain whereas the other one had
an approximate MW of 70 kDa, which could correspond to the albumin which has been
reported to have a MW of 69 kDa (Spitzauer et al., 1995) or the IgM heavy chain which
has a MW of 74 kDa (Grant, 1995). Nevertheless, Foster (1995) has found the MW of
feline IgM heavy chain to be 85 KDa. However after elution from DEAE at 0.05M
phosphate buffer pH 8.0 and gel filtration chromatography on Sephacryl S-200, the
fraction would be very unlikely to contain any IgM antibodies. Therefore it was assumed
that the light chain may belong to the feline protein which had a similar MW to canine
IgE and could have represented the IgE molecule. This is the reason why this fraction
was chosen to perform a terminal amino acid sequencing. Also, Foster et al. (1995)
demonstrated that although the fraction eluted from the protein A column induced
stronger positive passive cutaneous anaphylaxis (PCA) tests, the FT was also able to
induce positive PCA tests. It appears therefore that in cats, as in dogs (Peng et al., 1991),
a proportion of IgE does not bind to protein A. Peng et al. (1997) have suggested that
this could be reflective of heterogeneity of canine IgE. The N-terminal amino acid
sequencing of the band with a MW similar to the canine or mouse e chain was not
consistent with the expected IgE heavy chain. Whereas the amino acid homology
between s chain and other immunoglobulin heavy chains is low (Liu, 1986), e chain has
been shown to have a high homology between species. However while the N-terminal
amino acid sequencing allows to differentiate an antibody from another protein, this
method would not permit the differentiation between isotypes. The protein sequenced
may still have masked the presence of a smaller amount of s chain.
DeBoer et al. (1993) separated by SDS-PAGE feline serum proteins eluted from
a monoclonal anti-canine IgE immunoaffmity matrix. They have estimated the MW of a
putative feline IgE heavy chain to be of approximately 80 kDa and therefore to be
slightly higher than canine IgE heavy chain. The sample was contaminated by IgG and
another protein which had a MW of 71 kDa and was believed to be albumin (DeBoer et
al., 1993). However in this study the band corresponding to the light chain was almost
not apparent on the gel and should have been stronger in comparison to the thickness of
the IgE heavy chain band. Therefore the band of the light chain seems more to
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correspond to the weaker IgG heavy chain band, and the protein band of 79.7 kDa may
have been a contaminant rather than the s chain.
In dogs, Peng et al. (1991) have reported that 100% of the IgA and IgG, 98% of
the IgM and 87% of IgE binds to the protein A. The affinity of feline immunoglobulins
for protein A was found to be completely different from the affinity of canine
immunoglobulins (Grant, 1995). Indeed, the major fraction of cat IgM and IgA was
found not to bind to protein A, and this could be the result of different subclasses of
these immunoglobulins with different affinities. However, as in dogs (Peng et ah, 1991),
the bulk of the feline IgG subclasses have been reported to bind to protein A (Grant,
1995). In the present study, all the feline IgG was recovered in the fraction that bound to
the protein A column.
Feline immunoglobulins are reported to have a very low affinity for protein G
and therefore the latter is not useful to the purification of IgE in the cat (Foster et al.,
1995; Grant, 1995).
In the fractions eluted from the putative anti-feline IgE column and from the
HDM column, the band corresponding to the canine or mouse s chain was a doublet. The
bottom band was thicker than the top band. These findings could have resulted from the
denaturation of the protein by the acidity of glycine-HCl buffer. However only a single
band was present in the fraction eluted from the goat anti-canine IgE column. Because
the band protein was very thin, the double band may not have been visible.
IgG was found in almost all samples, even in the fraction eluted from the putative
anti-feline IgE column. However this anti-feline IgE coupled to the Sepharose 4B had
been absorbed by passage through column of heated normal cat serum and proved to be
specific for feline IgE in the ELISA. Thus it appears that non-specific binding of IgG
occurs easily and that it is difficult to obtain an IgE fraction that is not contaminated by
IgG. While the passage of such fractions through the protein A column allows depletion
of the IgG, it is not a good method for purifying IgE since not all IgE binds to protein A.
The antibody raised against the gel band which had a MW similar to the canine
IgE did not shown any activity against feline IgE. It is possible that the protein band
injected was composed of a protein other than IgE, as for example the protein which
was assessed by N-terminal amino acid sequencing. It could also be the result of the
denatuiation of the protein band by the mercaptoethanol contained in the SDS-PAGE
sample buffer since it has been shown that IgE is sensitive to the mercaptoethanol
(Rockey and Schwartzman, 1967; Ishizaka and Ishizaka, 1968a). Therefore the
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antiserum raised against the putative IgE heavy chain may not have been able to
recognise the native protein. It is also possible that there was not sufficient protein
present to generate an immune response.
It would have been of great interest to perform a western blot analysis on these
gel using the polyclonal anti-feline IgE (R294) and goat anti-canine IgE. Unfortunately
the small quantity available of the samples and the reagents made the performance of
such studies difficult.
5.4.2. Assessment of antigenic cross-reactivity of feline IgE with canine and human IgE
In the present study, while only a weak RCA was obtained using polyclonal
rabbit anti-human IgE, goat and sheep polyclonal antibodies were not able to induce
RCA. Also, the absorption of sera of cats sensitised to DF with polyclonal rabbit anti-
human IgE did not result in a reduction of reaginic antibody in those sera as compared
with multiple passages over a column of normal rabbit serum. However it is possible
that the net amount of anti-human IgE on the column was too low to bind sufficient
feline IgE to remove ELISA reactivity, which would have reduced the effective
sensitivity of this approach. On the other hand, the weak positive RCA at a dilution of
1/100 seen with the rabbit anti-human IgE is unlikely to be a false positive reaction but
rather reflective of a true but weak cross-reactivity between human and feline IgE, since
a negative control was used in each test.
In previously reported studies IgG, IgA and IgM were all demonstrated to cross-
react with the equivalent human isotype (Grant, 1995). The cross-reactivity between IgE
of several species with human IgE was assessed by gel diffusion and rat mast cell
binding using a sheep anti-human IgE (Nielsen, 1977). The percentage of cross-
reactivity of feline and canine sera with the sheep anti-human IgE was reported to be
very low (Nielsen, 1977). However, in another study, Halliwell et al. (1972)
demonstrated the antigenic similarity between canine IgE and human IgE. They showed
that the PK titre to ragweed was decreased by absorption of canine reaginic serum with
anti-human IgE and that anti-human IgE was able to elicit RCA in the dog. More
recently, Peng et al. (1993a and 1996) have directly demonstrated the cross reactivity of
dog IgE with human IgE by western blot analysis using either a polyclonal or a
monoclonal anti-human IgE. Moreover, canine reaginic antibody from dogs suffering
from allergic disease is able to sensitise both human and equine basophils (Prelaud et al.,
1993; Sainte-Laudy and Prost, 1996). It has been shown by RCA as well as by other
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methods (ELISA, RIA, gel diffusion, western blot and histamine release by mast cells
and basophils) that human IgE also cross-reacts with IgE from monkey (Ishizaka and
Ishizaka, 1968b), rat (Conrad et al., 1983; Kanyeresi et al., 1971; Perelmuter and Khera,
1970), bovine (Gershwin, 1981; Nielsen, 1977), ovine (Yilmaz et al., 1994) and equine
(Suter and Fey, 1983).
A recent study has demonstrated that polyclonal anti-mouse IgE and anti-human
IgE were able to induce RCA in dogs while monoclonal anti-human, anti-rat and anti-
mouse were not (Peng et al., 1996). Therefore the IgE structure appears to be well
conserved from species to species. However, of all five isotypes of immunoglobulin, the
sequence of the IgE C region is the least well conserved across species (Patel et al.,
1995).
Feline reaginic antibody has been demonstrated to cross react with canine IgE by
RCA and by absorption on affinity column using a monoclonal anti-canine IgE (DeBoer
et al., 1993). Both monoclonal and polyclonal anti-canine IgE induced a wheal reaction
at a dilution of 1/1000, 15 minutes after intradermal injection. In the present study, all
the polyclonal anti-canine IgE were able to induce RCA, with some of them showing
titres of 1600 and even 4000 for a specific purified goat anti-canine IgE.
In conclusion, feline IgE appears to be more difficult to isolate and purify than
canine IgE. One of the reasons is that cat sera are available in smaller quantities than dog
sera. However, feline IgE, through its affinity for protein A and protein G, behaves
differently from canine IgE and IgE from other species. The existence, in almost all
samples, of a protein contaminant with an apparent MW similar to the MW of IgE from
other species, makes it even more difficult to identify feline IgE. Cross-reactivity
between feline IgE and canine IgE has been demonstrated by RCA. However the level of
cross-reactivity between human IgE and feline IgE was obviously low in that, although a




THE EFFECTS OF ENDOPARASITISM AND OF THE
ADMINISTRATION OF VIRAL VACCINES ON THE
IMMUNE RESPONSE TO ORALLY ADMINISTERED
ANTIGEN IN CATS: POSSIBLE IMPLICATIONS FOR
THE PATHOGENESIS OF FOOD HYPERSENSITIVITY
6.1. Introduction
The immunopathogenesis of food hypersensitivity in cats remains unclear
although reaginic antibody has been clearly shown to be involved in one cat with allergy
to cows milk (Walton et ah, 1968). Recently, models of food allergy have been
successfully developed in dogs (Guilford and Badcoe, 1992, Ermel et ah, 1997). In the
first model, pups were sensitised to codfish antigen by oral and parenteral administration
and showed markedly elevated food-specific IgE in their serum (Guilford and Badcoe,
1992). Another model was developed in dogs from an atopic colony. The dogs showed
an IgE-response to food antigens after being immunised with a live attenuated
distemper/hepatitis vaccine and injected with three different food allergens and one
pollen (Ermel et ah, 1997). It is reported that endoparasitic infections as well as
immunoprophylaxis with live attenuated virus predispose to the development of an IgE
response to antigens administered at the same time (Turner et ah, 1979; Frick and
Brooks, 1983).
The aims of this study were to assess whether immunoprophylaxis with the
standard battery of viral vaccines and/or infection with Toxocara cati (T. cati) facilitates
the induction of IgE or other antibody responses in kittens to a specific antigen
administered with food. Fluman serum albumin (HSA) was chosen as the antigen
because none of the cats would have been previously exposed to this protein.
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6.2. Materials and methods
6.2.1. Animals
Seventeen domestic short hair (DSH) cats (13 males and 4 females) aged
approximately 4 months were obtained from Hill Grove Family Farm Ltd (table 6.1). All
cats were parasite-free, and came from a colony which has been parasite free for many
generations.
Twenty additional DSH male parasite free kittens, aged 7 to 10 weeks, were
obtained from the Central Animal Laboratory of the University of Nijmengen, The
Netherlands, for infestation with T. cati in Belgium (table 6.2).
After nursing, kittens were weaned onto Whiskas® chicken and beef for kittens
(Waltham Centre for Pet Nutrition, Leicestershire, UK). They were fed once a day and
water was available ad libitum.
Table 6.1. Parasite-free cats sensitised with hsa





W02 m 18 vaccinated
W05 m 18
W06 m 18 vaccinated
W07 m 18 vaccinated
Wll m 17 vaccinated
W14 m 17
88A m 18 vaccinated
88B m 18 vaccinated








Table 6.2. Cats infected with T. Cati and sensitised with HSA
Cat number Sex Age (weeks)
at the time of
infection
Age (weeks)







298 m 10 20 positive
301 m 10 20 positive
302 m 10 20 positive
303 m 10 20 positive vaccinated
304 m 10 20 positive
305* m 10 20 negative
307 m 8 18 positive
308 m 8 18 positive vaccinated
309 m 8 18 positive
310 m 8 18 positive
312 m 8 18 positive
317 m 7 17 positive vaccinated
318 m 7 17 positive vaccinated
319 m 7 17 positive
320 m 7 17 positive vaccinated
324* m 7 17 negative
325 m 7 17 positive vaccinated
326* m 7 17 negative
331 m 7 17 positive
337 m 7 17 positive
* Cats which were excluded from the study
6.2.2. Infection of cats with T. cati
The twenty kittens aged between 7 and 10 weeks were experimentally infected
with T. cati. Infective 2nd stage larvae were provided by Dr Epe from the Institute for
Parasitology der Tierarztliche Hochschule Hannover (Hannover, Germany). A single
dose of approximately 250 embryonated T. cati eggs suspended in 1 ml of water was
administered orally to each cat. Faeces were examined for the appearance of ova 2
months later. The parasitised cats were euthanised at the end of the study with 5 ml of
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sodium pentobarbital (Natriumpentobarbital 20%®) and the gastrointestinal (GI) tract
opened to assess the worm burden.
6.2.3. Antigen employed
Fraction V of human serum albumin (HSA), 96-99% pure (Sigma), was used for
oral sensitisation of the cats and for the detection by ELISA of HSA-specific IgE, IgG,
IgA and IgM.
6.2.4. Sensitisation of cats
Each cat was dosed with 100 mg of HSA added to their food daily from days 7 to
28 inclusive (fig. 6.1).
6.2.5. Vaccination protocol
Seven of the parasitised cats and the same number of parasite-free cats were
immunised with a live trivalent freeze-dried vaccine derived from attenuated feline
calicivirus, feline herpesvirus, and feline panleucopenia virus (Katavac CHP®, Solvay
Duphar B.V., Weesp, Holland) on day 7 and day 21 (tables 6.1 and 6.2, fig. 6.1).
6.2.6. Blood samples
Blood was obtained by jugular venepuncture at weeks 0, 2, 4 and 8 (bleedings 1
to 4) (fig. 6.1). After clot retraction, serum was harvested by centrifugation and stored at
-20°C.
6.2.7. Antisera employed
Polyclonal rabbit anti-feline IgE was the same antibody as used in the previous
studies (chapters 2 and 3).
Alkaline phosphatase-conjugated goat anti-feline IgG, IgA and IgM (heavy chain
specific) were obtained from Bethyl Laboratories Inc. (Montlucon, France).
Unconjugated goat anti-feline IgM was purchased from Nordic Immunology
(Tilburg, The Netherlands).
Mouse monoclonal alkaline phosphatase-conjugated anti-rabbit and anti-goat


























Fig. 6.1. Protocol for experiments in chapter 6: feeding of HSA, vaccination
(Vc <—) and bleeding (BI) schedules.
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6.2.8. ELISA for HSA-specific antibodies
6.2.8.1. Assay optimisation
Assay conditions were optimised in preliminary experiments (chapter 3). Sera
with a high level of HSA antibody of each isotype were pooled and used as the standard
and given an arbitrary relative antibody unit value (RAU) of 1000 when undiluted.
Doubling dilutions of the reference serum were prepared in ELISA buffer (2.5% donkey
serum (DS) in washing buffer) to generate a standard curve which was included in each
plate (see chapter 3). Preimmunisation bleedings were used as the negative controls and
were included in each assay.
6.2.8.2. Procedure for the detection ofHSA specific-IgE
Serum samples were assayed for HSA-specific IgE by indirect ELISA at an
initial dilution in ELISA buffer of 1/2. The ELISA was performed exactly as described
previously except that the plates were coated with 100 pi of 0.5% HSA and that 25% DS
was used as the blocking agent. The anti-feline IgE was diluted 1/35 in ELISA buffer.
Since the level of serum HSA-specific IgE was too low to generate a standard
curve with a minimum of 3 points, results for this isotype were reported in optical
density (OD) units. The OD was read when the standard reached an OD of 0.56.
6.2.8.3. Procedure for the detection ofHSA-specific IgG, IgA and IgM
Sera were assayed for HSA-specific IgG, IgA and IgM by direct ELISA. Serum
samples were initially assessed at a dilution of 1/10 in ELISA buffer. Incubation times
for the test sera were reduced from 2 hr to 1.5 hr and for the conjugate from 2 hr to 1 hr.
When samples were assessed with the unconjugated polyclonal anti-feline IgM, the
addition of the monoclonal alkaline phosphatase-conjugated mouse anti-goat
immunoglobulin was performed under the same conditions as for the detection of HSA-
specific IgE.
Polyclonal alkaline phosphatase conjugated anti-feline IgG and IgA were used at
1/500 and 1/150 respectively whereas alkaline phosphatase-conjugated anti-feline IgM
was used at 1/500 and 1/1000. The polyclonal unconjugated anti-feline IgM was
assessed at 1/100, 1/1000 and 1/5000 dilutions.
A standard curve was established with a minimum of 4 points for the detection
of IgG and IgA, and HSA-specific antibody was expressed in RAU by reference to the
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standard curve. If the result did not fall in the sensitive part of the standard curve, the
assay was repeated at a lower or higher dilution as appropriate. A serum sample whose
OD at 1/2 fell below the end point of the standard curve (EPSC) was deemed to be
negative. For the purpose of statistical analyses, these sera were assigned a value half
way between the RAU of the EPSC and zero, which was 3.906.
6.2.9. Statistical analysis
Results were analysed using a statistical computer package (MINITAB release
11.0 Minitab Inc., State College, PA, USA). The non-parametric Mann-Whitney test, an
unpaired statistical test, was used to compare the HSA-specific IgA and IgG responses
between different groups of cats whereas the levels of HSA-specific IgE were analysed
by analysis of variance (ANOVA). Results were considered significant at p<0.05.
Correlations between the levels of IgG and IgA at week 4 and 8 in the parasite-
free and parasitised cats were calculated using Spearman's Rank correlation test. Data
were previously transformed to log 10 values. Results were considered statistically
significant at p<0.01.
6.3. Results
6.3.1. Infection with T. cati
T. cati eggs were found in the faeces of 12 of the cats 8 weeks after being orally
dosed with embryonated eggs, whereas in 5 cats T. cati eggs were seen in the faeces only
after 10 weeks. Adult T. cati were found in the digestive tract in all the 17 cats at the end
of the study, four months after oral infection (table 6.2). In the case of three cats (305,
324 and 326) no ova were detected in the faeces and they were excluded from the study.
However as the latter 3 were not necropsied, their true infective status was unknown.
6.3.2. Immune response to HSA
6.3.2.1. HSA-specific IgE response
Positive OD were obtained in the presensitisation bleedings and were assumed to
be the result of non-specific binding (see discussion). In general these data were only
slightly positive however an OD>0.1 was seen in 24 cats and >0.2 in one of them (cat
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130) (table 6.3 (a and b)). There was no significant difference between the OD values
found in the presensitisation bleedings in the parasitised and parasite-free cats.
Although weak, an HSA-specific IgE response was detectable in most of the
parasitised cats one week after exposure to HSA (week 2) and rose to a maximum three
weeks after exposure to HSA (week 4). Levels of IgE at week 8 decreased in 29 cats out
of the 34 (tables 6.3 (a and b) and 6.4 (a), fig. 6.2). The lowest levels of HSA specific
IgE were found in the parasite-free cats with two of them showing essentially
undetectable responses (130 and W16) (table 6.3 (b), fig. 6.2).
The group of cats infected with T. cati had significantly higher levels of HSA-
specific IgE in each bleeding than did the group of parasite-free cats (p<0.001). However
the most significant differences between the two groups were found 3 weeks after
exposure to HSA (week 4) (table 6.4 (a), fig. 6.2 and 6.3).
Although the vaccinated cats had generally higher levels of antigen-specific IgE
than the non-vaccinated cats, significant differences between these two groups were only
seen at weeks 2 and 4 from the parasite-free cats (table 6.4 (a), fig. 6.2 and 6.3). The
parasitised cats which were not vaccinated had higher levels of HSA-specific IgE at
week 8 than did the vaccinated cats although this difference was not significant (fig. 6.2
and 6.3).
6.3.2.2. HSA-specific IgG response
The cats developed an HSA-specific IgG response between the first and the third
week following exposure to HSA (fig. 6.4 and 6.5). However, one cat from the
parasitised group (cat 301) and 4 cats from the parasite-free group (cats 13L, 13N, 130
and W17) remained negative during the 2 months of the study. Four parasite-free cats
(cats 563, W11, 13P and W16) had HSA-specific IgG only in the last bleeding (week 8),
and only at very low levels. IgG antibody levels decreased in 20 cats out of the 34 at
week 8, which was 4 weeks after conclusion of the antigenic challenge (tables 6.3 (a and
b) and 6.4 (b)). Interestingly, the parasite-free cats which had undetectable or only low
levels of HSA-specific IgG also showed either a weak or undetectable IgE response.
However this was not the case in the parasitised cats with the exception of one cat (312)
that showed a low response for all isotypes including IgE. Also all these non-responder
or weakly responding cats were non-vaccinated with the exception of one cat (W11).
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IgE IgG IgA
Wk-0 Wk-2 Wk-4 Wk-8 Wk-0 Wk-2 Wk-4 Wk-8 Wk-0 Wk-2 Wk-4 Wk-8
13L 0.172 0.183 0.571 0.216 3.906 3.906 3.906 3.906 3.906 3.906 22 23
13N 0.176 0.127 0.105 0.404 3.906 3.906 3.906 3.906 3.906 3.906 3.906 19
W02* 0.109 0.277 0.657 0.475 3.906 3.906 455 596 3.906 3.906 937 1182
W05 0.106 0.061 0.285 0.223 3.906 3.906 42 16 3.906 3.906 59 3.906
W06* 0.101 0.183 0.603 0.426 3.906 3.906 376 313 3.906 3.906 222 196
W07* 0.161 0.346 0.431 0.285 3.906 3.906 82 59 3.906 3.906 149 75
W11* 0.104 0.325 0.25 0.21 3.906 3.906 3.906 17 3.906 3.906 20 20
W14 0.073 0.084 0.24 0.166 3.906 3.906 50 139 3.906 3.906 100 59
88A* 0.098 0.063 0.152 0.278 3.906 3.906 104 32 3.906 3.906 83 62
88B* 0.139 0.507 0.328 0.115 3.906 3.906 38 47 3.906 3.906 79 32
30B* 0.117 0.413 0.437 0.316 3.906 3.906 27 35 3.906 3.906 31 19
558 0.16 0.418 0.46 0.202 3.906 3.906 29 15 3.906 3.906 18 20
563 0.139 0.192 0.342 0.275 3.906 3.906 3.906 37 3.906 3.906 12 35
130 0.258 0.24 0.336 0.273 3.906 3.906 3.906 3.906 3.906 3.906 3.906 3.906
13P 0.101 0.125 0.152 0.199 3.906 3.906 3.906 32 3.906 3.906 3.906 8
W16 0.036 0.126 0.084 0.137 3.906 3.906 3.906 17 3.906 3.906 3.906 11
W17 0.082 0.246 0.283 0.154 3.906 3.906 3.906 3.906 3.906 3.906 3.906 8
(a)
IgE IgG IgA
Wk-0 Wk-2 Wk-4 Wk-8 Wk-0 Wk-2 Wk-4 Wk-8 Wk-0 Wk-2 Wk-4 Wk-8
298 0.173 0.402 0.828 0.42 3.906 3.906 694 353 3.906 3.906 993 229
301 0.12 0.284 0.607 0.162 3.906 3.906 3.906 3.906 3.906 3.906 3.906 3.906
302* 0.074 0.18 0.662 0.178 3.906 3.906 163 89 3.906 3.906 215 104
303* 0.105 0.301 0.449 0.286 3.906 3.906 36 213 3.906 3.906 32 17
304 0.128 0.28 0.636 0.222 3.906 3.906 150 42 3.906 3.906 255 51
307 0.098 0.498 0.761 0.606 3.906 3.906 1224 1432 3.906 3.906 1586 1973
308* 0.073 0.447 0.702 0.242 3.906 3.906 453 254 3.906 3.906 501 247
309 0.118 0.341 0.701 0.304 3.906 3.906 345 190 3.906 3.906 355 198
310 0.124 0.473 0.703 0.352 3.906 3.906 397 248 3.906 3.906 584 356
312 0.134 0.216 0.318 0.056 3.906 3.906 52 33 3.906 3.906 114 60
317* 0.126 0.397 0.658 0.537 3.906 3.906 437 1571 3.906 3.906 339 387
318* 0.098 0.323 0.652 0.305 3.906 3.906 411 298 3.906 3.906 506 206
319 0.104 0.419 0.422 0.461 3.906 3.906 532 570 3.906 3.906 4497 591
320* 0.124 0.332 0.69 0.548 3.906 3.906 1037 613 3.906 3.906 1173 1857
325* 0.139 0.267 0.677 0.556 3.906 3.906 853 2560 3.906 3.906 5940 744
331 0.116 0.028 0.624 0.561 3.906 3.906 212 102 3.906 3.906 273 1860
337 0.034 0.29 0.574 0.337 3.906 3.906 258 262 3.906 3.906 571 635
(b)
Table 6.3. Levels of HSA-specific IgE antibody (in OD units), and IgG and IgA
antibodies (in RAU) in parasite-free cats (a) and parasitised cats (b)
* = vaccinated cats, Wk = week
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Table 6.4. Median and range of HSA-speciflc IgE (a), IgG (b) and IgA (c)









Vc+NVc 0.192* 0.323* Vc+NVc 0.328** 0.658** Vc+NVc 0.223* 0.337*
(0.063- (0.18- (0.152- (0.449- (0.115- (0.178-
0.507) 0.397) 0.657) 0.702) 0.475) 0.556)
Vc 0.32500 0.323 Vc 0.431°° 0.662 Vc 0.285 0.305
(0.063- (0.18- (0.152- (0.449- (0.115- (0.178-
0.507) 0.397) 0.657) 0.702) 0.475) 0.556)
NVc 0.155°° 0.315 NVc 0.284°° 0.63 NVc 0.209 0.344
(0.061- (0.028- (0.084- (0.318- (0.137- (0.056-
0.418) 0.498) 0.571) 0.828) 0.404) 0.606)
(b) HSA-specific IgG, results in RAU
Week 4 Week 8
Pf P Pf P
Vc+NVc 27** 397** Vc+NVc 32** 254**
(4-455) (4-1224) (4-596) (4-2560)
Vc 82° 437 Vc 47° 298
(4-455) (36-1037) (17-596) (89-2560)
NVc 4° 302 NVc 16° 219
(4-50) (4-1224) (4-139) (4-1432)
(c) HSA-specific IgA, results in RAU
Week 4 Week 8
Pf P Pf P
Vc+NVc 22** 501** Vc+NVc 20** 247**
(4-937) (4-5940) (4-1182) (4-1973)
Vc 83° 501 Vc 62° 247
(20-937) (32-5940) (20-1182) (17-1857)
NVc 8° 463 NVc 15° 293
(4-59) (4-4497) (4-35) (4-1973)
Vc = vaccinated cats and NVc = non vaccinated cats.
Differences between the levels of antibodies in the parasitised and parasite free cats:
*: test significant atp<0.05 and **: atp<0.001.
Differences between the levels of antibodies in the vaccinated and non-vaccinated cats in both
















































Fig. 6.2. Levels of HSA-specific IgE in OD units in vaccinated (Vc) and non-



















































































Fig. 6.2. (continued) Levels ofHSA-specific IgE in OD units in vaccinated (Vc)
and non-vaccinated (NVc) parasitised (P) and parasite-free (PF) cats at week 4









Fig. 6.3. Median and standard error of the levels of HSA-specific IgE in
OD units in vaccinated (Vc) and non-vaccinated (NVc) parasitised (P) and
parasite-free (PF) cats in the four bleedings.






















































Fig. 6.4. Levels ofHSA-specific IgG in RAU in vaccinated (Vc) and non-
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Fig. 6.5. Median and standard error of the levels of HSA-specific IgG in
RAU in vaccinated (Vc) and non-vaccinated (NVc) parasitised (P) and
parasite-free (PF) cats in the four bleedings.
A = vaccination, I hsa I = HSA fed.
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Cats infected with T. cati had significantly higher levels of antigen-specific IgG
antibody than did the parasite-free cats at weeks 4 and 8 (p<0.001) (table 6.4 (b), fig. 6.4
and 6.5).
Significant differences between the level of HSA-specific IgG from the cats
which were vaccinated and the cats which were not vaccinated were only seen at weeks
4 and 8 from the parasite-free cats, with the vaccinated cats showing higher levels (fig.
6.4 and 6.5).
6.3.2.3. HSA-specific IgA response
As was the case with HSA-specific IgG, HSA-specific IgA could only be
detected from week 4 (fig. 6.6 and 6.7). One parasite-free cat (cat 130) and one
parasitised cat (cat 301) never developed an IgA response to HSA. Four parasite-free
cats (cats 13N, 13P, W16 and W17) also showed only a weak IgA response in the last
bleeding. The levels of allergen-specific IgA in the last bleeding declined in 21 out of
the 34 cats (see tables 6.3 (a and b) and 6.4 (c)).
The group of parasite-free cats developed only a weak IgA response to HSA and
differences between the levels of HSA-specific IgA in both bleedings 3 and 4 (weeks 4
and 8) from parasitised and parasite-free cats were highly significant (p<0.001) (table 6.4
(c), fig .6.6 and 6.7).
Significant differences between the levels of HSA-specific IgA in the vaccinated
and non-vaccinated cats were only found at weeks 4 and 8 in the case of the parasite-free
cats, with higher levels resulting in the vaccinated group (fig. 6.6 and 6.7).
6.3.2.4. HSA-specific IgM response
HSA-specific IgM could not be detected in the sera of any of the 17 cats of either
group employing either the alkaline phosphatase-conjugated or unconjugated goat anti-
feline IgM.
6.3.2.5. Correlation between the levels ofHSA-specific IgG and IgA
The IgG and IgA responses at weeks 4 and 8, in the parasite-free and the
parasitised cats were highly correlated (p<0.01) (fig. 6.8 (a and b)). When the
correlations between the levels of IgG and fgA were assessed either at week 4 or week 8,



























































Fig. 6.6. Levels of HSA-specific IgA in RAU in vaccinated (Vc) and non-
















Fig. 6.7. Median and standard error of the levels of HSA-specific IgA in
RAU in vaccinated (Vc) and non-vaccinated (NVc) parasitised (P) and
parasite-free (PF) cats in the four bleedings.
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Fig. 6.8. Correlations between the levels of HSA-specific IgA and IgG at
week 4 and week 8 in parasite-free cats (a) and parasitised cats (b).
The levels of the 2 isotypes are significantly correlated ((a) r=0.869, p<0.01
















Fig. 6.9. Correlations between the levels of HSA-specific IgA and IgG in
parasite-free cats, at week 4 (a) and week 8 (b).
The levels of the 2 isotypes are significantly correlated ((a) r=0.923, p<0.01














1 1.5 2 2.5
LoglO HSA-specific IgG
Fig. 6.10. Correlations between the levels of HSA-specific IgA and IgG in
parasitised cats, at week 4 (a) and week 8 (b).
The levels of the 2 isotypes are significantly correlated ((a) r=0.930, p<0.01
and (b) r=0.751, p<0.01).
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4. Discussion
A single dose of approximately 250 T. cati embryonated eggs induced a patent
infection in 17/20 cats after 8 to 10 weeks, and the infection persisted during the 2
months of the study. The three kittens which were found to be negative 10 weeks after
exposure to T. cati eggs were excluded from the study and 3 females randomly selected
from the group of parasite-free cats (881, 564 and 565) were also excluded. Two groups
of 17 cats each (parasitised cats and parasite-free cats) were thus constituted.
Presensitisation bleedings (week 0) showed slightly positive OD values in the
HSA-specific IgE assay. IgE cross-reactivity has been reported against albumins of
different animal origins and the high frequency of asthma to animal hair/dander proteins
occurring in man may be a consequence of this cross-reactivity (Spitzauer et al., 1995).
Because the cats were fed a diet containing beef and chicken during the study, they may
have developed some IgE directed against bovine serum albumin and/or chicken serum
albumin. Such antibodies could have cross-reacted with HSA and given false-positive
ELISA results. Nevertheless the slightly positive OD values seen in the sera of cats
before being exposed to HSA were still present after heating at 56°C for 4 hr which
precludes this explanation. Slightly positive OD values were also detected in the heated
sera of the cats after exposure to HSA. However antibodies of other isotypes were not
detected in the presensitisation bleedings and thus these findings could not have resulted
from the detection of other isotypes by the polyclonal anti-feline IgE. Therefore these
values were attributed to non-specific binding. There was no significant difference
between the levels in the parasitised and parasite-free cats.
The oral administration of HSA daily for 3 weeks induced an antibody response
involving IgG, IgA and IgE isotypes which was detected in the serum. Although weak,
an IgE response was already detectable one week after oral exposure to HSA in the cats
infected with T. cati and in some of the parasite-free cats, whereas the IgG and IgA
responses started to develop later. However firm conclusions cannot be made as the
sensitivity of the ELISA for each isotype could have differed. The IgE response was of
shorter duration than that of the other isotypes. These results are in accordance with the
kinetics of the IgE and IgG antibodies in the study on the response to Dermatophagoides
farinae following parenteral immunisation (chapter 3) and the more rapid decline could
be a reflection of the shorter half-life of IgE. In the present study, the variations in the
antibody response seen in cats within each group is most probably the result of genetic
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differences between them. It has been shown in the dog that the length and the intensity
of the IgE response depends on the age at the time of immunisation and on the strain,
and that dogs can be segregated into high and low IgE responders (de Week, 1997; Zunic
et al., 1998).
The cats did not show any dermatological or GI signs. However it is not
impossible that the administration of a higher dose of HSA (rather than the 100 mg
which was given daily) and/or oral challenge of the cats with HSA after their 3 weeks of
sensitisation could have led to the development of clinical signs. On the other hand,
these cats had no known genetic predisposition to allergy. Guilford and Badcoe (1992)
were able to develop a model of food allergy in 20 puppies by oral administration of cod
protein and parenteral administration of the same protein in alum. All pups developed
positive IDSTs and detectable antigen-specific IgE in their serum. Oral challenge of the
sensitised puppies with codfish daily for 8 to 10 days resulted in transient vomiting and
pruritus in 20% and 85% of pups respectively and mild to moderate diarrhoea in the
majority of them. More recently a model for food allergy has been induced in an atopic
dog colony employing serial immunisations subcutaneously with three food antigens and
one pollen extract in alum, and subsequent oral challenge with the food antigens (Ermel
et al., 1997). The pups were also vaccinated with live attenuated distemper/hepatitis
vaccine (Ermel et al., 1997). All pups responded to the antigenic challenge by producing
high levels of food-specific IgE. However the overall IgE response was weak in
comparison to the response of other isotypes. In general, oral sensitisation with food
protein alone does not result in substantial food-specific IgE production, and animal
models of food allergy have usually required alternative routes of antigen presentation,
such as intravenous, intraperitoneal or subcutaneous with adjuvant. Frick et al. (1990)
and Ermel et al. (1997) have reported a highly significant difference in the IgE response
to food antigen in dogs immunised parenterally as compared with matched control dogs
that received the food antigens in their diet. However the former in no way mimics the
natural mode of sensitisation which occurs in food hypersensitivity. It was therefore
noteworthy that in the present study, most of the cats developed an HSA-specific IgE
response following oral administration of the antigen for 3 weeks.
Almost all the cats developed a serum IgG and IgA response to the HSA. It is
reported that low levels of IgG and IgA antibodies to various food are commonly found
in the serum of normal humans (Kletter et al., 1971; Johansson et al., 1984; Paganelli et
al., 1984). The presence of these food antibodies results from antigenic stimulation but is
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of limited clinical relevance. Absorption of small amounts of antigen through the gut
mucosa occurs under normal conditions in healthy adults (Husby et al., 1985).
Oral tolerance, a form of peripheral tolerance in which mature lymphocytes in the
peripheral lymphoid tissues are rendered non functional or hyporesponsive by prior oral
administration of antigen in a normal individual, has been shown to depend on the nature
and the dose of the antigen, and on a number of host factors such as the genetic
background, the maturity of the host, the digestive flora and the level of antigen uptake
(Strobel and Mowat, 1998). The parasite-free cats showed much lower levels of food-
specific antibodies than did the parasitised cats, with two of them apparently developing
tolerance to the HSA. With the exception of one cat, these poorly or non-responsive cats
were also unvaccinated. Therefore the presence of T. cati and the inoculation of the cats
with a live-attenuated virus seems to have prevented the development of oral tolerance in
favour of an active immunity with activation ofCD4+ T cells leading to the induction of
helper and memory cells. Interestingly, the cats which had a low IgE response to HSA
had also low levels of other isotypes in their sera whereas the opposite was not always
seen.
It was noteworthy that the apparently tolerant cats were both females.
Furthermore the other two females in the study had either undetectable or very low
levels of HSA-specific IgE, IgG and IgA. However because of the small number of
females and because none of them were parasitised, it is not possible to say if the sex
had any influence on the immune response.
Cats infected with T. cati gave a much stronger antigen-specific-antibody
response in the case of all three isotypes. Amongst the 5 cats which did not develop an
IgG response to HSA, 4 were parasite-free. One of the 2 cats which did not give an IgA
response and the two cats which responded weakly or not at all in respect of IgE were
also parasite-free. The marked increase of HSA-specific IgE seen in the cats infected
with T. cati was not unexpected since it is well known that the IgE antibody response to
unrelated allergens is potentiated in individuals with helminth infections. The increase in
total IgE has been reported to be largely a consequence of non-specific polyclonal
activation of IgE B cells (Jarret and Miller, 1982). A Th2 dominated response, exhibiting
a characteristic pattern of lymphokine production (11-4), versus a Thl response,
producing IFN-y, may be responsible for the elevated levels of IgE seen in helminth
infections (Romagnani, 1990; King et al., 1992). A preponderance of Th2 cells has been
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reported in human patients with IgE antibody against various helminths, including T.
canis (Romagnani, 1990).
There are conflicting hypotheses on the relationship between the non-specific
polyclonal potentiation of IgE induced by helminth infection and allergic conditions
(Moqbel and Pritchard, 1990). It has been proposed that infection with helminths
predisposes to atopy (Masters and Barrett-Connor, 1985). The contrary view suggest that
parasite infection prevents or modulate atopy (the "blocking theory") (Moqbel and
Pritchard, 1990). Thirdly, it is possible that the atopic state can be protective against
parasite infection (Moqbel and Pritchard, 1990). In the first hypothesis, the undeniable
ability of most helminths to induce a specific IgE response and a mastocytosis in the
infected host could undoubtedly enhance the allergic state. Also genetically predisposed
atopic individuals seem to be more prone to develop atopy/asthma following the
additional allergenic stimulation provided by parasite infection (Moqbel and Pritchard,
1990). The infection of cats with T. cati could therefore have a role in the development
of food hypersensitivity in predisposed cats by the potentiation of the IgE response to
orally administered antigen.
HSA-specific IgG was also found to be increased in the parasitised cats. Like the
IgE response, the IgG4 response in man has been shown to depend on Th2 cells and their
cytokine profile (Spiegelberg et ah, 1991a), and helminth infection results in heightened
parasite-specific and -non specific IgG4 antibody levels (IgGl in the mouse) (Zakroff et
ah, 1989). In the present study, all subclasses of IgG were presumably detected by the
ELISA and therefore the subclass specificity of the response is unknown.
Individuals with inflammatory bowel disease frequently have high levels of food-
specific antibodies of the IgE and other isotypes (May et ah, 1977; Johansson et ah,
1984). Therefore the higher levels of food-specific antibodies seen in the parasitised cats
may also have resulted from inflammation of the GI tract induced by the parasites. It
could be hypothesised that the inflammation could facilitate the absorption of food
antigens across the GI barrier. On the other hand, the inflammation could also facilitate
antigen capture by the antigen presenting cells, which would be increased in number and
situated in the mucosa close to the lumen of the GI tract. In such a case the induction of
oral tolerance could be prevented (Strobel et ah, 1985).
The level of total scrum IgG has also been shown to be increased in both atopic
and parasitised dogs (Hill et ah, 1995). However the concentration of total serum IgA
was found to be lower in both groups than in healthy dogs. The authors suggested that
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similar regulatory mechanisms governing immunoglobulin synthesis occurred in atopic
and parasitised dogs which may lead to heightened IgG synthesis but to down-regulation
of IgA production (Hill et ah, 1995). IgA deficiency has been also reported to be
associated with a higher incidence of atopic disease in humans (Kaufman and Hobbs,
1970; Buckley, 1975) and dogs (Campbell et al., 1991). However other studies failed to
demonstrate lower IgA levels in atopic dogs (Hall and Campbell, 1993; Mueller, 1993).
In the present study, the level of allergen-specific IgA was shown to be significantly
increased in the cats sensitised to HSA which were infected with T. cati. IgA producing
cells have also been shown to be upregulated by 11-5 and 11-6 (McGhee et al., 1989).
Therefore the increase in the levels of HSA-specific IgA found in the parasitised cats is
not surprising. However the level of total IgA was not assessed in these cats.
Inoculation of the kittens with a vaccine derived from attenuated feline
calicivirus, feline herpes virus and feline panleucopenia virus led to a significant
increase in the levels of HSA-specific IgE in weeks 2 and 4, and in the levels of HSA-
specific IgG and IgA in weeks 4 and 8 in the parasite-free cats. Vaccination with
respiratory viruses has been reported to enhance the production of total and allergen-
specific IgE in atopic individuals which suggests an IgE immunoregulatory role for
certain viral infections, especially in atopy-prone children (Frick et al., 1979). Using the
offspring of a colony of atopic dogs, Frick and Brooks (1983) showed that routine
immunisation with modified live distemper virus increased the production of IgE to
environmental allergens administered by injection. Pups given routine immunisation
with pollen extracts had higher titres of IgE antibodies than did their control littermates
which were not vaccinated until after the last pollen extract injection. However despite
the marked reaginic antibody production to pollens, the dogs showed no evidence of
atopy during the 14 months of study, except an occasional transitory rash on the face of
one of the dogs. In addition, this study did not rule out the possibility of concomitant
parasite infection.
In the model of food allergy induced in high IgE-producing atopic dogs
immunised subcutaneously with food and pollen antigen extracts, the pups were
vaccinated with live attenuated distemper/hepatitis vaccine (Ermel et al., 1997). The
inbred colony of hypersensitive dogs developed IgE antibody to pollens and food
antigens after immunisation with a live virus vaccine, followed immediately by a
subcutaneous injection of food antigen extract in alum. It has been demonstrated that the
stimulation of a naive immune system by a viral infection induces a response to the
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challenging antigens in a somewhat non-specific manner, which will develop more
specificity after further exposure (Frick and Brooks, 1983; Frick, 1986). In animals
genetically predisposed to allergy and exposed to an initial early infection or viral
challenge, the immune system is capable of responding to "bystander" antigens with
more vigour. The CD4+/CD8+ cell ratio has been shown to rise in both atopic and non
atopic humans immunised with a live attenuated measles virus vaccine (Peirsol and
Frick, 1983). The ratio was higher and took longer to return to baseline in the atopic
individuals than in the non atopic group. However the level of total serum IgE rose only
in atopic subjects who had a high initial IgE level and not in atopic patients with a low
IgE level or in non atopic patients (Peirsol and Frick, 1983).
More recently, Epstein-Barr virus in the presence of 11-4 has been demonstrated
to stimulate human B cells and to induce T cell-independent IgE-synthesis (Thyphronitis
et ah, 1989). Viral infection (e.g. rotavirus) can also damage the gut mucosa which will
become more permeable to other food allergens in the diet (Ermel et al., 1997). In the
present study, the HSA-specific IgE response was only enhanced following
immunoprophylaxis with live attenuated virus in parasite-free cats. It is unclear why the
response in the parasitised cats was not similarly enhanced. The potentiation of the
immune response induced by immunoprophylaxis was however much weaker than that
resulting from endoparasitism.
Highly significant correlations were found between the levels of HSA-specific
IgG and IgA. This would imply a similar mechanism in the immune responses involving
these two isotypes.
Surprisingly an IgM response was never detected despite using 2 different
polyclonal anti-feline IgM reagents. Small amounts of IgM antibodies to food have been
shown to be present in the sera of normal individuals (Paganelli et ah, 1984). In a study
on the immune response to cow's milk in normal infants, IgM antibodies were only
found in a few infants and were only present at low levels (Kletter et ah, 1971). Low
levels of IgM antibodies to cow's milk protein were also reported by Hunter et al. (1968).
In contrast, Minden et al. (1966) were not able to detect any bovine serum albumin-
specific IgM antibody in human sera. However in some pathological conditions such as
inflammatory bowel disease, sera were found to contain high levels of IgM antibody to
p-lactobglobulin (Faichuck and Isselbacher, 1976).
IgM producing cells are found in the mucosal lamina propria and secretory IgM
is generated in the same way as secretory IgA (Mestecky and McGhee, 1987). Therefore,
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the cats may still have had HSA-specific IgM in gastrointestinal secretions whilst failing
to show a systemic response. In contrast to IgA, it is possible that the IgM produced
locally may not be able to enter the circulation (Conley and Delacroix, 1987; Mestecky
andMcGhee, 1987).
In conclusion, the oral administration of HSA to kittens for three weeks induced
antigen-specific IgE, IgG and IgA responses although the response was weak in the
parasite-free cats. Administration of the trivalent freeze-dried virus vaccine significantly
enhanced the production of allergen-specific IgE, IgG and IgA in parasite-free cats but
had no effect on the production of allergen-specific antibodies in parasitised cats. These
findings are supportive of a possible role of endoparasitism and vaccination in enhancing
the IgE response to orally administered antigen, and hence possibly, in genetically




One aim of this work was to purify and further characterise feline IgE. The sera
employed came from cats which were parasitised with T. cati, either naturally or
experimentally. Therefore these sera were presumed to contain high levels of total IgE
since levels of serum IgE were reported to be even higher in parasitised cats than in
parasitised dogs (Alaba, 1997). Sera collected from several cats were pooled in order to
obtain larger volumes similar to those used previously for the purification of canine IgE
(Schwartzman et ah, 1971; Halliwell, 1973). An attempt was made to obtain a fraction of
IgE as pure as possible using the conventional methods of purification (Schwartzman et
ah, 1971; Peng et ah, 1993a; Foster et ah, 1995). However the fractions of semi-purified
IgE were still found to contain other proteins in much higher concentration than the IgE
antibody itself. An immunoaffinity column was made with the polyclonal anti-feline IgE
and the IgE-rich fractions were passed over this column. The eluate from the anti-feline
IgE column would be expected to be pure IgE. However the passage of these fractions
through the anti-feline IgE affinity column resulted in non-specific binding of other
proteins and the IgE antibodies in the eluate were still present in too low concentration to
be characterised.
Although a protein with an apparent MW of approximately 80 KDa was present
in all fractions assessed by SDS-PAGE, it was not possible to demonstrate the presence
of feline IgE since a protein contaminant with a similar MW was also present and may
have masked the IgE antibody. Foster (1995) also noted the presence of various proteins
in the PCA positive column fractions, and attempts to further purify feline IgE were
unsuccessful (Foster, 1995). On the other hand, Foster found the MW of the IgM heavy
chain to be 85 KDa, which is very close to the MW expected for the IgE heavy chain.
Therefore it would be even more difficult to isolate IgE on a gel where IgM is also
present, as the latter was still found in some of the IgE-rich fractions partially purified by
Foster (1995). However the chromatographic procedures used in the studies reported
herein would be extremely unlikely to yield contamination with IgM unless the feline
sera contained monomcric IgM, which has not been described.
Whereas feline IgE appears to share some antigenic determinants with the canine
protein, the antigenic relationship between human and feline IgE apparently is less close.
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Indeed, while a strong cross-reactivity between canine and feline IgE was demonstrated
using a polyclonal anti-canine IgE, human IgE was found to cross-react only weakly
with feline IgE when assessed by RCA using 3 polyclonal anti-human IgE sera. Similar
findings were noted by Foster (1995) who was not able to induce RCA by injection of
monoclonal anti-human IgE. However polyclonal antibodies which recognise multiple
epitopes are more likely to demonstrate cross-reactivity than are monoclonal antibodies
which react only with a single epitope (Peng et ah, 1996). Polyclonal anti-human IgE
was shown to cross-react with canine IgE whereas monoclonal anti-human IgE did not
(Becker et ah, 1993).
Although it was not possible to purify and to isolate IgE on a gel, Fr-R contained
sufficient IgE to immunise rabbits and induce polyclonal antisera directed against this
isotype. Using affinity chromatography it was possible, as assessed by the ELISA and
IEP, to remove any activity the antiserum had against other feline immunoglobulins and
other heat stable proteins.
This is thus the first study that has described the production of a polyclonal
antiserum to feline IgE and demonstrated the specificity of the antiserum for this isotype.
Indeed, although a few reports have assessed the level of total or allergen-specific IgE in
cats, none of them gave details of the production of the antisera employed or their
specificity (Foster and O'Dair, 1993; Alaba, 1997).
The specificity of the antiserum is a key factor in ensuring the accuracy of an
ELISA. Development of an ELISA using this polyclonal antiserum permitted a number
of studies aimed at the understanding of the pathogenesis of allergic diseases in cats.
The kinetics of both the DF and HSA-specific IgE responses was found to be
similar to the kinetics of IgE in other species. In general, the IgE response was shown to
be earlier than the IgG and IgA responses and the length of the IgE response was shorter
than that of the other isotypes. The IgE response to DF appeared to be boostable which
contrasts with the findings of Zunic and collaborators (1998) in dogs. In the latter study,
only puppies immunised immediately after birth were found to show such IgE responses
(Zunic et ah, 1998).
The studies on the DF-specific IgE levels in the three groups of cats (cats with
atopy, normal household cats, and the normal laboratory reared cats in which IgE was
induced experimentally) are of particular significance. DF-specific IgE was detected in
the atopic cats, and in the laboratory reared cats following immunisation with DF, but
also in normal household cats. Yet no clinical signs resulted in these two last groups.
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Antibody was essentially absent from sera from the laboratory reared cats. In the 10 cats
in which DF-specific IgE was induced experimentally, strongly positive skin tests were
always correlated with positive PK tests, but neither were correlated with ELISA results.
Furthermore, the development of HSA-specific IgE following oral immunisation
resulted in no clinical signs.
This emphasises that it is not only the presence of IgE that distinguishes allergic
individuals from normals and that the precise role of IgE in the pathogenesis of allergic
diseases (atopy and food allergy) is not clear. Similar findings have been demonstrated
in man and in dogs and strongly suggest the existence of heterogeneity of IgE. It seems
likely that there is more than one type of IgE; with a particular subtype being responsible
for allergic diseases.
As reported in both man and the dog, house dust mites (HDM) are reported to be
the strongest allergens involved in the pathogenesis of atopic disease in cats. Whereas
people react more frequently to D. pteronyssinus (DP) (Platts-Mills and Chapman,
1987), DF is more commonly involved in dogs (Prelaud 1991; Carlotti and Costargent,
1994; Sture et al., 1995; Lian and Halliwell, 1998) and cats (Carlotti and Prost, 1988;
Foster and O'Dair 1993; Prost, 1996a; Halliwell, 1997). Derp 1, a major allergen ofDP,
was demonstrated to be able, through its protease activity, to disrupt the IgE network and
to upregulate IgE production (Hewitt et al., 1995). It could be assumed that DF would
also have such protease activity. Thus Dermatophagoid.es antigens appear to have a
remarkable propensity to induce a response favouring the IgE isotype. It is not surprising
therefore, that IgE to DF is found commonly in normal dogs and cats with no sign of
allergic disease. The concept of heterogeneity of IgE could well account for discordance
between ELISA, IDST and PK test results found in this study and in previous studies in
dogs (Jackson et al., 1996; Lian and Halliwell, 1998; Peng et al., 1998). It is also of
interest that ELISA using the high affinity receptor for IgE seems to detect only a small
proportion of DF-specific IgE in the serum of dogs with atopic dermatitis and positive
IDST to DF (McCall, 1998). A logical explanation of these findings is that some of the
IgE induced by HDM may differ in its structure from the remainder and also from the
IgE induced by the other allergens in having a lower affinity for FceRI receptor. In such
a case, the level of DF-specific IgE would not be expected to correlate with the presence
and the severity of the clinical disease.
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However, although the IgE response to HDM appears to be a unique
phenomenon, it must be emphasised that IgE specific for other allergens is sometimes
found in normal individuals, although generally at low levels.
This is the first report that has shown a specific IgE response to a food antigen
given orally without concomitant parenteral administration. The studies also assessed the
influence of the vaccination and endoparasitism on the specific IgE response. The route
of antigenic challenge used was similar to that pertaining to spontaneous sensitisation
that would occur in individuals with food allergy. In the models of food hypersensitivity
successfully developed in dogs, puppies were sensitised not only via the oral route but
also employing concomitant parenteral administration of food and non-food related
antigens in aluminium hydroxide (Guilford et al., 1991; Frick et al., 1990; Guilford and
Badcoe, 1992; Ermel et ah, 1997).
Although weak, the majority of the parasite-free unvaccinated cats did develop an
HSA-specific IgE response. However endoparasitism and vaccination were clearly
shown to enhance the IgE response to the orally administered antigen. These factors may
have a role in the development of food hypersensitivity and also of atopy in cats with an
appropriate genetic background. This is important since a high percentage of pet cats are
still infected with T. cati and almost all of them are vaccinated at a young age, and then
revaccinated at intervals.
In conclusion, these studies have demonstrated for the first time the production
and the specificity of a polyclonal anti-feline IgE. Using this antiserum, DF-specific IgE
could be detected in atopic and also in normal household cats. However it was generally
absent or very low in laboratory reared cats. DF-specific IgE was induced in normal
laboratory reared cats following immunisation with DF in aluminium hydroxide. It was
noteworthy that the levels of DF-specific IgE did not correlate with skin tests or with PK
reactivity. No clinical signs resulted. These findings could not result from heterogeneity
of the Fes receptor, but can only be explained by the existence of a functional
heterogeneity of IgE in cats. It was also shown that both endoparasitism and vaccination
with a standard battery of viral vaccines in cats enhanced the IgE, IgA and IgG response
to an orally administered antigen, and could therefore have a role in the development of
food hypersensitivity in cats with an appropriate genetic background. Similarly to the
cats sensitised to DF, the cats sensitised to HSA developed no clinical signs. This is also
supportive of functional heterogeneity of feline IgE.
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Abstract
Cats, naturally or experimentally infected with Toxocara cati were immunised with dinitro-
phenylated ascaris antigen (DNP-Asc). All cats developed immediate skin reactivity to DNP
coupled to bovine serum albumin (DNP-BSA) and the sera of the nine cats had a heat labile
homocytotropic antibody detectable by homologous Prausnitz-Kiistner (PK) tests. Reagin-rich
fractions were prepared from these sera and used for the preparation of polyclonal antisera in
rabbits. Resultant antisera were passed through a immunoabsorbent column of Sepharose 4B
coupled to heated normal cat serum. An immunoabsorbent column prepared with the resultant
antisera removed the PK reactivity from the cat sera, and the activity was recovered following acid
elution. The antiserum failed to detect any recognised immunoglobulin in cat sera, but precipitated
with a heat labile protein with y-1 electrophoretic mobility in the sera of parasited cats. These
findings support the contention that the antisera are specific for feline IgE. © 1998 Published by
Elsevier Science B.V. All rights reserved.
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1. Introduction
Cats suffer from numerous skin diseases whose pathogenesis may involve
immediate-type hypersensitivity reactions but are still poorly understood. Among these
are miliary dermatitis, self-induced alopecia, eosinophilic granuloma complex and
pruritus of the face, neck and pinnae (Scott et al., 1995). Respiratory disease of allergic
origin, so-called feline asthma, may also result from an IgE-mediated pathogenesis
(Halliwell and Gorman, 1989; Corcoran et al., 1995). Unfortunately, many cases of
diseases that are probably allergic in aetiology remain undiagnosed because of their
corticosteroid responsiveness, and the relative lack of side effects of such drugs in the
feline species. Although IgE has not been immunochemically identified in the cat, there
is convincing evidence that reaginic antibody is produced in association with certain
disease states.
Reaginic antibody has been characterised in many species including the dog (Halli¬
well et al., 1972). IgE antibodies in animals share many physicochemical properties with
IgE antibody of man. They are characterised by a relatively fast electrophoretic mobility,
a sedimentation coefficient of approximately 8 S, a molecular weight of approximately
200000 Da, the capacity to fix to tissue following injection for > 3 weeks and a high
sensitivity to heat and reducing agents (Halliwell et al., 1972).
Several studies have already shown that cat serum contains a protein with IgE-like
properties (Walton et al., 1968; Powell et al., 1980; De Boer et al., 1993; Baldwin et al.,
1993; Foster et al., 1995). Walton et al. (1968) demonstrated the existence of reaginic
antibody to whole milk antigen in a cat with dermatitis and enteritis using Prausnitz-
Kiistner (PK) testing. In another study, reaginic antibodies to the ear mite Otodectes
cynotis were demonstrated and are believed to be responsible for the extreme pruritus
that is associated with some cases of parasitic otitis externa (Powell et al., 1980). More
recently, De Boer et al. (1993) showed that cats have a reaginic antibody that is
antigenically cross-reactive with canine IgE and has an apparent molecular weight
similar to that of IgE from other species. Foster et al. (1995) demonstrated that the
passive cutaneous anaphylaxis (PCA) reactivity was eluted following chromatography
using Sephadex G200 in a position similar to that of other species, and that feline
reaginic antibodies are bound by protein A. The latter author used PCA in which the
antigen is injected intravenously as opposed to the PK test in which the antigen is
injected intradermally.
The existence of myelomas have permitted the ready purification of IgE for the
subsequent production of monoclonal antibodies in man (Johansson and Bennich, 1967),
and the rat and the mouse (Bazin et al., 1974; Bottcher and Hammerling, 1978).
However, in the cat, the lack of myelomas secreting IgE, the presumably low level of
serum IgE and the small amount of serum obtainable make the isolation of IgE very
difficult.
The further characterisation of feline IgE and the development of specific antisera are
prerequisites for the elucidation of the role of IgE and of immediate type hypersensi¬
tivity in a number of common feline diseases. The goal of this study was thus to produce
polyclonal antisera against the immunoglobulin to permit quantification of total and
allergen-specific feline IgE in diseases which may involve immediate-type hypersensi¬
tivity.
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2. Materials and methods
2.7. Experimental animals
Infected and normal cats were obtained from a colony of experimental cats at the
University of Liege (Belgium).
Normal adult (ex-breeder) parasite-free cats for PK tests and reversed cutaneous
anaphylaxis (RCA) were obtained from Hill Grove Family Farm (Oxford, UK).
New Zealand white rabbits were obtained from Interfauna UK (Cambridge, UK).
All experimental protocols were in accordance with the requirements of an Animal
Care and Ethics Committee and/or the UK Home Office as appropriate.
2.2. Infection of cats with Toxocara cati
Three 10-month old cats (#5,#6,#7) and three 12 to 16-week old kittens (#1, #2,
#3) were found to be naturally infected with T. cati. All were secreting ova in their
faeces.
Three additional normal 10-week old kittens (#4, #8, #9) were experimentally
infected with T. cati. The eggs were isolated from the faeces of naturally infected cats.
They were washed three times in 1% sodium chloride and centrifuged at 1500 rpm for 5
min. After discarding the final rinse, the eggs were resuspended in 0.5% formalin
(Sigma, Poole, UK) and kept, under oxygen, in a dark room, at 27°C. Infective second
stage larvae were obtained after 3 weeks. The cats were dosed with 10 embryonated ova
daily for 3 days. Development of a patent infection was indicated by the appearance of
the ova in the faeces within 60 to 75 days.
2.3. Ascaris antigens
Purified antigen from Ascaris suum (Asc-1) was purchased from Greer (Lenoir, NC).
Adult T. cati were obtained post mortem from naturally infected cats and antigens
from body fluid were partially purified by gel filtration on Sephadex G100 (Pharmacia,
Uppsala, Sweden) to remove the low molecular weight histamine releasing fractions.
Material from the major protein peak was concentrated.
2.4. Preparation of dinitrophenylated antigen
Asc-1 and bovine serum albumin (BSA) (Sigma) were dinitrophenylated (DNP)
according to the method of Eisen (1964).
2.5. Induction offeline anti-DNP and anti-Ascaris antibodies
Cats were immunised with DNP-Asc in aluminium hydroxide (Imject Alum®; Pierce,
Rockford, IL, USA) in order to induce anti-DNP reaginic antibody as described for the
dog (Schultz and Halliwell, 1985). Each cat received two biweekly injections of 10 ^.g
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of DNP-Asc subcutaneously over the lateral thorax at two sites on either side of the
body.
2.6. Performance of intradermal skin tests (IDST)
Cats were anaesthetised with 1 mg/kg xylazine (Virbaxyl®, Virbac, Cambridge, UK)
and 10 mg/kg ketamine hydrochloride (Vetalar®, Parke-Davis, Pontypool, Gwent, UK)
intramuscularly. The lateral chest was clipped and 0.05 ml of a solution of 10 /xg/ml of
DNP-BSA was injected intradermally. Phosphate buffered saline (PBS) and 1/100000
w/v solution of histamine phosphate (ARTU Biologicals, Lelystad, Netherlands) were
used as negative and positive controls, respectively. Reactions were scored after 15 to 20
min using a +1 to +4 scale, incorporating both diameter and elevation above the
surface. A +1 reaction was just discernibly greater than the PBS wheal, and a +4
reaction approximated the size of the histamine wheal.
2.7. Fractionation of sera
T. cati-infected cats were bled by jugular venipuncture. Sera were harvested by
centrifugation after clot retraction and were stored at — 30°C.
Sera were fractionated by the same three-step procedure that was employed to
prepare IgE-rich fractions of canine sera (Halliwell et al., 1972). Briefly, serum that
precipitated between 33.33 and 45% saturation with ammonium sulphate was dialysed
against 0.05 M phosphate buffer, pH 8.0, and applied to a column of diethylaminoethyl
cellulose (DEAE; Watman, Maidstone, Kent, UK) equilibrated with the same buffer.
The excluded protein was concentrated and then applied to a three-in-series 4 X 60 cm
column set of Sephacryl S-200 (Pharmacia) and eluted using PBS. The protein eluting
immediately prior to the 7 S peak and the first one third of that peak was pooled and
concentrated using Centripet-10 concentrators (Amicon, Gloucester, UK) as fraction R
(Fr-R).
2.8. Preparation ofpolyclonal antisera to IgE
Three New Zealand white rabbits were immunised with three biweekly injections of
100 to 200 p,g of Fr-R in 1 ml of Freund's complete adjuvant (Sigma) subcutaneously at
four sites.
The resulting antisera were passed over an immunoabsorbent column of Sepharose
4B (Sigma) to which was coupled serum from a parasite-free cat that had been heated to
56°C for 4 h. This was repeated a number of times until no protein was eluted by
glycine-HCl buffer, pH 2.7. This column removed any activity against immuno¬
globulins other than IgE and also against other heat stable serum proteins (Vaerman and
Heremans, 1968).
The antiserum which had the best apparent anti-IgE activity as assessed by reverse
cutaneous anaphylaxis (RCA) (R294-7) was then used to prepare another immunoab¬
sorbent column. A 45% ammonium sulphate precipitate of the antiserum was dissolved
in PBS and then coupled to Sepharose 4B. Protein from sera of parasited cats that bound
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to the column following the subsequent elution with glycine-HCl, was used to immu¬
nise four further rabbits using the same procedure as above.
2.9. Preparation of anti-feline light chain serum
Feline IgG was first prepared from a 33.3% ammonium sulphate precipitate of
normal feline serum by exclusion from DEAE in 0.01 M phosphate buffer, pH 8.0.
Rabbit anti-feline IgG was subsequently prepared by immunising New Zealand white
rabbits with 3X1 mg aliquots biweekly in Freund's incomplete adjuvant. Anti-feline
light chain serum was then prepared by adsorption and elution of the anti-feline IgG
from an immunoabsorbent column of Sepharose 4B to which was coupled feline (Fab)2.
The latter was prepared by pepsin digestion of feline IgG at pH 4.5 for 24 h and
subsequent isolation using Sephadex G-100 (Pharmacia).
2.10. Induction of reversed cutaneous anaphylaxis
Antisera were assessed for activity against IgE by their ability to induce RCA on
intradermal injection in healthy parasite-free cats. Cats were anaesthetised with 10
mg/kg ketamine hydrochloride intramuscularly. The hair of the lateral chest area was
clipped and 0.05 ml of each dilution was injected intradermally. Antisera were tested at
1:10 and 1:100 and then at doubling dilutions. Normal rabbit serum (1/10, 1/100 and
1/1000) and PBS were included as negative controls and histamine phosphate 1/100000
w/v as a positive control.
Immediate skin reactions were recorded 15 to 20 min after the injection as above for
IDST.
2.11. Homologous Prausnitz-Kustner tests
Homologous PK tests were performed to assess the DNP-specific IgE and the
Asc-specific IgE in the sera from nine infected cats. Healthy parasite-free cats were
anaesthetised with 10 mg/kg ketamine hydrochloride intramuscularly. The hair of the
lateral chest area was clipped. One-tenth millilitre of 10-fold dilutions in PBS (1-
1/10000) of each serum was injected intradermally. Injection sites were challenged 48
h later by intradermal injection of 0.05 ml of a 10-/xg/ml solution of DNP-BSA, 100
/rg/ml of Asc-1 and 100 /rg/ml of T. cati antigen. Negative controls (PBS, DNP-BSA
10 /xg/ml or Asc 100 pg/m\) and a positive control (histamine phosphate 1/100000
w/v) were injected into unsensitised sites. Skin reactions were recorded 15 to 20 min
after the injection as above.
2.12. Neutralisation of PK reactivity of reactive sera
Antisera were also assessed for activity against IgE by their ability to remove PK
reactivity from feline sera. PK tests were performed as above with sera that gave
positive reactions before and after two and four passages through the anti-IgE im¬
munoabsorbent column (R294).
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2.13. Immunoelectrophoresis on agar gel
Immunoelectrophoresis (IEP) was performed using 1.5% agar in 0.03 M barbital
buffer pH 8.6. Gels were run for 55 min at 50 mA and incubated in a humidity chamber
at room temperature for 48 h (Grabar and Williams, 1953).
3. Results
3.1. Parasitological findings
All cats developed a patent infection with T. cati with ova appearing in the faeces
within 60 to 75 days. After euthanasia, adult T. cati were found in the duodenum of cats
#l-#4. No T. cati were recovered in the other cats. However Dypilidium caninum was
found in the large intestine of cats #4-#7.
3.2. IDST
All cats had a positive IDST to DNP-BSA with four cats (cats 1, 3, 6 and 7) showing
a + 3 reaction; four cats (cats 2, 4, 8 and 9), a +2 reaction; and one cat (cat 5), only a
+1 reaction.
3.3. Homologous PK tests
The 10-fold dilutions of sera from immunised cats were assessed for PK reactivity.
Positive results were recorded with dilutions out to 1 /100 (three cats), 1/10 (five cats),
with one cat reacting only with undiluted serum when challenged by DNP-BSA.
Serum from only one cat gave a positive reaction with T. cati. No sera showed PK
reactivity against Asc-1.
3.4. RCA tests
Six of the seven antisera raised against the putative IgE rich fraction (RI94-R394,
R794, R994 and R1094) were able to induce RCA at a dilution of > 1/100 (Table 1).
Table 1
RCA titres of seven polyclonal antisera raised against feline IgE preparations




R794* * * 400
R894 * * * negative
R994* * * 400
R1094* * * 1600
* Titre using doubling dilutions of each antiserum from 1/100.
* * Antisera raised against Fr-R.
* * * Antisera raised against the protein eluted from the putative anti-IgE immunoabsorbent column.
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Fig. 1. Effects of the passage of feline reagin-containing serum #6 through a putative anti-lgE immunoab-
sorbent column on the PK titre to DNP.
Although two antisera (R294 and R394) were able to induce a wheal on intradermal
injection at 1 /3200 dilution, the largest wheal at that dilution was obtained with R294
which gave stronger reactions. Reactions were not seen with normal rabbit serum.
3.5. Neutralisation of PK reactivity of reactive sera
PK activity to DNP and T. cati, respectively in sera #4 and #6 decreased progres¬
sively following each passage through the putative anti-lgE immunoabsorbent column
(R294). Although the diminution in PK reactivity was evident in both cases, it was most
significant in case of serum #6 (Fig. 1). In contrast, passage of the sera through a
column of normal rabbit serum coupled to cyanogen bromide activated Sepharose 4B
produced only a small decrease of PK reactivity (Fig. 1). Heating at 56°C for 4 h
removed all PK reactivity (Fig. 1). When the eluate from the immunoabsorbent column
used for serum #4 was assessed for PK reactivity to DNP, a +4 result was obtained
following injection of 0.1 ml of a 375-/rg/ml preparation of pooled eluates.
3.6. Immunoelectrophoresis on agar gel
3.6.1. Specificity of the putative anti-feline IgE
Rabbit antiserum R294 from the ninth bleeding and R1094 from the fifth bleeding
were able to precipitate with a protein which had -y-1 electrophoretic mobility in the nine
sera from infected cats and in the serum from a parasite-free cat, but this protein was not
detectable in heated sera (Fig. 2). The same antisera failed to detect purified feline IgG.
This protein was also no longer detectable after four passages of the serum through the
anti-lgE immunoabsorbent column.
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Fig. 2. Antibody activity of putative anti-feline IgE serum (R294) as revealed by immunoelectrophoresis. (a)
Top well: cat serum #4. Bottom well: cat serum #4 heated at 56° for 4 h. Trough: antiserum R294. (b) Top
trough: antiserum R294. Bottom trough: anti-feline light chain immunoglobulin. Well: eluate from R294
immunoabsorbant column.
3.6.2. Immunoelectrophoretic analysis of the eluate from the putative anti-IgE column
Rabbit antiserum against feline immunoglobulin light chain detected a single protein
which had y-\ electrophoretic mobility in the putative IgE preparation eluted from the
column R294-7 (Fig. 2). However, R294 was not able to precipitate with a protein in
this putative IgE, and equally the protein was not detected by anti-feline IgG (Fc-specific).
4. Discussion
Collectively, the data presented are persuasive evidence of the specificity of the
polyclonal antiserum for feline IgE. On IEP on agar gel, antisera R294 and R1094 were
able to precipitate with a heat labile immunoglobulin which had y-l electrophoretic
mobility. The protein eluted from the anti-IgE column was shown to be an immuno¬
globulin by its detection by a rabbit anti-feline light chain serum, but was not detected
by the anti-IgE sera R294 and R1094. Neither was it detected by Fc-specific anti-feline
IgG. It has been shown that canine IgE is sensitive to acid treatment (Halliwell et al.,
1975) and the same is likely to hold true for the feline isotype. Since 0.1 M glycine-HCl
pH 2,7 was used to eluate the solution from the putative anti-IgE affinity column, the Fc
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portion of the reaginic antibody may have been denatured although it was immediately
neutralised with 1 M Tris-HCl to pH 8. This could explain why R294 failed to
precipitate with the immunoglobulin in the putative IgE eluted from the anti-IgE
column. It could also explain why the antisera produced against this eluate were weaker
in terms of RCA activity.
Although many researchers recommend that CFA should only be used for the first
injection in antisera production for humane reasons, it was used in these studies on three
occasions with full permission of the Home Office. This was done because previous
experience in our laboratory has shown that the induction of antisera against IgE of
animal origin, which is likely to be present in very small quantities, is exceedingly
difficult using any other protocol. Painless granulomatous swellings which did not
ulcerate, were the only adverse effects observed, and the rabbits were not affected
systemically.
The PK test has proved to be a sensitive method to detect the presence of reaginic
antibody (Prausnitz and KUstner, 1921). The sensitivity of the test has been shown to be
0.2 ng/ml in human sera and 2-3 ng/ml in mice sera (Ishizaka, 1988). The optimal
period after sensitisation for the detection of IgE using PK or PCA tests is 24 to 48 h
while for IgG, this period is 1 to 6 h. Moreover, the sensitisation induced by IgG persists
only for a short time of 1 to 2 days while the IgE binds to mast cells for about 3 weeks
(Ovary, 1986). Those characteristics as well as the heat sensitivity permit distinction
between IgE and IgG homocytotropic antibodies. In cats, as in other species PCA tests
have also been used extensively to establish the presence of allergen specific IgE
(Walton et al., 1968; Powell et al., 1980; Baldwin et al„ 1993; Foster et ah, 1995).
Sera from eight of the nine cats immunised with DNP-Asc were able to give a
positive PK test to DNP at 1/10 dilution with three sera reacting out to 1/100.
However, results of PK tests when challenged by Asc-1 or T. cati antigen were
surprising in that only one serum gave a PK reaction when challenged with T. cati
antigen despite the fact that all had previous patent infection with T. cati. It is also
difficult to understand why the immunisation of the cats with DNP-Asc-1 failed to
induce detectable Asc-1-specific IgE. It has been shown by Strejan et ah (1973) that
Asc-1 allergen was strongly immunogenic and when coupled to DNP was far more
effective in inducing DNP-specific IgE than when coupled to other proteins (Strejan and
Marsh, 1971). A lower dose of Asc-1 could have been more effective since Strejan et ah
(1973) found that Asc-1 was more immunogenic at a dose of 1 /jlg than at 10 /xg.
Also, in some systems, the potentiation of reagin by helminth antigens seems to
require active infection and is usually transient and ceases when most of the parasites
have been expelled (Orr et ah, 1971). In this study, the IgE response to the DNP does
not appear to be related to the potentiation by helminth infection but may still be related
to the immunisation of the cats with DNP coupled to Asc-1. It is also possible that the
differences seen in this study in the level of DNP-specific IgE could depend upon the
genetic background (Tada, 1975).
Antigenic cross-reactivity between stages of Toxocara and other ascarid species has
been described (Page et ah, 1991). However, in one study, Foster et ah (1995) used
crude A. suum and T. canis antigens in PCA tests using sera from cats infected with T.
canis, with negative results. The author hypothesised that the antigens responsible for
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PCA activity may have been present in different quantities at different stages of the
parasite life cycle (Foster et al., 1995). Cox (1993) has shown that the various immune
responses are stage specific. The life cycle of T. cati is complex and depends on the
route of infection of the cat. In contrast to transmammary infection in which larvae
acquired by the kitten apparently do not migrate (Swerczek et al., 1971), infection by the
ingestion of embryonated eggs leads to somatic migration with accumulation of arrested
larvae in the body tissues (Bowman, 1995). Thus, the cats with negative PK activity to
antigens of the adult worm may still have had some IgE activity against larval stages of
T. cati.
The reasons for the failure of most of the cats to develop a detectable IgE response to
the parasite antigens studied using the PK test are thus obscure. However, since the
detection of specific-IgE was not performed by enzyme-linked immunoassay we should
not exclude the possibility of the existence of another Asc-1 or T. cati-specific IgE
isoform which was either less efficient in binding to mast cells or in inducing
degranulation. It is also quite possible that antibodies of other isotypes were produced.
In conclusion, the claim of the specificity of the antisera for feline IgE is supported
by a number of results. Firstly, the DNP-specific PK reactivity was removed by passage
through the putative anti-IgE immunoabsorbent column. Secondly, PK reactivity was
recovered in the eluate. Thirdly, this eluate contained immunoglobulin which was not
IgG. Also, the antisera were able to induce RCA in high dilution and finally, they were
able to detect a heat labile protein in the sera of parasited cats which had an
electrophoretic mobility compatible with that known for this isotype in other species.
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Abstract
Cats, naturally or experimentally infected with Toxocara cati were immunised with dinitro-
phenylated ascaris antigen (DNP-Asc). All cats developed immediate skin reactivity to DNP
coupled to bovine serum albumin (DNP-BSA) and the sera of the nine cats had a heat labile
homocytotropic antibody detectable by homologous Prausnitz-Kustner (PK) tests. Reagin-rich
fractions were prepared from these sera and used for the preparation of polyclonal antisera in
rabbits. Resultant antisera were passed through a immunoabsorbent column of Sepharose 4B
coupled to heated normal cat serum. An immunoabsorbent column prepared with the resultant
antisera removed the PK reactivity from the cat sera, and the activity was recovered following acid
elution. The antiserum failed to detect any recognised immunoglobulin in cat sera, but precipitated
with a heat labile protein with -y-1 electrophoretic mobility in the sera of parasited cats. These
findings support the contention that the antisera are specific for feline IgE. © 1998 Published by
Elsevier Science B.V. All rights reserved.
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1. Introduction
Cats suffer from numerous skin diseases whose pathogenesis may involve
immediate-type hypersensitivity reactions but are still poorly understood. Among these
are miliary dermatitis, self-induced alopecia, eosinophilic granuloma complex and
pruritus of the face, neck and pinnae (Scott et al., 1995). Respiratory disease of allergic
origin, so-called feline asthma, may also result from an IgE-mediated pathogenesis
(Halliwell and Gorman, 1989; Corcoran et al., 1995). Unfortunately, many cases of
diseases that are probably allergic in aetiology remain undiagnosed because of their
corticosteroid responsiveness, and the relative lack of side effects of such drugs in the
feline species. Although IgE has not been immunochemically identified in the cat, there
is convincing evidence that reaginic antibody is produced in association with certain
disease states.
Reaginic antibody has been characterised in many species including the dog (Halli¬
well et al., 1972). IgE antibodies in animals share many physicochemical properties with
IgE antibody of man. They are characterised by a relatively fast electrophoretic mobility,
a sedimentation coefficient of approximately 8 S, a molecular weight of approximately
200000 Da, the capacity to fix to tissue following injection for > 3 weeks and a high
sensitivity to heat and reducing agents (Halliwell et al., 1972).
Several studies have already shown that cat serum contains a protein with IgE-like
properties (Walton et al., 1968; Powell et al., 1980; De Boer et al., 1993; Baldwin et al.,
1993; Foster et al., 1995). Walton et al. (1968) demonstrated the existence of reaginic
antibody to whole milk antigen in a cat with dermatitis and enteritis using Prausnitz-
KUstner (PK) testing. In another study, reaginic antibodies to the ear mite Otodectes
cynotis were demonstrated and are believed to be responsible for the extreme pruritus
that is associated with some cases of parasitic otitis externa (Powell et al., 1980). More
recently, De Boer et al. (1993) showed that cats have a reaginic antibody that is
antigenically cross-reactive with canine IgE and has an apparent molecular weight
similar to that of IgE from other species. Foster et al. (1995) demonstrated that the
passive cutaneous anaphylaxis (PCA) reactivity was eluted following chromatography
using Sephadex G200 in a position similar to that of other species, and that feline
reaginic antibodies are bound by protein A. The latter author used PCA in which the
antigen is injected intravenously as opposed to the PK test in which the antigen is
injected intradermally.
The existence of myelomas have permitted the ready purification of IgE for the
subsequent production of monoclonal antibodies in man (Johansson and Bennich, 1967),
and the rat and the mouse (Bazin et al., 1974; Bottcher and Hammerling, 1978).
However, in the cat, the lack of myelomas secreting IgE, the presumably low level of
serum IgE and the small amount of serum obtainable make the isolation of IgE very
difficult.
The further characterisation of feline IgE and the development of specific antisera are
prerequisites for the elucidation of the role of IgE and of immediate type hypersensi¬
tivity in a number of common feline diseases. The goal of this study was thus to produce
polyclonal antisera against the immunoglobulin to permit quantification of total and
allergen-specific feline IgE in diseases which may involve immediate-type hypersensi¬
tivity.
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2. Materials and methods
2.1. Experimental animals
Infected and normal cats were obtained from a colony of experimental cats at the
University of Liege (Belgium).
Normal adult (ex-breeder) parasite-free cats for PK tests and reversed cutaneous
anaphylaxis (RCA) were obtained from Hill Grove Family Farm (Oxford, UK).
New Zealand white rabbits were obtained from Interfauna UK (Cambridge, UK).
All experimental protocols were in accordance with the requirements of an Animal
Care and Ethics Committee and/or the UK Home Office as appropriate.
2.2. Infection of cats with Toxocara cati
Three 10-month old cats (#5,#6,#7) and three 12 to 16-week old kittens (#1, #2,
#3) were found to be naturally infected with T. cati. All were secreting ova in their
faeces.
Three additional normal 10-week old kittens (#4, #8, #9) were experimentally
infected with T. cati. The eggs were isolated from the faeces of naturally infected cats.
They were washed three times in 1% sodium chloride and centrifuged at 1500 rpm for 5
min. After discarding the final rinse, the eggs were resuspended in 0.5% formalin
(Sigma, Poole, UK) and kept, under oxygen, in a dark room, at 27°C. Infective second
stage larvae were obtained after 3 weeks. The cats were dosed with 10 embryonated ova
daily for 3 days. Development of a patent infection was indicated by the appearance of
the ova in the faeces within 60 to 75 days.
2.3. Ascaris antigens
Purified antigen from Ascaris suum (Asc-1) was purchased from Greer (Lenoir, NC).
Adult T. cati were obtained post mortem from naturally infected cats and antigens
from body fluid were partially purified by gel filtration on Sephadex G100 (Pharmacia,
Uppsala, Sweden) to remove the low molecular weight histamine releasing fractions.
Material from the major protein peak was concentrated.
2.4. Preparation of dinitrophenylated antigen
Asc-1 and bovine serum albumin (BSA) (Sigma) were dinitrophenylated (DNP)
according to the method of Eisen (1964).
2.5. Induction offeline anti-DNP and anti-Ascaris antibodies
Cats were immunised with DNP-Asc in aluminium hydroxide (Imject Alum®; Pierce,
Rockford, IL, USA) in order to induce anti-DNP reaginic antibody as described for the
dog (Schultz and Halliwell, 1985). Each cat received two biweekly injections of 10 pg
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of DNP-Asc subcutaneously over the lateral thorax at two sites on either side of the
body.
2.6. Performance of intradermal skin tests (IDST)
Cats were anaesthetised with 1 mg/kg xylazine (Virbaxyl®, Virbac, Cambridge, UK)
and 10 mg/kg ketamine hydrochloride (Vetalar®, Parke-Davis, Pontypool, Gwent, UK)
intramuscularly. The lateral chest was clipped and 0.05 ml of a solution of 10 pg/m\ of
DNP-BSA was injected intradermally. Phosphate buffered saline (PBS) and 1/100000
w/v solution of histamine phosphate (ARTU Biologicals, Lelystad, Netherlands) were
used as negative and positive controls, respectively. Reactions were scored after 15 to 20
min using a +1 to +4 scale, incorporating both diameter and elevation above the
surface. A + I reaction was just discernibly greater than the PBS wheal, and a +4
reaction approximated the size of the histamine wheal.
2.7. Fractionation of sera
T. crztf-infected cats were bled by jugular venipuncture. Sera were harvested by
centrifugation after clot retraction and were stored at — 30°C.
Sera were fractionated by the same three-step procedure that was employed to
prepare IgE-rich fractions of canine sera (Halliwell et al., 1972). Briefly, serum that
precipitated between 33.33 and 45% saturation with ammonium sulphate was dialysed
against 0.05 M phosphate buffer, pH 8.0, and applied to a column of diethylaminoethyl
cellulose (DEAE; Watman, Maidstone, Kent, UK) equilibrated with the same buffer.
The excluded protein was concentrated and then applied to a three-in-series 4 X 60 cm
column set of Sephacryl S-200 (Pharmacia) and eluted using PBS. The protein eluting
immediately prior to the 7 S peak and the first one third of that peak was pooled and
concentrated using Centripet-10 concentrators (Amicon, Gloucester, UK) as fraction R
(Fr-R).
2.8. Preparation ofpolyclonal antisera to IgE
Three New Zealand white rabbits were immunised with three biweekly injections of
100 to 200 p.g of Fr-R in 1 ml of Freund's complete adjuvant (Sigma) subcutaneously at
four sites.
The resulting antisera were passed over an immunoabsorbent column of Sepharose
4B (Sigma) to which was coupled serum from a parasite-free cat that had been heated to
56°C for 4 h. This was repeated a number of times until no protein was eluted by
glycine-HCl buffer, pH 2.7. This column removed any activity against immuno¬
globulins other than IgE and also against other heat stable serum proteins (Vaerman and
Heremans, 1968).
The antiserum which had the best apparent anti-IgE activity as assessed by reverse
cutaneous anaphylaxis (RCA) (R294-7) was then used to prepare another immunoab¬
sorbent column. A 45% ammonium sulphate precipitate of the antiserum was dissolved
in PBS and then coupled to Sepharose 4B. Protein from sera of parasited cats that bound
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Feline immunoglobulin E: induction of
antigen-specific antibody in normal cats and levels
in spontaneously allergic cats
Department of Veterinary Clinical Studies, Royal (Dick) School of Veterinary Studies, University of
Edinburgh, Summerhall Square, Edinburgh EH9 1QH, Scotland, UK
Sera from 10 cats with symptoms consistent with atopy, from 15 normal household cats and
from 11 laboratory maintained cats were assessed for allergen-specific IgE and IgG to Der-
matophagoides farinae (DF) by enzyme-linked immunosorbent assay (ELISA). In addition, 10
normal cats were immunised with DF and intradermal skin tests (IDST) were performed weekly.
Sera from the latter were also assessed for DF-specific IgE by ELISA and using Prausnitz-Kiistner
(PK) tests. Although DF-specific IgE was detectable in all the atopic cats, there was no significant
difference between the levels in this group and in the clinically normal household cats. However
levels in both these groups were significantly higher than those in the laboratory maintained cats.
Detectable DF-specific IgE was induced in all of the 10 cats, but the levels were not correlated
with the development of positive IDSTs, nor with the level of IgE as assessed by PK tests. These
findings are consistent with a possible heterogeneity of IgE antibody in cats. © 1998 Elsevier
Science B.V. All rights reserved.
Keywords: Immunoglobulin E (IgE); Dermatophagoides farinae (DF); Enzyme-linked immunosorbent assay
(ELISA); Intradermal skin test (IDST); Cat
1. Introduction
Allergic skin disease is a common reason for the presentation of cats to veterinarians.
One important cause is believed to be feline atopy, although an inherited predisposition
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to this disease has not been proved and thus the true designation of atopy in this species
remains uncertain. The existence of reaginic antibody in cats has already been shown by
passive cutaneous anaphylaxis (PCA) tests and by demonstrating heat or mercapto-
ethanol sensitivity (Walton et al., 1968; Powell et ah, 1980; Foster et ah, 1995). Further
evidence was provided by DeBoer et ah (1993) who also demonstrated shared anti¬
genicity between canine immunoglobulin E (IgE) and the feline homologue. Cat bladder
tissue was sensitised with sera from a parasitised cat and contraction noted following
challenge with monoclonal anti-canine IgE antibody. The development of in vitro tests
for the measurement of allergen-specific IgE is thus an important goal as an aid to the
practice of feline dermatology.
Although enzyme-linked immunosorbent assays (ELISAs) are marketed for the
detection of allergen-specific feline IgE, details supporting the specificity of these
antisera have not yet been published in the scientific literature. In a study of one of these
assays, Foster and O'Dair (1993) found that the correlation with intradermal skin tests
was very poor. Both the specificity and the sensitivity of the ELISA as compared with
the intradermal skin test results were low with a positive or negative predictive value of
0.1 and 0.4, respectively.
The previous paper has documented the production of polyclonal antisera that were
adjudged specific for feline IgE (Gilbert and Halliwell, 1997). It was important therefore
to ensure that the antisera could detect IgE antibodies in the sera of cats with symptoms
consistent with atopy and in the sera of normal cats in which allergen specific IgE was
induced experimentally under controlled conditions. As house dust mites are the most
common allergens involved in atopic disease in dogs and cats in Europe (Foster and
O'Dair, 1993; Carlotti and Costargent, 1994; Sture et al., 1995) Dermatophagoides
farinae (DF) was chosen as the antigen. The kinetics of IgE and IgG responses specific
for DF in cats experimentally immunised were followed during the 8 weeks of the study.
2. Materials and methods
2.1. Animals
2.1.1. Clinical study
Serum was collected from 10 cats seen at the Royal (Dick) School of Veterinary
Studies (R(D)SVS) at the University of Edinburgh and at the Faculte de Medecine
Veterinaire, Universite de Liege in Belgium, in which a diagnosis of atopic disease was
made by a combination of compatible clinical signs and positive intradermal skin tests
(IDSTs) to one or more environmental allergens. The mean age of the cats was 6.5 years
(range 3 to 12 years). Six of the cases were spayed females and the 4 males were
castrated. In addition serum was collected from 15 healthy pet cats with no history of
skin disease, presented to the Universite de Liege for routine procedures (negative
control group 1) and from 11 healthy laboratory reared cats (Hill Grove Family Farm,
Oxford, UK) which had presumably never been exposed to significant amounts of DF
allergens (negative control group 2). The mean ages of control group 1 and group 2 were
4.5 years (range 9 months to 13 years) and 9 years (range 4 to 12 years), respectively.
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While all cats from control group 2 were entire females, control group 1 was composed
of 7 females (2 spayed) and 8 males of whom 6 were castrated.
2.1.2. Experimental study
Ten healthy adult cats were obtained from Hill Grove Family Farm (Oxford, UK) and
were used for immunisation with DF.
Five additional healthy adult cats, also from Hill Grove Family Farm, were used as
recipients for Prausnitz-Kiistner (PK) tests.
2.1.3. Antiserum production
New Zealand white rabbits, for antibody production, were obtained from Interfauna
UK (Cambridge, UK).
All experimental protocols were in accordance with the requirements of the UK
Home Office.
2.2. Allergen extracts
Dermatophagoides farinae (DF) extract (1/100 w/v) was purchased from Greer
Laboratories (Lenoir, NC, USA).
Atopic cats were skin tested with a range of 52 additional allergens as described in a
previous study on canine atopic disease (Sture et al., 1995).
2.3. Induction ofDF-specific antibodies in normal cats
Ten parasite free cats were given 3 injections of 50 pg of DF in aluminium
hydroxide (Imject Alum®; Pierce, Rockford, USA) at weeks 0, 2 and 5. Five of the 10
cats were also given, at the same time, 50 pg of Ascaris antigen (Asc-1; Greer
Laboratories) mixed with the DF antigen in the same adjuvant. All cats were bled prior
to immunisation (week 0) and at weekly intervals thereafter for 7 weeks (week 1 to
week 7).
2.4. Performance of IDST
Cats were anaesthetised with 1 mg/kg xylazine (Virbaxyl®, Virbac, Cambridge, UK)
and 10 mg/kg ketamine (Vetalar®, Parke-Davis, Pontypool, Gwent, UK). The lateral
chest was clipped and 0.05 ml of 2 fold dilutions of a 1/1000 w/v dilution of DF
(experimental cats) or of a 1/10000 w/v dilution of DF (clinical cases) and of
appropriate dilutions of the other allergens were injected intradermally. Phosphate
buffered saline (PBS) and a 1/100000 w/v solution of histamine phosphate (ARTU
Biologicals, Lelystad, Netherlands) were used as negative and positive controls, respec¬
tively. Reactions were scored after 15 to 20 min on a +1 to +4 scale, incorporating
both diameter and elevation above the surface. A + 1 reaction was just discernibly
greater than the PBS wheal, and a +4 reaction approximated the size of the histamine
wheal.
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2.5. PK tests
Healthy parasite-free cats were anaesthetised with 10 mg/kg ketamine hydrochloride
intramuscularly and the hair of the lateral chest area was clipped. One-tenth ml of
doubling dilutions from 1/10 of sera from the experimental cats were injected intrader-
mally. Injection sites were challenged 48 h later by intradermal injection of 0.05 ml of a
1/1000 w/v dilution of DF. The antigen and also PBS were injected into unsensitised
sites as negative controls, with a 1 /100 000 w/v injection of histamine phosphate as a
positive control. Skin reactions were recorded 20 min later using a + 1 to +4 scale as in
the IDST. For standardisation of responses between PK tests in different recipient cats, a
reference serum from a cat which had a strong positive skin test to a high dilution of DF
was used in each test.
2.6. Antisera employed
Polyclonal rabbit anti-feline IgE was prepared as described in the previous paper
(Gilbert and Halliwell, 1997). The antiserum was passed through an affinity chromatog¬
raphy column containing DF coupled to cyanogen bromide activated Sepharose 4B
(Pharmacia, Uppsala, Sweden) to remove possible naturally occurring antibodies with
activity against DF.
Goat anti-feline IgG, Fc specific, alkaline phosphatase-conjugated, was obtained from
Bethyl Laboratories (Montgomery, AL, US) for the measurement of DF-specific IgG in
sera from clinical cases.
Rabbit anti-feline IgG, Fc specific, was purchased from Nordic Immunology
(Tilburg, Netherlands) for the detection of DF-specific IgG in sera from experimental
cats.
Monoclonal alkaline phosphatase-conjugated anti-rabbit immunoglobulin was pur¬
chased from Sigma (Poole, UK).
2.7. Enzyme-linked immunosorbent assay (ELISA)
2.7.1. DF-specific IgE
DF-specific IgE in feline sera was assessed by indirect ELISA. Polystyrene microtitre
plates (Immulon 4®, Dynatech Laboratories, Billingshurst, UK) were coated overnight
at 4°C with 100 yul/well of 1/5000 W/V dilution of DF extract in 0.1 M sodium
carbonate buffer, pH 9.6 (coating buffer). Plates were washed three times with washing
buffer which was 0.05% Tween 20 (Sigma) in 0.015 M PBS, pH 7.2 and blocked
overnight at 4°C with 0.05% human serum albumin (HSA) (Sigma) in washing buffer
(150 pi/well). After further washing, 50 p. 1 of each sample diluted in ELISA buffer
(0.05% Tween 20, 0.1% of HSA in 0.015 M PBS, pH 7.2) was added to duplicate wells.
After incubation at 37°C for 2 h and further washing, 50 p\ of the polyclonal anti-feline
IgE diluted in ELISA buffer (1 /50) was added in each well. After incubation for 2 h at
37°C, the plates were washed and 50 p.\ of the alkaline phosphatase-conjugated
monoclonal anti-rabbit immunoglobulin diluted in ELISA buffer (1 /2000) was added to
each well and plates were incubated for a further hour at 37°C. After a last wash, 50 p\
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of alkaline phosphatase substrate, namely 5 mg of PNP substrate tablets (Sigma) in 5.5
ml of MgCl2 in diethanolamine buffer, pH 9.8, was added to each well. Plates were
incubated at 37°C for 30 min and the optical density (OD) at 405 nm read using an
automated microtitre plate reader after subtraction of the mean blank well values.
2.7.2. DF-specific IgG
In the case of the clinical study, a direct ELISA was used for the detection of
DF-specific IgG, whereas in the case of the experimental study, DF-specific IgG was
assayed by indirect ELISA as performed for allergen-specific IgE.
Incubation times were reduced from 2 h to 1 h 30 for the serum samples and from 2 h
to 1 h for both the polyclonal rabbit anti-feline IgG and the alkaline phosphatase-con-
jugated goat anti-feline IgG. Incubation time for the monoclonal mouse anti-rabbit
immunoglobulin was 1 h. Rabbit and goat anti-feline IgG were used at 1 /5000 and
1 /100, respectively. Monoclonal mouse anti-rabbit immunoglobulin was used at 1 /2000.
2.8. Standardisation of results
A serum containing a high level of allergen-specific IgE or IgG antibody was selected
as the standard and assigned a value of 1000 relative antibody units (RAU). Dilutions of
the standard were included in each plate, and the results were recorded in RAU by
reference to the standard curve.
2.9. Statistical analyses
Non-parametric Mann-Whitney test was used in the clinical study to perform the
statistical analysis and to compare the IgE and IgG levels in the atopic cats and the 2
groups of negative control cats. Differences were considered significant at P < 0.05.
Correlation between the IgE and IgG antibody levels were calculated using a
Pearson's rank coefficient correlation. The results were considered statistically signifi¬
cantly different if the probability (P) was less than 0.05.
3. Results
3.1. Validation of the assay
Allergen-specific IgE and IgG were measured in sera before and after heating to 56°C
for 4 h. DF-specific IgE was no longer detected after heating, whereas IgG levels were




All the 10 cats showed a skin reactivity to at least one of the house dust mite (HDM)
and/or house dust (HD) antigens (Table 1). The most common allergens implicated by
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Dilutions
Fig. 1. DF-specific IgE (a, n = 2) and IgG (b) in cat sera before and after heating at 56°C for 4 h (h = sera
after heating). IgE and IgG levels reported as absorbance at 405 nm.
the IDST were DF and HD which both gave positive reactions in 8 cats (Table 1). Six
cats were positive to Dermatophagoides pteronyssinus (DP) and four cats were also
positive to the flea antigen (Table 1). Other allergens to which positive reactions were
seen were Tyrophagus putresceantiae (n = 2), mixed moth (n = 1), cockroach (n = 1),
white ash (n= 1), birch (n = 1), american elm (n — 1), Brassica spp. (n= 1), Chrysan¬
themum spp. (n = 2), red clover (n = 2), Heather (n = 1), Velvet/Yorkshire fog
(n = 1), red top/bent (n = 1), and couch (« = 1).
3.2.2. ELISA results
Although the median level in the atopic cats of both isotypes was higher than that of
control group 1 (457.5 vs. 330 RAU for IgE and 16451 vs. 9860 RAU for IgG) in
neither case was the difference significant (Table 2, Fig. 2a and b). However, in the
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Table 1
Levels of DF-specific IgE and IgG, and IDST results for DF, DP and HD antigens in the 10 atopic cats
Atopic cats IDST DF-specific IgE (RAU) DF-specific IgG (RAU)
DF DP HD
166324 + 3 + 4 + 3 953 295793
165767 neg. neg. + 3 576 15259
166349 + 3 neg. + 2 282 1722
166064 neg. + 1 + 1 657 31170
161640 + 3 neg. neg. 97 14456
165841 + 2 + 1 + 2 447 1317
166735 + 3 neg. + 2 680 5543
8317 + 4 neg. + 3 421 26031
640 + 2 + 2 neg. 327 17644
Noirfa + 3 + 3 + 2 468 21177
control group 2, the median levels (37 RAU for IgE and 343 RAU for IgG) were
significantly lower than in both the atopic cats and control group 1 (/><0.05). The




OD values slightly greater than the blanks were detected in some of the preimmunisa-
tion sera. These values were unchanged after the sera were passed through an im-
munoabsorbant column of DF coupled to Sepharose 4B (data not shown) which implied
non-specific binding. These OD values were therefore subtracted from the results in
each case before expression in RAU following reference to the standard curve.
All cats developed both an IgG and an IgE response to DF following immunisation
(Fig. 4a,b). The kinetics appeared different, in that a detectable IgE response appeared
earlier, and had fallen by week 5 prior to the third immunisation. In contrast, a
detectable IgG antibody response commenced later and rose gradually through the 8
Table 2
Median and range of level of DF-specific IgE and DF-specific IgG in RAU in the atopic, normal household
(control group 1) and laboratory maintained cats (control group 2).
Atopic cats n— 10 Control group 1 n = 15 Control group 2 n = 11
DF-specific IgE
Median 457.5 330 37
Range 97-953 108-478 31-87
DF-specific IgG
Median 16451 9860 343
Range 295493-1317 78-38539 78-8367
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Fig. 3. DF-specific IgE and IgG in RAU in sera from atopic and normal cats. The levels of the two isotypes
are significantly correlated (r = 0.617, P < 0.01).
weeks (Fig. 4a,b). Assessment of both isotypes in all serum samples in each cat did not
reveal a significant correlation between them. However, when all the ELISA values for
DF were considered together, there was a significant correlation between log DF-specific
IgE and IgG antibodies (r = 0.790, P < 0.01), although some samples had very high
IgG and low IgE levels and vice versa (Fig. 5). The 5 cats immunised with DF alone in
alum produced responses that did not differ noticeably from those immunised with both
DF and Asc-1 in alum.
3.3.2. IDST results
The 10 cats immunised with DF were skin tested weekly commencing immediately
prior to the first injection. Assessment of the level of serum DF-specific IgE by ELISA
and of the highest dilution of DF antigen to induce a positive skin test following
intradermal injection revealed some striking anomalies and no correlation. Firstly,
DF-specific IgE was, in general, detectable in sera prior to the time at which the cat
showed positive skin tests. Indeed, 4 cats failed to develop positive skin tests during the
8 weeks of the experiment despite developing some of the highest levels of serum
allergen-specific IgE. In general, strongly positive skin tests to high dilutions of antigen
were always accompanied by high levels of detectable allergen-specific IgE. However
the reverse was not the case. Representative examples of the varying responses are
' shown in Fig. 6a — d).
Fig. 2. The level of DF-specific IgE (a) and DF-specific IgG (b) in RAU in serum from atopic cats, normal pet
cats (control group 1), and laboratory reared cats (control group 2). Bar represents the geometric mean for each
group.





























Fig. 4. Mean and standard error of the DF-specific IgE (a) and DF-specific IgG (b) responses in RAU in 10
cats (I,, I2, I3 = immunisation dates).
Time (weeks)
3.3.3. PK test results
Positive PK tests were only obtained from cats with positive IDSTs and the IDST
reactivity tended to parallel the PK titre. Thus the strongest PK test results were in
general obtained with postimmunisation sera from cats which had strong positive skin
tests to high dilutions of DF (up to 1 /320). On the other hand sera from cats which had
positive IDSTs only to low dilutions of DF, gave either negative or only weakly positive
PK reactions. Furthermore postimmunisation sera from the 4 cats which failed to
develop positive skin tests but had high levels of serum allergen-specific IgE as assessed
by ELISA showed no PK reactivity. On the other hand, allergen-specific IgE was
detected by ELISA in cats which had PK reactivity as well as in cats which had no such
















Log10 DF-specific IgG in RAU
Fig. 5. DF-specific IgE and IgG in RAU in 78 blood samples from cats immunised with DF. The levels of the
two isotypes are significantly correlated (r = 0.790, P < 0.01).
reactivity. In both situations the IgE was heat labile and was not detected by the ELISA
after the serum was heated at 56°C for 4 h. Heating the sera also completely abolished
the PK reactivity.
4. Discussion
One of the classical characteristic properties of reaginic antibody is its sensitivity to
heating (Coca and Cooke, 1923). Ishizaka et al. (1967) observed that reaginic antibody
to ragweed failed to precipitate with monospecific antiserum to IgE after exposure to
56°C for 2 to 4 h. Schwartzman and Rockey (1967) demonstrated that canine reaginic
antibody is comparable to human reaginic antibody in many characteristics including
heat sensitivity. Powell et al. (1980) demonstrated the heat sensitivity of reaginic
antibody in cats. Such treatment does not inactivate other classes of antibody and thus
allows the differentiation between IgE and other isotypes. In the present study, the
complete abolition of detectable allergen-specific IgE in postimmunisation sera heated to
56°C for 4 h demonstrated the specificity of the rabbit anti-feline IgE.
Dermatophagoides farinae is believed to be the most common allergen implicated in
feline atopy. Positive reactions to DF have been reported in 77 to 100% of the atopic
1 cats (Carlotti and Prost, 1988; Foster and O'Dair, 1993; Prost, 1996). The results of the
IDST in the present study were in agreement with other reports, with 80% of the cats
showing positive reactions to DF.
The ELISA has only been introduced recently in the establishment of the diagnosis of
atopic disease in cats (Foster and O'Dair, 1993). The antiserum used in the latter assay
was raised against a chimaeric feline/murine IgE antibody and there is no published
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data supporting its specificity. A comparison of this test with results of IDST, assuming
the latter as the gold standard, showed a poor correlation between the two and it was
concluded that ELISA was unreliable in establishing a diagnosis of feline atopy. In the
present study the IDST also did not always correlate well with the in vitro test. Of the 10
atopic cats, 2 cats were IDST negative to DF but had a high level of DF-specific IgE as
assessed by ELISA whereas one had a very low level of DF-specific IgE but showed a
strong skin reactivity to DF. Although DF antigen at 1/10000 dilution is believed to be
non-irritant, it is possible that it was close to an irritant concentration in one cat and
therefore could have represented a true false positive reaction in this cat. All the normal
w. 0 w. 1 w. 2 w. 3 w. 4 w. 5
h '2 I3
Time (weeks)
w. 0 w. 1 w. 2 w. 3 w. 4 w. 5 w. 6 w. 7
h I2 b
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Fig. 6. The relationship between the DF-specific IgE and IgG (in RAU) and the highest dilution of antigen to
give positive IDST (skin reaction titre) in 4 representative cats immunised with DF: cats U49 (a). B85 (b), A71
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pet cats had detectable levels of DF-specific IgE, and high levels were found in 2 of
them. However the median level of DF-specific IgE in sera from these cats was not
significantly different from the median of that in the atopic cats. But it should also be
emphasised that the normal pet cats were not skin tested and some of the cats may have
had a positive IDST to this antigen, as was recently reported in normal dogs (Lian,
1997). On the other hand, it was also shown in the present study that normal cats may
have allergen-specific IgE without developing skin test reactivity to this antigen. It was
noteworthy that levels of both DF-specific IgE and IgG in the laboratory reared cats
were significantly lower than that in both the other groups.
The fact that not only is DF-specific IgE the most frequently implicated allergen in
feline atopy, but also is found in normal cats is of great interest. It has been suggested in
man that the powerful allergic immune response commonly provoked by HDM could
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result from its ability to cleave the low affinity IgE Fc receptor (CD23) from the surface
of IgE-secreting B cells (Hewitt et al., 1995). This could ablate an important feedback
inhibitory mechanism that normally limits IgE synthesis. Furthermore, fragments of
CD23 released by HDM have been reported to promote IgE production (Sutton and
Gould, 1993).
Injections of Asc-1 together with DF in 5 parasite free cats failed to stimulate a
higher DF-specific IgE than in cats given DF alone. It is well-known that helminths are
particularly adept at stimulating IgE synthesis. Helminth infection has the ability to
produce an increase in non-parasite-specific IgE (Ogilvie, 1964; Zakroff et al., 1989)
and furthermore to potentiate IgE responses to unrelated antigens. They also may
disproportionately elevate serum levels of total non-specific IgE (Jarrett and Bazin,
1974; Turner et al., 1979). Halliwell (1972) showed that subcutaneous injections in dogs
of Ascaris suum antigen alone or coupled to haptens was able not only to stimulate the
production of reagin to haptens to which the antigen was coupled but also to any protein
with which it was simultaneously administered. However the parasite status of the dogs
was not known, although in those days Toxocara canis infection in the dogs was almost
universal. The apparent disparity in the ability of ascaris antigens to stimulate allergen-
specific IgE production in the 2 experiments may thus merely relate to the parasite
status.
The DF-specific IgE response commenced early, being detectable 2 weeks after
immunisation whereas IgG was essentially undetectable until week 3. Furthermore, the
IgE level tended to fall off after the second immunisation whereas the IgG antibody
continued to rise. IgE thus appears to be an early antibody in the cat, as has been shown
in the rat (Tada, 1975). The decrease in DF-specific IgE after 5 weeks, as contrasted
with the IgG response, could, of course merely be reflective of the shorter half-life of
the former isotype, rather than an actual lowering of the production relative to IgG. The
IgE antibody level depends not only on the dose of the antigen and the adjuvant used but
also on the interaction of genetic background and environmental factors (Levine and
Vaz, 1970; Vaz et al., 1971). It has been demonstrated that the IgE response to an
allergen in mice depends on the strain immunised (Levine and Vaz, 1970). The marked
variations of the antibody response seen in these cats are most probably the result of the
genetic differences between them as it was suggested for the outbred dogs in the study
of Schultz and Halliwell (1985).
The level of specific IgG to some aeroallergens has been shown to be higher in cats
with either atopy, food and/or flea allergy than in normal cats or cats with pruritic skin
disease but negative IDSTs (Foster et al., 1997). However this was not so in the case of
HDM-specific IgG levels which were not significantly greater in allergic cats as
compared to normal cats (Foster et al., 1997). In both the clinical and the experimental
studies the levels of DF-specific IgE and IgG were significantly correlated. This is not
suiprising since both isotypes are under the control of a Th-2 type response.
The cats immunised with DF developed no clinical signs of allergy in spite of the
strongly positive IDST developed by some of them. It is possible that this resulted from
the limited exposure to DF in the laboratory conditions. However, the subcutaneous
route used for antigen administration, both for the induction of IgE and for antigen
challenge, is different to the natural disease in which the percutaneous route is believed
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to be responsible for clinical signs (Halliwell, 1990; Olivry et al., 1996). However it is
noteworthy that no species in which IgE was experimentally induced, including man,
have shown any clinical signs of allergic disease (Marsh et al., 1972). This emphasises
the fact that it is not merely the presence of IgE that distinguishes atopic individuals
from normals. It has been suggested that this might be because the reaginic response can
be accompanied by high levels of blocking antibodies (Marsh et al., 1972) but another
reason could be the heterogeneity of the reaginic antibody response as discussed below.
It was also noteworthy that relatively high levels of DF-specific IgE were also found in
sera from some normal cats kept in normal household conditions, and presumably
exposed to HDM antigen.
In the present study, circulating levels of DF-specific IgE did not correlate with
tissue-bound IgE as assessed by IDSTs. In particular, 4 cats with high levels of IgE
never developed a positive IDST. Moreover, it was noteworthy that there was a marked
lack of correlation between the level of IgE as assessed by ELISA and by PK tests.
Also, positive PK tests were never obtained using sera from cats which were IDST
negative, although such sera had high levels of IgE as assessed by ELISA. On the other
hand, sera from the cats which were only IDST positive to a low dilution of DF showed
only a weak PK reactivity whereas sera from cats which had a positive IDST to high
dilutions of DF showed much greater reactivity. It is, of course, possible that the cats
which developed a high level of DF-specific IgE without a positive IDST may have
developed a high level of blocking IgG. However, the level of IgG measured in these
cats was not higher than in the cats with a positive IDST to a high dilution of DF who
showed strong PK reactivity.
It could also be hypothesised that the negative IDST in the face of the positive
ELISAs could be due to a delay in circulating IgE fixing to mast cells. Such a
phenomenon is believed to occur clinically in some cases of canine atopic disease in
which the positive in vitro tests develop weeks or months before a positive IDST.
However this possibility could be excluded as the sera from these cats failed to give
positive PK tests.
The most rational explanation for this finding would be the existence of heterogeneity
of IgE in cats. Theoretically, a number of possibilities exist by which subclasses of IgE
could differ. Firstly, the IgE antibody could be heterogeneous in terms of its ability to
respond to histamine releasing factors (HRF), which are cytokines derived from
macrophages, lymphocytes, mononuclear cells, platelets and vascular endothelial cells. It
has been hypothesised that it is not the production of IgE but, rather the ability of the
IgE to interact with the HRF which differentiates atopics from non atopic individuals
(Lichtenstein, 1988). Thus the type of IgE produced by the cats experimentally
immunised with DF and also that found in normal cats, in contrast to that produced by
atopic cats, may not be reactive with HRF. In cats which become positive to the IDST,
this first IgE antibody response (IgE —) could have been followed by the production
(switching) to the second type of IgE antibody (IgE + ). The cats which stayed negative
to the IDST would never have developed the second IgE isotype and such animals
would have positive ELISA results without positive IDST or PK reactivity. However
HRF's appear to be involved only in the late phase reaction resulting from the activation
of basophils. This reaction is seen in only a subpopulation of allergic individuals
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(MacDonald, 1996). Therefore it is unlikely that, in the present study, the interaction of
IgE with HRF would explain why some of the cats in which DF-specific IgE was
experimentally induced did not develop an immediate response to the IDST.
Secondly, it is possible that the IgE antibody experimentally induced in the normal
cats may be less effective at inducing degranulation, as is the case with IgG homocy-
totropic antibody (Valent and Bettelheim, 1992). It could also be that the IgE experimen¬
tally induced in the normal cats may have a low affinity for mast cell receptors and
therefore not be able to interact with them in order to sensitise mast cells. In a recent
study, Lyczak et al. (1996) demonstrated the existence of 4 human IgE isoforms. They
suggested that this could be an additional possible explanation for the functional
heterogeneity of IgE and that IgE may differ in its primary protein structure as well as
glycosylation. Each isotope may have some unique properties as circulating, cytophilic
immunoglobulins, and may differ in their ability to carry out IgE-mediated functions
through binding to their different receptors (Lyczak et al., 1996). Interestingly, it has
also been shown that the relative levels of mRNAs encoding various isoforms appears to
be altered in allergic and parasitic diseases (Diaz-Sanchez et al.. 1995). These findings
suggest that the existence of more than one type of IgE in cats is not unexpected, and
that the IgE antibody experimentally induced in normal cats may be different from the
IgE produced in allergic cats. Moreover, it is not impossible that the cats which
developed a positive IDST were genetically predetermined to be atopic.
Jackson et al. (1996) studied the leucocyte histamine release in atopic dogs, normal
dogs and artificially sensitised dogs and found comparable results to those found in the
present study, in that histamine release induced by antigen or anti-IgE was generally
found only in atopic dogs. The same concepts could also account for the presence of IgE
in normal cats without clinical disease, although, of course, the latter were not skin
tested.
In conclusion, the present studies showed that normal cats developed a reaginic
antibody response to an environmental allergen (DF) which was readily detected by use
of the polyclonal anti-IgE in an ELISA. This antiserum also detected allergen-specific
IgE in atopic cats and in normal pet cats kept under normal household conditions, but
significantly lower levels were found in laboratory reared cats. In both the experimental
and clinical studies there was a significant overall correlation between allergen-specific
IgE and IgG responses. However, the level of allergen-specific IgE was not correlated
with either skin test or PK reactivity, whereas the positive PK reactivity was generally
correlated with positive skin test reactivity. These results are consistent with the
existence of a heterogeneity of IgE antibodies in cats.
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